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Lacunar stroke accounts for one quarter of all ischaemic stroke and in the long term 
carries a greater risk of death and disability than was previously realised. Much of 
our current knowledge originated from neuropathological studies in the 1950s and 
1960s. In the last thirty years, brain computed tomography (CT) and magnetic 
resonance imaging (MRI) have revolutionised our understanding of lacunar stroke 
and associated features of cerebral small vessel disease (SVD), namely white matter 
lesions (WML), enlarged perivascular spaces (EPVS) and brain microbleeds (BMB). 
The purpose of the projects which led to the writing of this thesis was to improve 
understanding of imaging characteristics of cerebral SVD. We aimed to assess (i) 
clinical and imaging features which might explain misclassification of lacunar 
infarcts as cortical infarcts and vice versa, (ii) the proportion of symptomatic lacunar 
infarcts progressing to lacunar cavities and associations of cavitation, (iii) 
completeness of reporting of lacunar lesions in the lacunar stroke literature, (iv) 
definitions and detection of lacunar lesions amongst SVD researchers, (v) the 
relationship between WML and carotid stenosis, (vi) clinical and imaging 
associations of EPVS and, (vii) observer variability in the assessment of EPVS and 
BMB, in order to develop visual rating scales.  
Section one describes neuroimaging of lacunar stroke. To investigate features which 
might explain clinical stroke subtype misclassification (‘clinical-imaging 
dissociation’), I used data from a stroke study. The main factor associated with 
clinical-imaging dissociation was diabetes, and in patients with acute lacunar 
infarction, proximity of the lacunar infarct to the cortex, age, diabetes and left 
xiii 
hemisphere location. To investigate the proportion of symptomatic lacunar infarcts 
progressing to cavities, I used data from two stroke studies. A fifth of patients with 
acute lacunar ischaemic stroke showed definite cavitation on follow-up imaging at a 
median of 227 days; cavitation was associated with increasing time to follow-up. To 
assess completeness of reporting of lacunar lesions in the lacunar stroke literature, I 
reviewed 50 articles from three journals with a stroke focus. There was marked 
variation in terminology and descriptions of imaging definitions of lacunar lesions. 
To assess lacunar lesion definitions and detection amongst SVD researchers, I used 
an online survey consisting of case-based and non-case-based questions. There was 
marked variation in definitions and descriptions. Cavitated lesions were detected 
with the highest degree of confidence.  
Section two describes neuroimaging of associated features of cerebral SVD. Using 
data from two stroke studies, I examined the relationship between WML and 
ipsilateral carotid artery stenosis. There was no association between carotid stenosis 
and WML. I tested the association of EPVS with WML and lacunar stroke subtype 
using data from a stroke study. Total EPVS were associated with age and deep 
WML; basal ganglia (BG) EPVS were associated with age, centrum semiovale (CS) 
EPVS, cerebral atrophy and lacunar stroke subtype. Quantification of observer 
variability in EPVS rating was assessed on 60 MRI scans selected from a stroke 
study and an ageing cohort. Intrarater agreement was good and interrater agreement 
was moderate. Main reasons for interrater disagreement included the visualisation of 
very small EPVS and the presence of concomitant WML and lacunar lesions. 
Observer variability in BMB rating was quantified using MRI scans from a stroke 
study. Interrater agreement was moderate but improved following modification of the 
xiv 
pilot rating scale (BOMBS; Brain Observer MicroBleed Scale), which had its main 
effect by differentiating ‘certain’ BMB from ‘uncertain’ BMB and BMB ‘mimics’. 
In conclusion, neuroimaging, particularly MRI, is a valuable tool for the 
investigation of lacunar stroke and associated features of cerebral SVD. With recent 
technological advances in both CT and MRI, neuroimaging will remain central to 
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Chapter 1 Introduction   1 
Chapter 1. Introduction  
1.1. The burden of stroke  
Stroke is a major cause of death and disability. It is the third commonest cause of 
death worldwide after coronary heart disease and all cancers combined (Lopez et al. 
2006), causing an estimated 5.7 million deaths in 2005, 87% of which were in low- 
and middle-income countries. Without intervention, the number of global deaths 
from stroke is predicted to rise to 6.5 million in 2015 and to 7.8 million in 2030 
(Strong et al. 2007). Stroke is also a leading cause of disability (Lopez et al. 2006, 
Strong et al. 2007) and is the most important single cause of severe disability in 
people living in their own homes in the UK, costing the NHS and the economy 
approximately £7 billion per year, and accounting for about 6% of NHS and Social 
Services expenditure (Martin et al. 1988, National Audit Office 2005, Rothwell 
2001).  
1.2. Pathological types of stroke  
Once stroke mimics (e.g. infection, neoplasm) have been excluded and a clinical 
diagnosis of stroke has been made, it is important to determine whether the stroke is 
due to cerebral ischaemia or haemorrhage. Approximately 80% of all strokes are due 
to cerebral ischaemia, and about a fifth to haemorrhage, which may be either 
parenchymal (15%) or subarachnoid (5%) in location (Feigin et al. 2003, Sudlow and 
Warlow 1997). The presence or absence of haemorrhage is most easily assessed on 
brain computed tomography (CT), although sensitivity for detection of haemorrhage 
may vary with stroke type and timing of imaging (Keir et al. 2002, Wardlaw et al. 
2003a). 
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1.3. Classification of ischaemic stroke subtypes: large vs small 
vessel disease  
In ischaemic stroke, the underlying cause is atherothromboembolic in approximately 
half of cases (originating in the extracranial neck vessels in most cases), cardiogenic 
emboli in 20% and small vessel disease (SVD) in approximately 25% (Warlow et al. 
2003). Amongst the several classification systems currently used to categorise 
patients into large or small vessel disease (Amarenco et al. 2009), some use clinical 
assessment alone and are risk factor-free (Bamford et al. 1991), whilst others use a 
combination of clinical assessment, risk factors and investigations, and are therefore 
risk factor-based (Adams et al. 1993). Classification into ischaemic stroke subtypes 
helps guide patient management in day-to-day clinical practice but is also important 
for categorising patients in aetiological, epidemiological and pathophysiological 
studies.  
1.4. The burden of lacunar stroke  
Until recently, there has been relative neglect of small vessel lacunar stroke (once 
considered the most benign ischaemic stroke subtype), with attention having been 
mainly focussed on large artery cortical ischaemic stroke. This trend is reflected in 
the advances which have been made in therapeutic options for stroke, which are 
primarily concerned with large artery stroke. However, although the prognosis of 
small vessel stroke is more favourable (in terms of survival and disability) than large 
vessel ischaemic stroke during the first few years, in the long term, there is a greater 
risk of death, stroke recurrence, cognitive dysfunction and dementia than previously 
realised (Norrving 2003, Norrving 2008) and a similar loss of quality-adjusted life 
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expectancy compared to large artery stroke (Lee et al. 2010). Despite an increased 
focus on the causes and associations of cerebral small vessel disease in recent years, 
the exact mechanisms underlying lacunar stroke remain unclear, with proposed 
mechanisms including lipohyalinosis, arteriosclerosis, poor cerebral blood flow, 
vasospasm and abnormal endothelial function (Wardlaw et al. 2009). Acute 
treatment and secondary prevention of ischaemic stroke is therefore currently similar 
across all stroke subtypes.  
1.5. Lacunar infarction  
The term ‘lacune’ derives from the Latin lacuna, meaning a tiny hole, pit or cavity. 
The lacunar hypothesis suggests that symptomatic lacunar infarcts usually present 
with specific lacunar syndromes and usually are caused by a distinct vasculopathy of 
the small perforating arteries (Bamford and Warlow 1988; Figure 1). Five classic 
lacunar syndromes (pure motor hemiparesis, pure sensory stroke, sensorimotor stroke 
ataxic hemiparesis, dysarthria-clumsy hand syndrome and atypical lacunar 
syndrome; Boiten and Lodder 1991) have been described, although several other 
syndromes exist. Most of our current knowledge about lacunar infarction originates 
from the seminal clinicopathological studies of Miller Fisher in the 1950s and 1960s, 
who defined lacunes as ‘infarcts caused by occlusion of small perforating arteries’ 
(Fisher 1982). Neuropathological descriptions of lacunar lesions have subsequently 
been translated to imaging and defined as ‘small, deep lesions measuring ≤20 mm (or 
≤15 mm in some studies) located in the BG, thalamus, internal capsule, corona 
radiata and brainstem, resulting from occlusion of a single perforating artery’ (Fisher 
1991, Lammie 2000). However, clinicopathological studies in lacunar stroke are few 
in number due to the low early case fatality rate with most neuropathological 
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material being examined after clinical symptoms have occurred (Fisher 1969, Fisher 
1979).  
1.6. Imaging in stroke  
In the 1970s, CT revolutionised brain imaging and made indirect imaging techniques, 
such as ventriculography, obsolete. The original EMI (Electric and Musical 
Industries Ltd.) scanner took 6 minutes to perform one slice and 20 minutes to 
reconstruct the image; with current multislice scanners, an unenhanced CT brain can 
be performed in only a few seconds and images reconstructed in minutes. Magnetic 
resonance imaging (MRI) was first used as a clinical tool in the early 1980s. A 
routine structural MR brain examination for stroke commonly consists of multiple 
sequences including T1- and either T2-weighted or fluid attenuated inversion 
recovery (FLAIR) imaging, diffusion-weighted imaging (DWI) and gradient echo 
(GRE, or T2*) imaging. For cooperative patients, this is normally performed in less 
than half an hour. Whilst MR is considered equivalent to CT for the detection of 
acute haemorrhage and superior to CT for the detection of ischaemia, CT remains the 
mainstay of routine imaging in patients presenting with possible stroke and is quick 
and easy to perform (Wardlaw et al. 2006). There are several constraints to MRI 
scanning in acute stroke, including the problem of restless and sick patients (Hand et 
al. 2005); however, those with mild stroke (lacunar or cortical) are more able to 
cooperate meaning a much larger proportion can be scanned (Wardlaw et al. 2003a). 
GRE and susceptibility-weighted MRI may be particularly useful in detecting 
haemorrhage in patients who present several days to weeks after symptom onset, 
when the distinguishing signs on CT will have gone. 
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The recent search for improvements in diagnostic and therapeutic strategies for 
patients with acute ischaemic stroke, and in particular large artery stroke, has been 
paralleled by rapid development in CT and MRI technology (Warach and Wardlaw 
et al. 2006) and it is now possible (using CT and/or MRI) to detect not only 
ischaemia and haemorrhage, but also vascular occlusion and ‘tissue at risk’ 
(ischaemic penumbra) in the same sitting by means of angiographic and perfusion 
techniques, respectively. The role of CT perfusion imaging in day-to-day clinical 
practice, particularly in terms of improved diagnostic accuracy (Lin et al. 2009, 
Wintermark et al. 2005), outcome prediction (Parsons et al. 2005), identification of 
penumbral tissue (Murphy et al. 2006, Wintermark et al. 2005) and thresholds of 
tissue viability (Bandera et al. 2006), has yet to be fully established, as have the roles 
of CT angiography (Ritter et al. 2006) and MR perfusion imaging (Kane et al. 2007, 
Ritter et al. 2006, Warach 2003). 
In patients with suspected lacunar stroke, MRI is particularly useful compared to CT 
due to its greater sensitivity for detecting small lesions (Chalela et al. 2007; Figure 
2); however, without DWI, many acute lacunar infarcts may not be detected, 
particularly in the presence of concomitant white matter lesions (WML). 
1.7. The spectrum of cerebral small vessel disease 
Lacunar infarction may be one manifestation of a spectrum of radiological markers 
of cerebral small vessel disease. Since the initial recognition of WML on cross 
sectional imaging, their aetiology, clinical associations and prognostic importance 
have been the focus of much research. WML are associated with increasing age, 
hypertension and lacunar stroke (Basile et al. 2006, De Leeuw et al. 2001, Fazekas et 
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al. 1988, Longstreth et al. 1996, Romero et al. 2009) and are also a marker of poor 
prognosis, particularly in terms of increased mortality and risk of dementia (Inzitari 
et al. 1997, Prins et al. 2004). Quantification of WML using visual and automated 
methods (Fazekas et al. 1987, Kappeller et al. 2003, Scheltens et al. 1993, Wahlund 
et al. 2001) has been central to their investigation.  
Increasing use of MRI, including newer sequences such as GRE, or T2* imaging, has 
led to the increasing recognition of two other possible imaging markers of 
microangiopathy: enlarged perivascular spaces (EPVS) and brain microbleeds 
(BMB). EPVS (Virchow-Robin spaces) are cerebrospinal fluid (CSF)-filled cavities 
that surround the walls of vessels as they course from the subarachnoid space 
through the brain parenchyma (Kwee and Kwee 2007) and are best seen on T2-
weighted imaging (T2WI) (Figure 3). EPVS are seen in normal individuals at all 
ages, but are found in increased numbers with age and have been associated with 
cerebral autosomal dominant arteriopathy with subcortical infarction and 
leukoencephalopathy (CADASIL; Cumurciuc et al. 2006), impaired cognitive 
function (MacLullich et al. 2004), dementia (Patankar et al. 2005), depression 
(Patankar et al. 2007), impaired cognition in diabetics (Ferguson et al. 2003), 
multiple sclerosis (Wuerfel et al. 2008) and more recently, with lacunar ischaemic 
stroke and WML (Doubal et al. 2010). BMB, first described in the mid-1990s (Chan 
et al. 1996, Greenberg et al. 1996, Offenbacher et al. 1996) and best seen on GRE 
sequences as small, homogeneous, round foci of hypointensity, are found in 5% of 
healthy adults, 34% of people with ischaemic stroke and 60% of those with non-
traumatic intracerebral haemorrhage (Cordonnier et al. 2007; Figure 3). Extensive 
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studies are currently ongoing to determine the prognostic utility of BMB and whether 
or not they should influence treatment (Lovelock et al. 2010). 
1.8. Unanswered questions 
1.8.1. Clinical misclassification of lacunar stroke  
Up to a fifth of lacunar infarcts are misdiagnosed as cortical infarcts clinically and 
vice versa (Potter et al. 2010a). The reasons for this are unclear, but there are 
important implications for categorising patients into aetiologic and prognostic 
subgroups in clinical practice and in studies of lacunar stroke. Research studies 
relying on clinical assessment alone to assign stroke subtype without radiological 
assessment – as is the case in large proportions of patients in epidemiological studies 
- may incorporate ‘noise’ from misclassification of lacunar stroke as cortical stroke 
and vice versa. The influence of lacunar infarct site, as well as other patient- and 
imaging-related factors, on stroke subtype misclassification, have not been assessed, 
but are important for further understanding of pathophysiology and avoidance of 
misclassification of lacunar stroke in other research. 
1.8.2. Detection and definitions of lacunar-related lesions and the long-term 
appearances of symptomatic lacunar infarction  
Despite the rapid accumulation of imaging studies of lacunar stroke since the 
introduction of cross sectional brain imaging, there remain uncertainties regarding 
the aetiology of lacunar infarction. Some of these uncertainties may have arisen from 
variation in lacunar lesion definitions and the imaging sequences used for diagnosis, 
as well as from difficulties in lacunar lesion detection, in part due to overlapping 
appearances of imaging markers of SVD. Lacunes, or CSF-containing cavities, are 
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often counted in epidemiological studies as old lacunar infarcts (Vermeer et al. 
2007), but so far, the proportion of symptomatic lacunar infarcts progressing to 
lacunes has not been assessed; therefore many lacunes may be counted in error as 
lacunar infarcts and many true lacunar infarcts may never be counted if they do not 
cavitate. Clarification is required to make progress in understanding in lacunar 
disease. 
1.8.3. The association between white matter lesions and carotid stenosis 
As with lacunar stroke, the precise cause of WML is unclear. If lacunar stroke and 
associated features such as WML are primarily embolic in origin, more WML would 
be expected to occur distal to an embolic source such as a tight carotid stenosis. 
However, it is difficult to use lacunar stroke to look for an association with emboli 
because lacunar lesions are infrequent and several patients have more than one 
possible cause of stroke. Whilst several studies have assessed in various ways the 
relationship between carotid stenosis and WML, no studies have assessed the 
specific relationship between carotid stenosis asymmetry and asymmetric WML. 
1.8.4. Associations of enlarged perivascular spaces 
The pathophysiology and associations of EPVS are uncertain at present. They are not 
included in any classification of WML. Although several associations of EPVS are 
now beginning to emerge, the association between EPVS and lacunar stroke or WML 
has been addressed in only two previous studies (Adachi et al. 2000, Doubal et al. 
2010). Progress is hampered by a lack of reliable methods of quantification, either by 
visual rating or by automated assessment. 
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1.8.5. Quantification of enlarged perivascular spaces and brain mircobleeds 
Validated scales for assessing radiological features of cerebral SVD are important in 
helping to minimise interobserver variation, enable cross-comparison between 
studies, for use in analyses of associated clinical or other variables and to facilitate 
metaanalysis. Compared to the radiological assessment of WML, there is a relative 
lack of validated methods for quantifying both EPVS and BMB at present.  
1.9. Aims of the thesis  
Section one: Lacunar stroke and lacunar-related lesions 
(1) To assess clinical and imaging features that might explain clinical 
misclassification of lacunar infarcts as cortical infarcts and vice versa, including 
the influence of lacunar lesion site.  
(2) To assess the proportion of symptomatic lacunar infarcts which progress to 
cavities and to assess patient-related, stroke-related, and imaging-related 
associations of the cavitation process. 
(3) To assess completeness of reporting of lacunar-related lesions in the lacunar 
stroke literature, including a range of related methodological features. 
(4) To assess definitions and detection of lacunar-related lesions amongst 
researchers with an interest in cerebral SVD.  
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Section two: Associated features of cerebral small vessel disease 
(5) To review the existing literature on the relationship between carotid stenosis and 
WML and to assess specifically the relationship between carotid stenosis and 
ipsilateral WML while controlling for the contralateral stenosis/WML. 
(6) To validate clinical and imaging associations of EPVS in a large, prospective 
ischaemic stroke cohort, including the association between EPVS and other 
features of cerebral SVD. 
(7) To review existing methods for quantifying EPVS, to develop an improved 
visual EPVS rating scale, and to quantify intra- and interrater agreement in the 
assessment of EPVS on structural brain MRI.  
(8) To develop a visual BMB rating scale and to quantify interrater agreement in the 
visual assessment of BMB.  
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1.10. Figures 
Figure 1 (A) Diagrammatic representation of the likely vascular process underlying lacunar 
infarction. One of the lenticulostriate arteries is occluded (dashed line), causing an infarction 
in the internal capsule. (B) Post-mortem demonstration of the deep perforating 
(lenticulostriate) arteries arising from the main stem of the middle cerebral artery (arrow).  
 
Reproduced from Warlow CP, van Gijn J, Dennis M, Wardlaw J, Bamford J, Hankey G, 
Sandercock P, Rinkel G, Langhorne P, Sudlow C, Rothwell P, eds. Stroke: Practical 
Management, 3
rd
 edition, Chapter 4, pp146 & 148, by permission of Wiley InterScience. 
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Figure 2 MRI appearances of acute lacunar infarction 
Axial MRI brain showing an acute lacunar infarct (arrows) in the left corona radiata on 
FLAIR (A), T2WI (B) and diffusion-weighted imaging (C). This lesion was hypointense on 
the corresponding apparent diffusion coefficient map (not shown). The block arrow indicates 
a probable enlarged perivascular space, with a surrounding FLAIR-hyperintense rim, 
adjacent to periventricular white matter lesions. 
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Figure 3 Axial brain MRI showing enlarged perivascular spaces (EPVS) and brain 
microbleeds (BMB) 
(A) Magnified T2WI showing EPVS (arrowheads) in the three major anatomical locations: 
centrum semiovale, basal ganglia and midbrain. (B) Gradient echo imaging showing a ‘true’ 
microbleed in the right thalamus (arrow, left image). Solitary foci of hypointensity in the 
basal ganglia (arrow, right image), probably due to basal ganglia mineralisation, are 
common, and should be interpreted with caution. 
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Section one Neuroimaging of lacunar stroke 
 
Chapter 2. Associations of clinical stroke misclassification (‘clinical-
imaging dissociation’) in acute ischaemic stroke  
2.1. Introduction 
Classification of acute ischaemic stroke subtypes is important for categorising 
patients into aetiologic and prognostic subgroups in clinical trials, epidemiological 
and pathophysiological studies and may help guide patient management in clinical 
practice (Amarenco et al. 2009). Although it is well established that infarcts in 
particular locations are associated with specific neurological symptoms, clinical 
diagnosis of stroke lesion location may be difficult in the acute setting when the 
patient’s neurological status may be unstable, meaning that a proportion of patients 
with acute ischaemic stroke will be incorrectly subtyped based on clinical assessment 
alone.  
The Oxford Community Stroke Project (OCSP) clinical classification categorises 
patients based on clinical assessment alone into those with a lacunar syndrome 
(LACS), a partial anterior circulation syndrome (PACS), a total anterior circulation 
syndrome (TACS) or a posterior circulation syndrome (POCS) (Bamford et al. 
1991). PACS and TACS both indicate cortical stroke syndromes. The OCSP 
classification can predict correctly the site and size of cerebral infarct, if visible, on 
CT or magnetic resonance (MR) brain imaging in about three quarters of patients 
(Mead et al. 2000). However, numerous studies demonstrate that about a fifth of 
patients with a cortical syndrome clinically have an acute lacunar infarct on imaging 
that accounts for their recent stroke symptoms; similarly some patients with a lacunar 
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syndrome clinically have an acute cortical infarct on brain imaging that accounts for 
their recent stroke symptoms (Al-Buhairi et al. 1998, Allder et al. 2003, Anderson et 
al. 1994, Ay et al. 1999, Kobayashi 2009, Lindgren et al. 2000, Lodder et al. 1994, 
Mead et al. 1999, Pittock et al. 2003, Seifert et al. 2005, Wessels et al. 2005, Wlodek 
et al. 2004), creating a ‘clinical-imaging dissociation’ (Table 2.2). This dissociation 
is important because epidemiological studies, primary treatment and secondary 
prevention trials in stroke have so far relied heavily on clinical classification so are 
likely to have incorporated ‘noise’ due to approximately one fifth of LACS and 
PACS patients being misclassified.  
Several factors may contribute to clinical-imaging dissociation. Previous studies 
suggested that the side of brain affected by stroke (Mead et al. 2000), leukoaraiosis 
(Lodder et al. 1994), clinical severity (Allder et al. 2003, Lodder et al. 1994) and 
asymptomatic infarcts on imaging (Lodder et al. 1994) were associated with clinical-
imaging dissociation. Other contributing factors have not been assessed. Delays in 
clinical assessment may allow neurological signs to resolve making an accurate 
history difficult to obtain (e.g. dysarthria and dysphasia can be difficult to distinguish 
on history alone); clinical examination may be insensitive to some subtle cortical 
signs (e.g. mild inattention) which would distinguish PACS from LACS. However 
the one previous study that examined delay to diagnosis did not find any association 
with clinical-imaging dissociation (Mead et al. 2000). Reliability of classification is 
affected by observer expertise in use of the OCSP classification, particularly in minor 
stroke (Selvarajah et al. 2009). Clinical-imaging dissociation may also arise when 
there is failure of brain imaging to ascertain relevant ischaemic lesions, either 
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because the imaging is relatively insensitive to small acute lesions (Chalela et al. 
2007) or is performed too late to identify the acute lesion reliably.  
2.2. Aims 
Small subcortical infarcts are considered to cause their symptoms because their 
location in the subcortical white matter or BG effectively disconnects a larger section 
of cortex than is affected by an equivalent-sized lesion in the cortex (Figure 4). We 
hypothesised that a small subcortical infarct lying close to the cerebral cortex could 
mimic symptoms of a mild cortical syndrome (PACS) by causing functional 
disconnection of only a small area of cortex compared to one of the same size lying 
in the periventricular white matter or BG which would disconnect a larger area of 
cortex. We also considered that other factors, such as previous stroke, could increase 
the proportion with clinical-imaging dissociation, as residual features of a previous 
stroke could make interpretation of features due to the acute stroke difficult, and that 
common stroke risk factors might influence symptomatology. 
2.3. Methods 
2.3.1. Patient recruitment 
We included patients from the Edinburgh Stroke Study (ESS), a prospectively-
collected hospital-based stroke register of consecutive stroke and transient ischaemic 
attack (TIA) patients seen at a large academic teaching hospital between April 2002 
and May 2005 (http://www.dcn.ed.ac.uk/ess/) (Jackson et al. 2009). In the present 
study we included only those patients who underwent MRI brain. We performed MR 
when time from stroke onset was greater than 5-7 days or uncertain, if there was 
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clinical uncertainty about the definite diagnosis of stroke (particularly in patients 
with prior stroke) or of the vascular territory involved (carotid or vertebrobasilar), if 
there was a potential underlying cause of stroke that required further investigation by 
advanced brain imaging, or if the patient was suitable for inclusion into other studies 
of large artery or subcortical stroke requiring brain MR. The ESS was approved by 
the Local Research Ethics Committee and all patients (or their relatives) gave written 
informed consent. 
2.3.2. Clinical assessment 
All patients were assessed by an experienced stroke physician who took a detailed 
history, performed a general and neurological examination and recorded the National 
Institutes of Health Stroke Scale (NIHSS) score (Appendices 1, 2). Patients were 
assigned a clinical subtype according to the OCSP classification based on the 
maximum stroke deficit. Lacunar and mild cortical syndromes (LACS and PACS, 
respectively) were defined according to the OCSP classification (Bamford et al. 
1991). LACS was defined as one of the classical lacunar syndromes - i.e. pure motor 
weakness and/or sensory loss of face and arm, arm and leg or all three; or ataxic 
hemiparesis (ipsilateral corticospinal and cerebellar-like dysfunction without other 
features clearly localising to the posterior circulation, including dysarthria-clumsy 
hand syndrome and homolateral ataxia and crural paresis) - in the absence of visual 
field defect or higher cerebral dysfunction. In patients with faciobrachial or 
brachiocrural motor and/or sensory deficits, only involvement of the whole limb was 
considered acceptable for LACS; patients with involvement of less than the whole 
limb were classified as PACS. Mild cortical stroke syndrome (PACS) was defined as 
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a maximum clinical deficit of either: weakness or sensory loss in the face, arm or leg; 
loss of higher cerebral function (e.g. dysphasia or neglect); or weakness in more than 
one limb in the presence of loss of higher cerebral dysfunction or homonymous 
hemianopia. Isolated homonymous hemianopia was classified as a POCS (Bamford 
et al. 1991), a relatively crude grouping of posterior circulation cortical and lacunar 
lesions with clinical consequences which are generally less predictable because of 
the greater frequency of developmental vascular anomalies and greater variability of 
the territory supplied by individual arteries.  
2.3.3. Investigations and assessment of risk factors 
All patients had MRI including DWI, carotid Doppler ultrasound,
 
electrocardiogram, 
blood tests and other investigations as indicated. We recorded risk factors including 
diabetes mellitus (defined as having a previous diagnosis of, or being on current 
medication for, diabetes),
 
hypertension (defined as having a history of hypertension 
requiring medication) and prior history of stroke (i.e. clinical presentation with 
stroke).  
2.3.4. Brain imaging 
Patients underwent 1.5T MRI (GE Signa LX EchoSpeed scanner, Milwaukee, WI, 
USA). We collected sets of axial diffusion-weighted-echo planar images 
(sensitisation levels b=0 and 1000 s/mm
2
) with diffusion gradients applied 
sequentially along 6 non-collinear directions (5 acquisitions including baseline 
T2WI-EP image and 6 diffusion-weighted echo planar images per slice position) 
with 5mm slice thickness, 1mm slice gap, 128 x 128 image matrix and 24 x 24 field 
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of view. Other MR parameters are shown in Table 2.1. Images were reviewed by a 
neuroradiologist (GMP), blinded to all clinical details. 
2.3.5. Imaging classification 
Location and size of recent infarcts were recorded (Appendix 1). Recent infarcts 
were defined as hyperintense on DWI, hypointense on the apparent diffusion 
coefficient map and either normal or hyperintense to normal brain on FLAIR/T2WI 
(less hyperintense than cerebrospinal fluid on T2). Lacunar infarcts were defined as 
round or ovoid lesions measuring ≤20mm in maximal diameter in the white matter, 
BG or brainstem. Proximity to cortex of recent lacunar infarcts was noted on any 
sequence on which the infarct was visible. We defined ‘close to cortex’ as the edge 
of the infarct lying within 2mm of the cortical margin in the white matter. Infarcts 
were defined as cortical where there was a typical configuration with involvement of 
cortex ± adjacent white matter, and striatocapsular where located in the BG or CS 
and measuring ≥20mm. Uncertain lesions were checked with a second 
neuroradiologist (JMW). A lacunar infarct was considered ‘appropriate’ in patients 
presenting with LACS; a lacunar infarct in the brainstem or thalamus, i.e. in the 
vertebrobasilar territory, was also considered ‘appropriate’ to a POCS. A small- or 
medium-sized cortical infarct was considered ‘appropriate’ in PACS. We also 
recorded white matter hyperintensities (WMH) (0-3 on the Fazekas scale (Fazekas et 
al. 1987); old strokes using all sequences; EPVS (defined as ≤2mm round or linear 
CSF-isointense lesions along the course of penetrating arteries, T2-hyperintense and 
T1/FLAIR-hypointense) in the BG and CS (0-4 on a local scale, where 0=none and 
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4=>40 (MacLullich et al. 2004); and atrophy (0-3 on a validated scale, where 0=none 
and 3=severe (Farrell et al. 2009). 
2.3.6. Analysis 
We assessed the statistical significance of differences in baseline characteristics and 
brain imaging features using Student’s t-test for continuous variables, the Mann-
Whitney test for non-normally distributed continuous variables and the χ
2 
test for 
dichotomous variables. We performed multivariable analyses using logistic 
regression to determine independent factors for clinical-imaging dissociation. In the 
logistic regression model we included all variables from univariate analysis and 
obtained adjusted odds ratios (OR) (comparing patients with clinical-imaging 
dissociation versus those without) and 95% confidence intervals (CIs). We 
dichotomised scores for WMH (0-1 vs 2-3), brain tissue loss (0-1 vs 2-3) and EPVS 
(0-1 vs 2-4) due to low frequencies. We performed analyses using Minitab Statistical 
Software Version 15 (Minitab, Inc., State College, PA, USA).  
2.4. Results  
Amongst the 1311 acute ischaemic stroke patients recruited to the ESS, 313 
underwent MR brain imaging, of whom 136 (43%) presented clinically with a PACS, 
79 (25%) with a LACS, 24 (8%) with a TACS, 64 (21%) with a POCS and 10 (3%) 
with an uncertain OCSP classification (Figure 5). Ninety-three out of 136 (68%) 
patients with PACS and 44/79 (56%) patients with LACS had a diffusion-positive 
infarct relevant to the clinical presentation (Figure 5). Six (4%) patients with PACS 
and three (4%) LACS in whom DWI was normal had lesions on other sequences as 
the likely cause of symptoms. Patients undergoing MRI were slightly younger when 
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compared with the 1311 ischaemic stroke patients from which we identified our 
study population, with a higher proportion of males and a lower prevalence of 
diabetes but the proportion of PACS and LACS were similar (Table 2.2). 
Sixty-nine (74%) patients presenting with a PACS had an acute cortical infarct (all 
small or medium-sized and considered appropriate to clinical syndrome) (Figure 5), 
21 (23%) had an acute lacunar infarct (Figure 5) and three (3%) had a cerebellar 
infarct on DWI. Of patients presenting with a LACS, 37/44 (84%) had an acute 
lacunar infarct and seven (16%) had an acute cortical infarct. Most acute lacunar 
infarcts identified on DWI in patients presenting with a LACS or a PACS were 
located in the CS (18/37 LACS, 20/21 PACS). Amongst patients with an acute 
infarct on DWI, 65/138 (47%) patients had old infarcts on imaging, the median 
WMH score was 1.62 (range 0-3) and the median EPVS score was 2 (range 0-4).  
In the cohort of 137 patients with PACS and LACS and an acute infarct on DWI, 
clinical-imaging dissociation was associated on univariate analysis with diabetes 
(p=0.001), increasing time from onset of stroke symptoms to MRI (p=0.05), EPVS 
(p=0.02) and old stroke lesions on brain imaging (p=0.02), but not with age (p=0.69), 
history of previous stroke (p=0.08), brain tissue loss (p=1.0) or WMH (0.12; Table 
2.4). On multivariate analysis, diabetes (OR 7.12, 95% CI 1.86 to 27.2; p=0.004) was 
independently associated with clinical-imaging dissociation (Table 2.4).  
Multiple acute infarcts were not associated with clinical-imaging dissociation either: 
amongst 44 LACS, five (11%) had multiple DWI-positive infarcts (all lacunar 
lesions) and none had clinical-imaging dissociation. Amongst 93 PACS, 15 (16%) 
had multiple DWI-positive infarcts, of whom two (13%) had clinical-imaging 
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dissociation (all multiple lacunar infarcts) and 13 (87%) were correctly associated 
(showing multiple cortical, or cortical plus cerebellar, infarcts; Figure 5). 
We examined characteristics associated with a lacunar infarct causing a PACS 
clinical syndrome in all 72 patients with an acute lacunar infarct on DWI; 37 (51%) 
patients presented with LACS, 21 (29%) with PACS, and 14 (20%) with POCS 
(Table 2.5). Lacunar infarcts in POCS patients were located (appropriate to 
symptoms) in the posterior circulation territory (12 brainstem, 1 thalamus, 1 posterior 
borderzone) and were therefore not considered to have clinical-imaging dissociation. 
Clinical-imaging dissociation was associated in univariate analyses with increasing 
age (p=0.03), hypertension (0.004), increasing delay from symptom onset to clinical 
examination (p=0.001) and to MRI (p=0.04) and infarct positioned close to cortex 
(p=0.001) (Table 2.5). In multivariate analysis, closeness to cortex (OR 14.5, 95% CI 
1.61 to 130.1; p=0.02) and older age (OR 1.16, 95% CI 1.0 to 1.30; p=0.01) 
remained independently associated with clinical-imaging dissociation; diabetes (OR 
17.1, 95% CI 1.49 to 195.16; p=0.02) and left-hemispheric location (OR 8.95, 95% 
CI 1.23 to 64.99; p=0.03) were also independent associates (Table 2.5). There was no 
difference in the size of the lacunar infarcts between those causing PACS and those 
causing LACS clinical syndromes (mean 11.7 ± 3.4 versus 10.8 ± 4.3mm; p=0.32, 
nor in the size of those lacunar infarcts that were close to cortex and caused a PACS 
(n=16) or a LACS (n=15) (mean 12.3 ± 5.3mm versus 12 ± 3.7mm; p=0.8; Table 
2.5).  
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2.5. Discussion 
In our study of acute stroke patients with PACS and LACS and an acute infarct on 
DWI, we found that 23% of patients presenting with a PACS had an acute lacunar 
infarct, and 16% of patients presenting with a LACS had an acute cortical infarct and 
no other explanation for their recent stroke symptoms. The main factor associated 
with clinical-imaging dissociation amongst all patients in this study, after adjusting 
for potential confounders, was diabetes (old stroke lesions and previous history of 
stroke were associated in univariate analysis only) and in patients with an acute 
lacunar infarct on imaging, proximity of the lacunar infarct to the cortex, older age, 
diabetes and left hemisphere location. Lesion size, multiple acute infarcts, time to 
scanning, WMH, brain atrophy and history of prior stroke were not associated with 
clinical-imaging dissociation.   
The present study had some methodologic strengths. We performed a more 
comprehensive examination of associated features than in previous studies of 
clinical-imaging dissociation. We identified consecutive stroke and TIA patients 
presenting to our stroke service. Patients undergoing MRI had similar proportions of 
PACS and LACS to the registry cohort as a whole. The minor differences between 
patients undergoing MRI and those that did not (slightly younger, more males, fewer 
with vascular risk factors) is unlikely to have influenced the generalisability of our 
results. All patients were very carefully examined by an experienced stroke physician 
and categorised according to strict interpretation of the OCSP criteria. Images were 
reviewed systematically according to a structured proforma by a trained rater using 
validated scales.  
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There were limitations in our study. Overall, only 313/1311 (24%) of patients 
presenting with acute stroke underwent MRI, which may have introduced a selection 
bias. Other factors which may have led to selection bias were the inclusion of 
patients with increasing delay, or uncertain time, since stroke onset, and where there 
was clinical uncertainty about stroke diagnosis. Our sample may therefore have 
included an overrepresentation of patients who were more difficult to subtype. 
However, this does not negate the observation that lacunar lesion location was 
associated with clinical-imaging dissociation. Median time from stroke onset to MRI 
was 19 days (many were out-patients, with mild stroke), i.e. outwith the time period 
generally considered optimal for DWI, and only 64% (137/215) patients had a 
diffusion-positive infarct. However, a previous small study showed no difference in 
the proportion with an acute infarct on DWI in those scanned before versus after four 
weeks (Schulz et al. 2003). Although several patients had DWI outwith the optimal 
time period, previous work has shown that DWI may also be useful up to several 
weeks after stroke onset (Keir et al. 2004). We also cannot exclude the possibility 
that the infarct responsible for initial symptoms was no longer visible on DWI by the 
time the patient underwent brain imaging, and that a new, silent DWI infarct (but 
sufficiently consistent with the infarct location as suggested by the symptoms and 
signs as to be considered as the acute index infarct) had appeared in this period, but 
this possibility was considered to be low and consequently not a significant 
confounding factor. We did not investigate underlying mechanisms as a cause of 
clinical-imaging dissociation, and the study was not designed to test the effect of 
clinician experience on misdiagnosis, a factor identified in one previous study 
(Selvarajah et al. 2009). 
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Previous studies did not consider proximity of lacunar infarcts to cortex or diabetes 
as possible factors for clinical-imaging dissociation. The association with diabetes 
may be partly explained by a co-association with old ‘silent’ infarcts; however, 
although old infarcts were associated with clinical-imaging dissociation in univariate 
analysis, they did not remain independently associated in multivariate analysis, as 
found previously (Lodder et al. 1994). Assigning clinical subtype may be more 
difficult in the presence of an old infarct, even if clinically silent, as signs from the 
previous infarct may confuse the clinical picture. The association of left hemisphere 
location and clinical-imaging dissociation is consistent with previous studies which 
found that left-sided lesions were more common in patients with PACS/non-lacunar 
syndrome with clinical-imaging dissociation (Lodder et al. 1994) and that right-sided 
lesions were more common in LACS presenting with clinical-imaging dissociation 
(Mead et al. 2000). This may be explained by the difficulty in distinguishing 
dysarthria from dysphasia, especially if symptoms and signs were mild or had 
resolved by the time of assessment. We did not find an association between clinical-
imaging dissociation and WMH, in contrast to one previous study (Lodder et al. 
1994), possibly because the latter used CT, which is less sensitive to WMH than MR 
FLAIR or T2.  
We found that 11% of patients with LACS had multiple acute lacunar infarcts, 
similar to previous studies (Ay et al. 1999, Seifert et al. 2005, Wessels et al. 2005), 
but multiplicity of infarcts did not contribute to clinical-imaging dissociation. We did 
not find an association between time lapse from stroke onset to MRI and clinical-
imaging dissociation, in agreement with one previous study using CT (Mead et al. 
2000). Ability to recall symptoms and signs may deteriorate with increasing time to 
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assessment, particularly with speech disorders. Others have reported problems with 
very early or very late diagnosis of lacunar stroke (Toni et al. 1995). Our use of 
maximum deficit in assigning the OCSP subtype may have overcome any effect of 
time on clinical features, and so stroke diagnosis.  
Clinical-imaging dissociation has important implications for research into the 
epidemiology, pathophysiology and treatment of lacunar stroke as well as for clinical 
practice. In research which relies heavily on clinical presentation alone, results may 
be affected by 'noise' caused by clinical-imaging dissociation in between 10% and 
20% of patients with mild stroke. Studies in which CT is used in conjunction with 
clinical classification will also be affected, since CT is less sensitive than DWI for 
small acute infarcts (Chalela et al. 2007), particularly when performed soon after 
symptom onset, as is increasingly the case. Acute ischaemic stroke lesions are visible 
on CT in <20% of LACS and <35% PACS (i.e. mild stroke) at <3 hours, rising to 
approximately 45% and 60%, respectively, at 36 hours (Wardlaw et al. 2003b). The 
debate over mechanisms of lacunar stroke - up to 20% are said to be associated with 
cardiac and large artery atherothromboembolism (Futrell 2004, Kazui et al. 2001) 
rather than intrinsic SVD - could be explained by clinical-imaging dissociation. 
Similarly, large primary and secondary prevention trials of ischaemic stroke testing 
aspirin, cholesterol-lowering drugs and antihypertensives, have relied heavily on 
clinical classification and CT (CAPRIE Steering Committee 1996). ‘Noise’ from 
clinical-imaging dissociation may have impeded the demonstration of any difference 
in treatment effects between stroke subtypes, if one existed. In future, where precise 
diagnosis of stroke subtype and lesion location is important, lesion location should be 
verified by sensitive imaging. 
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2.6. Tables  
Table 2.1 MRI scan parameters used in the Edinburgh Stroke Study and Mild Stroke Study 
 
Sequence TE TR Slice thickness (mm) Slice gap (mm) Matrix Field of view Flip angle 
T2WI 102 6300 5 1.5 256 x 256 24 x 24  
T1WI Min 450 5 1.5    
FLAIR 140 9000 5 1    
GRE 15 625 5 1.5 256 x 192 24 x 24 20o 
TE, time to echo; TR, time to repetition; T2WI, T2-weighted imaging; T1WI, T1-weighted imaging; FLAIR, fluid attenuated inversion recovery; GRE, gradient echo 
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Table 2.2 Previous studies identifying clinical-imaging dissociation and features examined 








Lacunar syndrome + 
large subcortical or 









Features examined in relation to 
clinical-imaging dissociation 
Lodder et al. 
1994 
Hospital CT - 147 23 (16) 203 19 (9) Disability (OR 4.31, 95% CI 1.25-
14.88) 
Leukoaraiosis (non-lacunar 
syndrome; OR 3.79, 95% CI 1.32-
10.05) 
Asymptomatic infarcts (non-lacunar 
syndrome; OR 4.13, 95% CI 1.45-
11.71) 
Hemisphere affected (non-lacunar 
syndrome) 
Al-Buhairi et 
al. 1998  
Hospital CT OCSP - - 121 4 (5) - 
Pittock et al. 
2003 
Hospital CT OCSP 47 2 (10) 24 3 (11) - 
Wlodek et al. 
2004  
Hospital CT OCSP 101 29 (29) 193 29 (15) - 
Kobayashi et 
al. 2009 
Hospital CT OCSP 60 19 (31) 183 3 (2) - 




OCSP 180 35 (19) 395 62 (16) - 




OCSP 144 35 (24) 298 38 (13) Hemisphere affected (PACS, LACS) 






OCSP 69 12 (17) 75 16 (21) - 
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a
Patients with subcortical or brainstem lesions <1.5cm in diameter 
b
4 with single cortical lesion, 9 with scattered or multiple lesions containing a cortical lesion 
CT, computed tomography; OR, odds ratio; CI, confidence interval; OCSP, Oxford Community Stroke Project; MRI, magnetic resonance imaging; PACS, 
partial anterior circulation syndrome; LACS, lacunar syndrome; DWI, diffusion-weighted imaging 
         
Table 2.2 continued 








Lacunar syndrome + 
large subcortical or 








Features examined in relation to 
clinical-imaging dissociation 
Ay et al. 1999  Hospital DWI - 62 1 (2) - - - 
Lindgren et al. 
2000  
Hospital DWI - 23 2 (9) - - - 
Allder et al. 
2003 
Hospital  DWI OCSP - - 42 6 (14) Clinical severity (χ 
2 
18.9, p < 0.01) 
Seifert et al. 
2005  
Hospital DWI OCSP - - 93
a
 14 (15) - 
Wessels et al. 
2005 
Hospital DWI - 73 13 (18)
b
 - - - 
 
















Old infarcts (OR 3.02, 95% CI 1.06 
to 8.59) 
Diabetes (OR 7.17, 95% CI 1.86 to 
27.71) 
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Table 2.3 Baseline characteristics of patients undergoing MRI compared to all acute ischaemic 
stroke patients recruited to the stroke register 
 
 All acute ischaemic stroke patients 
(n=1311) 
Patients with MRI 
(n=313) 
Age in years (mean ± SD) 71.4 ± 12.9 68.5 ± 13.4 
Male sex (%) 671 (51.2) 169 (54) 
Risk factors 





 Hypertension 704 (53.7) 164 (53.1) 



















MRI, magnetic resonance imaging; SD, standard deviation; TACS, total anterior circulation  
syndrome; PACS, partial anterior circulation syndrome; POCS, posterior circulation syndrome; 
LACS, lacunar syndrome
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Table 2.4 Factors associated with clinical-imaging dissociation in patients with partial anterior circulation syndrome (PACS) and lacunar syndrome  















    Age (mean years ± SD) 
    Male gender 
 
71 ± 11 
19 (61) 
 
70 ± 13 
64 (60) 
 





























    Hypertension n (%) 23 (74) 58 (56) χ 
2 
3.52 0.06 0.88 1.09 (0.36-3.34) 
    Diabetes n (%) 9 (29) 6 (6) χ 
2
 11.2 0.001 0.004 7.12 (1.86-27.2) 
Clinical 
    Median days, onset to assessment 
    Range, (IQR) 
 
16 













    Median days, onset to MRI 





Mann Whitney 8 (0-14) 0.05 0.71 1.01 (0.9-1.06) 
MR brain imaging characteristics 















    WMH 2-3
a
 n (%) 16 (53) 39 (37) χ 
2
 2.62 0.12 0.85 1.12 (0.35-3.55) 
    EPVS 2-4
b
 n (%) 19 (63) 41 (340) χ 
2
 5.2 0.02 0.38  1.61 (0.56-4.60) 
    Brain tissue loss 2-3
c
 n (%) 8 (28) 29 (28) χ 
2
 <0.001 1.0 0.1 0.33 (0.09-1.24) 
    Old stroke lesions n (%) 20 (65) 45 (42) χ 
2
 5.49 0.02 0.08 2.56 (0.89-7.36) 
†Odds ratio (OR) per additional year of age; 
a
On Fazekas scale ; 
b
On EPVS scale ; 
c
On brain tissue loss scale; SD, standard deviation; CI, confidence interval; 
IQR, interquartile range; WMH, white matter hyperintensities; EPVS, enlarged perivascular spaces 
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    Age (mean years ± SD) 
    Gender, male (%) 
 
75 ± 10 
14 (64) 
 
69 ± 11 
27 (54) 
 


























    Hypertension n (%) 18 (82) 22 (44) χ 
2
 8.85 0.004 0.12 3.72 (0.72-19.2
    Diabetes n (%) 6 (27) 4 (8) χ 
2
 4.75 0.06 0.02 17.1 (1.49-195.1
Clinical 
    Median days, onset to assessment 













    Median days, onset to MRI 





Mann Whitney -6 0.04 
 
0.76 0.98 (0.84-1.1
MR brain imaging characteristics 













    Infarct size (mm) 11.7 ±  3.4 10.8 ± 4.3  t-test -1.01 0.32 0.99 1.00 (0.82-1.2
    Left hemisphere location n (%) 15 (68) 26 (52) χ 
2
 1.22 0.27 0.03 8.95 (1.23-64.9
    WMH 2-3
a
 n (%) 12 (55)  20 (40) χ 
2
 1.31 0.25 0.43 0.48 (0.08-2.9
    EPVS 2-4
b
 n (%) 14 (64) 25 (49) χ 
2
 0.98 0.32 0.67 1.52 (0.22-10.4
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    Brain tissue loss 2-3
c
 n (%) 7 (32) 9 (18) χ 
2
 1.69 0.19 0.35 0.30 (0.02-3.7
    Old stroke lesions n (%) 14 (64) 23 (46) χ 
2
 1.9 0.17 0.13 0.20 (0.02-1.6
†Odds ratio (OR) per additional year of age; 
a
On Fazekas scale ; 
b
On EPVS scale ; 
c
On brain tissue loss scale ; OR, odds ratio; CI, confidence interval; SD, 
standard deviation; IQR, interquartile range; WMH, white matter hyperintensities; EPVS, enlarged perivascular spaces 
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2.7. Figures  
Figure 4 Coronal T1-weighted MRI brain to demonstrate how the site of a small subcortical 
(lacunar) infarct could influence clinical presentation 
 
A small subcortical infarct lying in the left internal capsule, i.e. deep white matter (A), would 
cause functional disconnection of a large area of cortex (B, shaded). A peripheral small 
subcortical infarct lying close to cortex (C) would affect only a limited area of cortex (D, 
shaded), and could mimic a mild cortical stroke. 
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Figure 5 Identification of patients with partial anterior circulation syndrome (PACS) and lacunar 
syndrome (LACS) for assessment of clinical-imaging dissociation and imaging findings 
 
 
MRI, magnetic resonance imaging; POCS, posterior circulation syndrome; TACS, total anterior 
circulation syndrome; PACS, partial anterior circulation syndrome; LACS, lacunar syndrome  
a
14 with acute lacunar infarct used in separate analysis (Table 2.5) 
b
3/93 (3%) with cerebellar infarct (not shown) 
c
11/13 multiple cortical infarcts, 2/13 cortical plus cerebellar infarct
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Chapter 3. Counting cavitating lacunes underestimates the burden of 
lacunar infarction 
3.1. Introduction 
A lacune is commonly defined as a small, deep 3-20mm (or in some cases 3-15mm) 
CSF-containing cavity. The term ‘lacune’ was first used by Dechambre in 1838 
(Dechambre 1838) and later in 1901 by Marie, who suggested these could be due to 
infarcts (Marie 1901). Sixty years later, Fisher defined lacunes pathologically as infarcts, 
either clinically silent or symptomatic, resulting from occlusion of a penetrating branch 
of a cerebral artery (Fisher 1965, Fisher 1969, Fisher 1982). The term ‘lacune’ is often 
used interchangeably with the terms ‘lacunar infarct’ and ‘lacunar stroke’. Tissue loss 
replaced by CSF (or near-CSF) is also known radiologically as cerebromalacea, and can 
affect grey or white matter, but this term is usually applied to cortical infarcts. 
Silent lacunes (on imaging or histopathology, without clear evidence of relevant stroke 
symptoms) are often termed ‘silent lacunar infarcts’ or ‘silent brain infarcts’. Silent 
lacunes are frequently seen in healthy older people, occur in 8-28% of the general 
population, are associated with increasing age, hypertension and subtle deficits in 
physical and cognitive function, and more than double the risk of stroke and dementia 
(Vermeer et al. 2007). In most studies of ‘silent brain infarcts’, there is no definitive 
pathological evidence that the lesion was due to infarction. 
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3.2. Aims 
The association between clinically evident lacunar ischaemic stroke and silent lacunes is 
unclear because the proportion in whom the symptomatic lacunar infarct progresses to a 
cavity, and in whom the lesion continues to resemble a WML, are unknown. This has 
significant implications for epidemiology (including risk factor) and pathogenesis 
studies of lacunar infarction and cerebral SVD, where it is common practice to count 
lacunes and only consider these as silent lacunar infarcts, omitting to correlate these with 
symptoms.  
We investigated the proportion of symptomatic lacunar strokes progressing to lacunes, 
and assessed patient-related, stroke-related, and imaging-related associations of 
cavitation. 
3.3. Methods 
3.3.1. Patient recruitment 
We identified patients with acute lacunar ischaemic stroke, diagnosed following clinical 
and radiological evaluation, with baseline and follow-up MR or CT brain imaging, from 
the ESS, a prospective register of consecutive stroke patients presenting to an academic 
teaching hospital (full details given in Chapter 2, ‘Methods’), and the Mild Stroke Study 
(MSS; Appendix 4). In the MSS, patients with clinical lacunar or mild cortical stroke 
presented to our teaching hospital within three months of symptom onset between April 
2005 and December 2007. Exclusion criteria were contraindications to MRI, unstable 
medical condition, and severe or haemorrhagic stroke.  
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3.3.2. Clinical assessment and assessment of risk factors 
A stroke physician assigned a classification using the OCSP classification (Bamford et 
al. 1991), measured NIHSS score and assessed vascular risk factors. Written consent 
was obtained from all patients. Both studies were approved by the Local Research Ethics 
Committee.  
3.3.3. Brain imaging 
We included patients with baseline imaging with either brain MRI (including DWI, 
T2WI and FLAIR) or CT. We included patients with or without an acute lacunar infarct 
on MRI (because the high sensitivity of MR enabled us to exclude as fully as possible 
patients with cortical infarction), but on CT, only included patients with a visible recent 
lacunar infarct in the appropriate area for symptoms (because the low sensitivity of a 
negative CT would not allow us to exclude cortical stroke, which may give rise to 
lacunar-type symptoms) (Mead et al. 2000). Baseline and follow-up imaging was with 
either MR (including T1-weighted imaging (T1WI), T2WI, FLAIR and GRE sequences) 
or CT. Full MRI parameters are shown in Table 2.1 (ESS) and Table 3.1 (MSS). Patients 
with baseline diffusion-positive MRI and follow-up MRI were considered to represent a 
‘pure’ subgroup, as diagnosis was most sensitive and specific for stroke subtype. The 
inclusion of the larger group in whom baseline imaging was either CT-positive or MR-
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3.3.4. Imaging classification 
A neuroradiologist (GMP) recorded site and diameter of the acute index symptomatic 
lacunar infarct, WML, EPVS, cerebral atrophy, lacunes (separate from index lesion) and 
spongiform lesions (separate from index lesion). Acute lacunar infarcts were defined as 
round or ovoid lesions of increased signal relative to white matter on DWI, FLAIR or 
T2WI, or decreased attenuation relative to white matter on CT, 3-20mm in diameter, in 
the white matter, BG or brainstem. WML were rated on MRI (0-3 on Fazekas scale 
(Fazekas 1987) or CT (0-2 on van Swieten scale; van Swieten et al. 1990). EPVS, 
defined as ≤2mm round or linear CSF-isointense lesions along the course of penetrating 
arteries, were rated on MRI in the BG and CS (MacLullich et al. 2004) (0-4, where 
0=none, 1=<10, 2=<20, 3=20-40 and 4=>40); atrophy was also rated (0-3 on validated 
scale (Farrell et al. 2009), where 0=none, 3=severe). Lacunes were defined as round or 
ovoid lesions of CSF attenuation/signal measuring 3-20mm in the white matter, BG or 
brainstem; correlation with appropriate symptoms was not sought. Coding was 
performed unblinded to clinical symptoms (to be certain of correct identification of the 
index lesion) but blind to all other clinical data. 
At follow-up, a ‘definite’ cavity was defined as a lesion of CSF, or near-CSF, 
attenuation on CT, or of CSF signal on T2WI or FLAIR MRI, at the site of the index 
infarct (Figure 6). A ‘possible’ cavity was defined on FLAIR as a lesion of spongiform 
appearance with areas of marked hypointensity showing early confluence at the site of 
the index infarct. ‘Definite’ (CT and MRI) and ‘possible’ cavitation (FLAIR only) were 
considered together as ‘any evidence of cavitation’. In cases of uncertainty, images were 
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reviewed by a second experienced neuroradiologist (JMW). Lacunes developing 
elsewhere in the brain between baseline and follow-up imaging were also recorded; 
correlation with appropriate symptoms was not sought for these lesions.  
3.3.5. Analysis 
We calculated proportions with any evidence of, and definite, cavitation (with 95% CIs) 
in the whole group, the ‘pure’ subgroup and the subgroup with an index infarct. We 
assessed statistical significance of differences in baseline characteristics and imaging 
features in patients with ‘definite’ and ‘any’ (‘definite’ plus ‘possible’) cavitation of the 
index lacunar infarct in the whole group and ‘pure’ subgroup. We used the Student’s t-
test for continuous variables, the Mann-Whitney-U test for non-normally distributed 
continuous variables and the χ2 test for dichotomous variables. We performed 
multivariate analysis using logistic regression to determine independent predictors of 
cavitation, allowing one variable per five outcome events. We obtained adjusted OR and 
95% CIs, comparing patients with ‘any’ and ‘definite’ cavitation versus those without. 
For ‘any evidence of cavitation’, we used significant variables from univariate analysis 
(hypertension, diabetes, time to follow-up), and concomitant lacunes at baseline and 
deep atrophy, considered more likely than other features to be associated with cavitation. 
For ‘definite’ cavitation, we included time to follow-up (significant on univariate 
analysis), hypertension (significant in univariate analysis for ‘any evidence’ of 
cavitation’), and deep atrophy. We dichotomised scores for WML (Fazekas 0-1 vs 2-3, 
Fazekas 1987; van Swieten 0 vs 1-2, van Swieten et al. 1990), brain tissue loss (Farrell 
et al. 2009) and EPVS (0-2 vs 3-4) due to low frequencies. We also examined the 
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proportion with any progression of cavitation of existing ‘spongiform’ non-index 
lesions. All statistical analyses were carried out Minitab Statistical Software Version 15 
(Minitab, Inc., State College, PA, USA).  
3.4. Results  
Ninety patients met our inclusion criteria. Mean age was 67±12 years, 48 (53%) had a 
history of hypertension, 18 (20%) diabetes and 12 (13%) a history of previous stroke. A 
‘pure’ subgroup of 47/90 (52%) patients had a DWI-positive acute lacunar infarct and 
follow-up MRI (Table 3.2); six had baseline MR and follow-up CT; and 21 had baseline 
CT with either CT or MR follow-up. 
Of the 74/90 (82%) patients with an acute index lacunar infarct, 45/74 (60%) were in the 
CS, 18/74 (24%) in the internal capsule, 9/74 (12%) in the thalamus and 3/74 (4%) in 
the brainstem. Of the 16/90 MRI-negative patients, follow-up MRI was normal in 15, 
and showed a non-cavitating lesion in an appropriate site for original symptoms in one 
(Table 3.2).  
On follow-up imaging, 18/90 (20%, 95% CI 12 to 28%) patients showed ‘definite’, and 
a further seven ‘possible’, cavitation, making a total of 25/90 (28%, 95% CI 19 to 37%) 
with ‘any evidence of’ cavitation (Table 3.2). In the ‘pure’ subgroup, 7/47 (18%) had 
‘definite’ cavitation and a further seven showed ‘possible’ cavitation, making a total of 
14/47 with ‘any evidence of ‘cavitation (30%, 95% CI 17 to 43%). In sensitivity 
analyses to exclude patients without a DWI-positive lesion at baseline (i.e. 74 patients 
with visible lacunar infarction), ‘definite’ cavitation was visible in 18 (24%, 95% CI 15 
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to 34%) and ‘possible’ cavitation in a further seven; therefore 25/74 (34%, 95% CI 23 to 
45%) showed ‘any evidence of’ cavitation. In one case, an acute lacunar infarct on 
baseline CT was not visible on follow-up MRI.  
In the entire group of 90 patients, cavitation was associated with increasing time to 
follow-up imaging in those with both ‘definite’ and ‘any’ evidence of cavitation on 
univariate analysis (p=0.0003 and p=0.03, respectively, Tables 3.3 and 3.4); and with 
deep atrophy in patients with ‘definite’ cavitation (p=0.03). Figure 7 shows the time 
from stroke onset to follow-up imaging in patients with ‘definite’ cavitation. In patients 
with ‘any evidence of’ cavitation, hypertension and diabetes were negatively associated 
with cavitation (p=0.01 and 0.02, respectively). In multivariate analysis, increasing time 
to follow-up and deep atrophy remained significant for patients with ‘definite’ cavitation 
(OR 1.81, 95% CI 1.12 to 2.92% and OR 3.24, 95% CI 1.02 to 10.27%). No other 
patient-related, stroke-related or imaging-related variables (age, NIHSS and all other 
features of SVD) were associated with ‘any evidence of’, or ‘definite’, cavitation. 
In the subgroup of 47 patients with a positive baseline diffusion scan and follow-up 
MRI, ‘definite’ cavitation was associated on univariate analysis with increasing time to 
follow-up (p=0.009) and superficial atrophy (p=0.03). In those with ‘any’ evidence of 
cavitation, hypertension was negatively associated with cavitation (p=0.009). No other 
clinical or imaging features were associated with cavitation in either the whole group or 
‘pure’ subgroup. 
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At baseline, 13/90 patients (14%) had subcortical spongiform lesions separate from the 
index acute lacunar infarct (single lesion in 10, two lesions in 3). Progression to a 
‘definite’ cavity on follow-up occurred in two of these patients, but in neither patient did 
the index lesion show ‘any evidence of’ cavitation; from the 11 spongiform lesions 
which did not progress to a ‘definite’ cavity, the index lacunar infarct showed 
progression to a ‘definite’ cavity in two patients.  
At baseline, 31/90 (34%) patients had concomitant lacunes. Of these, 18/31 (58%) had 
higher WML scores, than the 17/59 (29%) without concomitant lacunes at baseline (χ
2
 
p=0.007); 4/31 (4%) patients developed new lacunes between baseline and follow-up 
imaging (unrelated to the index lesion) over an interval ranging from 76 to 185 days.  
3.5. Discussion 
The proportion of symptomatic lacunar infarcts which undergo cavitation to lacunes is 
unknown. In this study, a fifth of patients with acute lacunar ischaemic stroke showed 
‘definite’ cavitation on follow-up imaging at a median of 227 days (range 54-1722) after 
stroke onset. In a ‘pure’ subgroup (DWI-positive infarct with follow-up MRI), 15% of 
patients showed ‘definite’ cavitation. ‘Definite’ cavitation was associated with 
increasing time to follow-up in univariate and multivariate analysis, but not with age, 
NIHSS, lesion size or location, or other features of cerebral SVD, including other 
lacunes. The association with increasing time to follow-up remained significant in the 
‘pure’ subgroup. If these proportions are similar in other populations, up to 4/5 of 
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symptomatic lacunar infarcts may resemble, and be misidentified as, WML at any time 
up to approximately five years after stroke, possibly longer.  
‘Definite’ cavitation was associated with deep atrophy in univariate and multivariate 
analysis and with superficial atrophy in the ‘pure’ subgroup. Our data indicate that age, 
stroke severity, and other features of SVD (WML, concomitant lacunes and EPVS) were 
not linked to cavitation. On the other hand, hypertension was negatively associated with 
cavitation in patients with ‘any evidence of’ cavitation (in both the whole group and 
‘pure’ subgroup) and diabetes in the whole group.  
The main strengths of our study were that patients were carefully characterised clinically 
to be certain of the clinical diagnosis of lacunar stroke, all data were collected according 
to pre-specified criteria, and most patients had baseline MRI, including diffusion. Thus, 
we could pinpoint precisely when the index lesion started and follow its evolution with 
precision. The two studies from which these data are derived were performed 
prospectively in the same hospital, using the same data collection, case ascertainment, 
diagnostic methods, physicians, radiologists and imaging equipment. We tested 
associations in the whole, as well as ‘pure’, subgroup, and found that they were similar.  
Potential limitations were inclusion of a small proportion of patients without a lesion on 
MRI at baseline; some patients with non-lacunar stroke may have been inadvertently 
included, despite careful clinical characterisation. This may have meant we 
underestimated the proportion of patients with cavitation. However, after excluding 
MRI-negative patients, proportions with ‘any evidence of’ and ‘definite’ cavitation were 
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similar to the whole group, and to the ‘pure’ subgroup, with overall point estimates 
around 15% to 33%.  
Minimum time to follow-up imaging was relatively short, but several patients without 
‘definite’ cavitation had follow-up imaging at almost four years, and we identified 
patients with ‘definite’ cavitation at 54 days. Sample size was relatively small and 
precluded more complex analyses, so we cannot exclude weak associations between 
cavitation and imaging-, stroke-, or patient-related features. We were unable to 
investigate the influence of some factors, e.g. duration of symptoms or contrast 
enhancement, as this information was not collected. Follow-up timing was not fixed 
with variable times to follow-up; in the study of lacunar stroke, follow-up was at 
between one and three months and all patients were recalled for imaging (although not 
all attended), whereas in the stroke registry, follow-up mostly occurred if the patient 
developed new symptoms. These selection criteria in the original studies may have 
influenced cavitation detection rates. Larger studies with fixed follow-up time points are 
required to obtain more precise data on cavitation.  
No previous studies have examined cavitation rates in symptomatic lacunar ischaemic 
stroke, so there is little information with which to draw comparisons. Longitudinal 
studies show that WML and lacunes increase in number over time, with hypertension 
(amongst others) being a risk factor for new lacunes, and diabetes and hypertension 
being risk factors (amongst others) for WML progression (Basile 2006, Gouw et al. 
2008). We found that increased WML severity was associated with concomitant lacunes 
on baseline imaging, in agreement with previous studies (Mantyla et al. 1999, Vermeer 
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et al. 2003). Gouw et al. (Gouw et al. 2008) found that WML progression was modestly 
correlated with number of new lacunes at follow-up; we were unable to investigate for 
such a correlation. The apparent co-association of lacunes and WML suggests that 
lacunes may represent the extreme end of a spectrum of small vessel changes.  
Factors associated with cavitation have been investigated in multiple sclerosis (MS); in 
longitudinal studies, a ring-enhancing lesion pattern is associated with cavity 
development (Bagnato et al. 2003, Minneboo et al. 2005, van Waesberghe et al. 1998, 
Zivadinov and Zorzon 2002), but predictive power is limited because of variability in 
cavity development, with some evidence that cavitation is patient-specific. Differences 
in MS lesion evolution in the same patient have also been demonstrated, suggesting 
local inflammatory reaction or location may be more relevant than individual 
susceptibility in leading to permanent axonal loss (Ciccarelli et al. 1999). Duration of 
symptoms may influence whether cavitation occurs (we did not record this), although we 
found no association with NIHSS, another marker of stroke severity. In animals, 
duration of middle cerebral artery occlusion has been shown to influence infarct 
cavitation (Garcia et al. 1997).  
The molecular processes underlying cerebral tissue damage and repair, through the 
stages of tissue infarction and ‘rarefaction’, leading to gliosis and cavitation, are 
complex, and as yet incompletely identified (del Zoppo 2009). Histologically, a phase of 
chronic inflammation, including cavitation, was identified from 10 days to 53 years in 
patients with cortical and lacunar infarction (Mena et al. 2004). In our study, the earliest 
time at which a lesion demonstrated ‘any evidence of’ cavitation was 39 days, and at 54 
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days for ‘definite cavitation’. Matrix metalloproteinases are important factors for tissue 
remodelling implicated in all main cerebrovascular diseases including ischaemia and 
white matter lesions in vascular dementia (Rosenberg et al. 2001). Higher levels of 
matrix metalloproteinase (MMP-9) may be related to neurological deterioration in the 
first seven days after acute lacunar infarction, but there is no information on whether 
high MMP levels are associated with cavitation (Kim et al. 2006). 
Thirteen patients in our study had spongiform lesions (possible cavities) separate to the 
index lesion at baseline; in two patients these progressed to definite cavities, but the 
index lesion showed no cavitation. Similarly, two patients with definite cavitation of the 
index lesion showed no progression to cavitation in non-index spongiform lesions. 
Cavitation may therefore occur on a ‘per lesion’ rather than ‘per patient’ basis.   
What are the implications if only 1/5 of acute symptomatic lacunar infarcts become 
cavities and the other 4/5 continue to resemble WML? In epidemiology (including risk 
factor) and pathophysiology studies of lacunar infarction which only count lacunes as 
old lacunar infarcts, the true burden of lacunar disease may be underestimated by as 
much as five times. With the difficulties in distinguishing between WML and non-
cavitated lacunar infarction, consideration should be given to abandoning the term 
‘white matter lesions’ in favour of a term such as ‘small vessel changes’, correlating 
acute lacunar infarcts, ‘WML’ and lacunes with symptoms wherever possible. Our 
findings should be confirmed in larger prospective studies of acute lacunar stroke, with 
follow-up at pre-specified time intervals. 
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3.6. Tables  
Table 3.1 MRI scan parameters used in the Mild Stroke Study 
Sequence TE TR Slice thickness (mm) Slice gap (mm) Matrix Field of view Flip angle 
T2WI 102 6300 5 1.5 256 x 256 24 x 24  
T1WI Min 450 5 1.5    
FLAIR 140 9000 5 1    
GRE 15 625 5 1.5 256 x 192 24 x 24 20
o
 




Chapter 3 Counting cavitating lacunes underestimates the burden of lacunar infarction 49 
 
Table 3.2 Type of brain imaging, including follow-up appearance of symptomatic lacunar infarct (n=90) 
 





positive n Yes No None Possible Definite 
MR MR Yes 47
a
 47 0 33 7 7 
MR CT Yes 6 6 0 4 NA 2 
MR MR No 16 1 16 1 0 0 
CT MR NA 10 9 1 6 0 3 
CT CT NA 11 11 0 5 NA 6 
a
‘Pure’ subgroup; DWI, diffusion-weighted imaging; MR, magnetic resonance; CT, computed tomography; NA, not applicable 
 
 
Chapter 3 Counting cavitating lacunes underestimates the burden of lacunar infarction 50 
 
Table 3.3 Clinical and imaging associations of lacunar infarct cavitation in patients with any evidence of cavitation (n=90) 
 n where not 90 Any evidence of cavitation Test 
p 
value 
  Yes (n=25) No (n=65)  
Age in years (mean ± SD)  68.3 ± 12.3 66.8 ± 12 t test 0.59 
Male (%)  16 (64) 38 (58) χ
2
 0.81 
NIHSS median score (range) 86 1 (0-11) 2 (0-9) Mann-Whitney 0.66 
Stroke (%)  1 (4) 11 (17) Fisher's 0.17 
Hypertension (%)  8 (32) 40 (62) χ
2
 0.01 
Diabetes (%)  1 (4) 17 (26) Fisher's  0.02 
Onset to assessment, median days (range)  16 (0-43) 9 (0-104) Mann-Whitney 0.56 
Onset to baseline imaging, median days (range)  17 (0-43) 9 (0-104) Mann-Whitney 0.44 
Onset to follow-up imaging, median days (range)  102 (39-1722) 74 (6-1440) Mann-Whitney 0.03 
Lacunar size mm (mean ± SD) 74 9.9 ± 3.2 9.7 ± 4.2 t test 0.87 
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Table 3.3 continued      
Periventricular WML
a





 (0 v 1:2) 10 3 (50) 3 (75) Fisher's  0.57 
Posterior WML
b
 (0 v 1:2) 10 1 (17) 2 (50) Fisher's  0.5 
Deep atrophy (0:1 vs 2:3)  11 (44) 24 (37) χ
2
 0.54 
Superficial atrophy (0:1 vs 2:3)  5 (20) 11 (17) χ
2
 0.74 
Basal ganglia EPVS (0:2 vs 3:4) 80 3 (16) 18 (30) Fisher's 0.37 






van Swieten scale 
SD, standard deviation; NIHSS, National Institutes for Health Stroke Scale; WML, white matter lesions; EPVS, enlarged perivascular spaces 
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             Definite cavitation  
 
n where not 90 
Yes (n=18) No (n=72) Test p value 
Age in years (mean ± SD)  69.6 ± 11.1 66.6 ± 12.3 t test 0.33 
Male (%)  13 (72) 41 (57) χ
2
 0.23 
NIHSS median score (range) 86 2 (0-11) 1 (0-9) Mann-Whitney 0.61 
Stroke (%)  1 (6) 11 (15) Fisher's  0.45 
Hypertension (%)  6 (33) 42 (58) χ
2
 0.056 
Diabetes (%)  1 (6) 17 (24) Fisher's  0.11 
Onset to assessment, median days (range)  17 (0-43) 9 (0-104) Mann-Whitney 0.43 
Onset to baseline imaging, median days 
(range)  18 (0-43) 10 (0-104) Mann-Whitney 0.49 
Onset to follow-up imaging, median days 
(range)  227 (54-1722) 72 (6-1440) Mann-Whitney 0.0003 
Lacunar size mm (mean ± SD) 74 9.28 ± 2.82 9.95 ± 4.14 t test 0.44 
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Table 3.4 continued      
Deep WML
a
 (0:1 vs 2:3)  80 4 (39) 27 (40)  0.76 
Periventricular WML
a
 (0:1 vs 2:3)  80 8 (67) 40 (59) Fisher's 0.75 
Anterior WML
b
 (0 vs 1:2) 10 3 (50) 3 (75) Fisher's  0.57 
                                   Definite cavitation  
 n where not 90 Yes (n=18) No (n=72) Test p value 
Posterior WML
 b
 (0 vs 1:2) 10 1 (17) 2 (50) Fisher's  0.5 
Deep atrophy (0:1 vs 2:3)  11 (61) 24 (33) Chi squared 0.03 
Superficial atrophy (0:1 vs 2:3)  5 (28) 11 (15) Chi squared 0.24 
Basal ganglia EPVS (0:2 vs 3:4) 80 3 (25) 3 (25) 18 (26) 1 




van Swieten scale; 
SD, standard deviation; NIHSS, National Institutes for Health Stroke Scale; WML, white matter lesions; EPVS, enlarged perivascular spaces 
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3.7. Figures  
Figure 6 Examples of definite and possible lacunar infarction cavitation on MRI and a cavitated 
lesion on CT  
Definite (A) and possible (B) cavities in the centrum semiovale on FLAIR MRI, both with 
concomitant white matter lesions (not labelled). C. Cavity in the right thalamus on CT. 
 
 
FLAIR MRI, fluid-attenuated inversion recovery magnetic resonance imaging; CT, computed tomography 
 
Chapter 3 Counting cavitating lacunes underestimates the burden of lacunar infarction 55 
 
 Figure 7 Time to follow-up imaging in patients with and without definite cavitation 
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Chapter 4. Wide variation in reporting of lacunar-related lesions on  
  imaging in lacunar stroke studies – literature review  
4.1. Introduction 
Lacunar stroke accounts for about 25% of ischaemic stroke (Bamford et al. 1991). On 
brain imaging, lacunar lesions form part of a spectrum of features of cerebral SVD, 
which includes WML, EPVS and microbleeds. Several terms used for lacunar lesions 
found on imaging (e.g. ‘lacunar infarct’, ‘lacunar stroke’, ‘lacune’) appear to be used 
interchangeably (Wardlaw 2008). Non-specific and interchangeable use of terms for 
lacunar lesions on imaging may be contributing to the current debate on causes of 
lacunar stroke (Davis and Donnan 2004, Futrell 2004, Norrving 2004). Variations in 
clinical, neuropathological, and radiological terminology and definitions have 
complicated research in other related areas such as vascular dementia (Chui et al. 2000, 
Erkinjuntti et al. 1997, Leys and Pasquier 1998, Pantoni et al. 2006, Pohjasvaara et al. 
2000, Román et al. 1993, Skinner et al. 2000, van Straaten et al. 2003). Ways of 
reducing heterogeneity by providing standardised classification systems for the imaging 
assessment of other radiological features of SVD - WML (Pantoni et al. 2002) and BMB 
(Cordonnier 2009) - have been addressed, but the consistency of imaging assessment in 
lacunar stroke has not been addressed. Therefore the literature was surveyed to quantify 
the range and variation of imaging definitions of acute and old lacunar stroke lesions and 
related methodological features.  
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4.2. Aims 
In this study, we assessed reporting of imaging definitions of acute and old lacunar 
stroke lesions in the lacunar stroke literature, including a range of related 
methodological features. 
4.3. Methods  
We searched PubMed for articles between 1998-2008 in three journals with a focus on 
stroke (Stroke, Cerebrovascular Diseases and the Journal of Neurology), using the terms 
‘lacunar’, ‘lacune’ and ‘subcortical’. We performed initial testing of the data collection 
form on 10 articles before assessing a further 50 articles describing lacunar stroke 
studies in patients. We had intended to sample more, but as marked diversity was 
apparent in the first 50, we did not assess any further articles. Articles were selected 
from each journal at random using a random number generator. Data extraction was 
done by two observers (GMP, FJM), with data cross-checked by GMP. A third author 
arbitrated on any disagreements. Articles describing animal studies were excluded. 
Where there were two or more articles by the same authors, we used the methodology 
from only one article to avoid duplication of data.  
We collected data on corresponding author and inclusion of a general radiologist or 
neuroradiologist in the authorship (Appendix 5). For acute and old lacunar lesions we 
collected details as shown in Table 4.1. We also collected imaging-related data about 
discipline, number, blinding and experience of those interpreting images.  
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4.3.1. Analysis 
We assessed the proportion of articles providing clinical and imaging definitions, the 
imaging modality used, the discipline of corresponding author and the number of papers 
with a radiologist in the authorship. We listed all terms used to describe lacunar lesions 
on imaging and the proportion using each. We determined proportions (1) describing 
lesion size, site, attenuation/intensity and clinical terminology, (2) providing details 
about timing of imaging in relation to acute stroke symptoms, (3) attempting to relate 
old lacunar lesions to symptoms, and (4) attempting to differentiate old lacunar lesions 
from EPVS.  
4.4. Results 
4.4.1. Article type, authorship and type of lesion 
From a total of 362 articles, we randomly selected 50 articles (22 from Stroke, 13 from 
the Journal of Neurology, 15 from Cerebrovascular Diseases), consisting of 47 original 
articles and 3 case reports. The corresponding author was usually a neurologist (34/50, 
68%). A radiologist was included in the authorship in 13 (26%) articles, of whom 8/13 
(62%) were general radiologists, and 5/13 (28%) neuroradiologists (i.e. a 
neuroradiologist contributed to 10% of papers overall).  
Thirty (60%) studies concerned acute and 7 (14%) old, lacunar lesions, and 13 (26%) 
studies concerned both. Thus, a total of 43 articles were relevant for definitions of acute, 
and 20 of old, lacunar lesions.  
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4.4.2. Imaging definitions 
Terminology and definitions for lacunar lesions: Thirteen different terms were used for 
acute and 10 for old lacunar lesions (Table 4.2). ‘Lacunar infarct’ and ‘lacunar stroke’ 
were used for both acute and old lesions.  
A definition for lacunar lesions was provided in 26/43 (60%) articles describing acute 
and 8/20 (40%) describing old lesions. Amongst these, 13 articles concerned both acute 
and old lesions, of which most (6/13, 46%) failed to provide a definition for either type 
of lesion, 4 /13(31%) provided a definition for only one lesion type, 1/13 (8%) used the 
same definition for both, and only 2/13 (15%) provided a separate definition for each. 
Imaging descriptors for lacunar lesions: site, size and shape: Lacunar lesion site was 
defined in 18/43 (42%) studies of acute and 4/20 (20%) of old lesions with marked 
variation in descriptions (Table 4.3a); size was provided in 21/43 (49%) and 9/20 (45%), 
respectively, with a greater maximum size used for acute (25mm) vs old (20mm) lesions 
(Table 4.3b).  
EPVS and their differentiation from lacunes: A description of EPVS was given in 7/50 
(14%) articles (all on acute lesions only), with 7 different descriptions given. Of studies 
on old lacunar lesions, most (17/20, 85%) articles did not distinguish EPVS from old 
lacunar lesions.  
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4.4.3. Clinical definitions 
Thirty eight (76%) articles specified terminology used for the clinical stroke syndrome, 
of which the majority included the term ‘lacunar’ (Table 4.4). A clinical stroke 
classification system was used in 8/50 (16%) papers (six using a risk factor-based 
system (Adams et al. 1993), one a risk factor-free system (Bamford 191), and one a 
combination of systems. A clinical stroke definition was provided in 25/50 (50%) 
articles, with most (19/25, 76%) referring to a ‘classical lacunar syndrome’ (either with 
or without reference to associated imaging findings; Table 4.4). From 20 articles 
concerning old lesions, correlation with possible previous, relevant stroke symptoms 
was attempted only 2 (10%) cases. 
4.4.4. Other imaging-related data 
Use of MRI and details of readers: Amongst 43 studies concerning acute lesions, 22 
(51%) used MRI and 7 (16%) used CT. Diffusion imaging was performed in 33%. Most 
(31, 72%) did not provide any details on timing of imaging in relation to onset of stroke 
symptoms. For old lesions, MRI was used in 15/20 (75%) articles, CT in 4 (20%) and 
both modalities in 1 (5%). MR sequences used to diagnose lacunar lesions were 
described in 11 (31%) studies concerning acute, and 7 (44%) concerning old, lacunar 
lesions. Most papers did not provide a description of lesion attenuation on CT or 
intensity on MRI. 
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Discipline, number and blinding of readers: Amongst the 20/50 (40%) articles providing 
details on who interpreted brain imaging, most (13/20, 65%) indicated that imaging was 
interpreted by non-radiologists (including at least one neurologist in 12 papers and a 
neuropathologist in 1). Overall, 17/50 (34%) studies provided information on blinding of 
readers, 6/50 (12%) indicated level of reader experience, and 23/50 (46%) the number of 
readers. Of these, 13/23 (57%) had 2 or 3 readers and 10/23 (43%) a single reader only. 
4.5. Discussion 
In a sample of 50 articles from the lacunar stroke literature, in which the corresponding 
author was most often a neurologist, there was marked variation in terminology and 
descriptions of imaging definitions of lacunar lesions. Any type of imaging definition 
was provided in 26 (60%) studies of acute and 8 (40%) of old, lacunar lesions, with the 
terms ‘lacunar infarct’ and ‘lacunar stroke’ used for both acute and old, symptomatic 
and asymptomatic lesions. Definitions were heterogeneous and often incomplete. A 
minority of papers attempted to differentiate old, cavitated lacunes from EPVS and to 
seek relevant previous symptoms. Clinical terminology also varied widely. A clinical 
stroke definition was provided in only 50% of studies. Most papers used a risk factor-
based clinical stroke classification system. For acute lesions only a third of those using 
MRI used DWI. Non-radiologists interpreted images in most cases. Most studies did not 
describe lesion attenuation/signal intensity or diagnostic sequences used.  
Strengths of our study included assessment of multiple aspects of definitions and 
terminology for both acute and old lacunar lesions. We selected articles at random from 
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three journals with a stroke focus, which are likely to be reasonably representative of 
articles in the rest of the stroke literature. We collected data on clinical, as well as 
imaging-related data, thus enabling a wider overall impression of potential problems 
relating to lacunar stroke research.  
There are limitations of our study. We randomly selected 50 articles from a total of 362 
articles in a PubMed search of three stroke-related journals, therefore our data represent 
a small sample of the lacunar stroke literature. We had planned to sample a larger 
proportion but there seemed little point when the first 50 papers yielded so much 
variation in imaging/clinical definitions of lacunar lesions and related methodologies. 
We did not attempt to provide a ‘gold standard’ for imaging definitions of lacunar 
lesions as this was not our primary aim. 
On imaging, lacunar lesions are commonly defined as 3- to 15mm lesions found in the 
territory of deep perforating arteries, a definition which is often applied to all types of 
lesion, whether acute or old, symptomatic or asymptomatic. We found marked variation 
in completeness of lacunar lesion definition and lesion descriptions, with both limited 
radiological involvement and limited correlation of old lacunar lesions with relevant 
prior symptoms. These, combined with a marked heterogeneity in the reporting of other 
lacunar stroke-related methodology, such as provision of information on timing of 
imaging and MRI sequences performed, may be contributing to ongoing controversies in 
lacunar stroke (Davis and Donnan 2004, Futrell 2004, Norrving 2004). Additional 
contributory factors include bias in clinical classification systems (Adams et al. 1993, 
Jackson and Sudlow 2005), used in most papers in this study, misclassification of 
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cortical as lacunar stroke (and vice versa) based on clinical symptoms alone (Potter et al. 
2010a), misclassification of symptomatic lacunar infarcts as WML due to only a 
proportion of genuine, DWI-proven symptomatic lacunar infarcts undergoing cavitation 
(Potter et al. 2010b), suboptimal detection of acute lacunar infarcts (especially with 
concomitant WML and without DWI), misclassification of old, cavitated lacunes due to 
difficulties differentiating these from EPVS, and limited information on previous 
relevant neurological symptoms.  
We found multiple terms in use for both acute and old lacunar lesions. Both the terms 
‘lacunar infarct’ and ‘lacunar stroke’ were used for acute and old lesions. This 
interchangeable use of terminology and definitions for all types of lacunar lesions 
(whether or not related to symptoms, and for lesions of varying appearances) infers a 
similar aetiology for each lesion, even though underlying aetiology may be 
heterogeneous (Wardlaw 2008). 
Ultimately, a full appreciation of cerebral lesions in lacunar stroke can only be reached 
at the neuropathological level. However, even neuropathological assessment may be 
difficult and mortality in lacunar stroke is low. A standardised approach to the imaging 
definitions of lacunar lesions – including careful lesion description, using appropriate 
MRI sequences, correlation with relevant symptoms, and avoidance of assumptions 
about underlying aetiology - is essential. Harmonisation in the approach to lacunar 
lesion reporting may help towards an improved understanding of lacunar stroke and 
cerebral SVD, with its subsequent implications for improvements in patient 
management. 
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4.6. Tables 
Table 4.1 Imaging and clinical data collected from 50 articles on lacunar stroke 
 
Acute and old lacunar lesions Old lacunar lesions only 
Imaging-related data Differentiation from EPVS 
    Terms used 
Correlation with previous 
symptoms 
    Provision of an imaging definition  
    Lesion descriptors: site, size, attenuation/intensity  
    Use of the same or separate definitions  
    Modality  
    Timing in relation to acute symptoms  
    Description of MRI sequences performed/used for diagnosis  
Related clinical data  
   Clinical stroke terminology  
    Provision of a clinical definition  
    Stroke classification system used (risk factor-based or risk 
factor-free)   
EPVS, enlarged perivascular spaces; MRI, magnetic resonance imaging 
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Table 4.2. Terms used for acute (n=43) and old (n=20) lacunar lesions on imaging 
 
Acute lacunar lesions (n=43)  n (%)  Old lacunar lesions (n=20)  n (%)  
‘Infarct’/‘lesion’   No reference to age   
    Lacunar infarct/lesion  
22 
(51.2)  
     Lacunar infarct/lesion  
8 (40)  
    Subcortical infarct/lesion  6 (14)       Lacunar stroke  1 (5)  
    Subcortical MCA territory infarct  1 (2.3)       Subcortical lesion  1 (5)  
    Deep subcortical infarct  1 (2.3)       Deep infarct  1 (5)  
    Small, deep lesion  2 (4.7)       Small infarct  1 (5)  
    Deep brain/focal infarct  2 (4.7)  Reference to age   
    Hypodense lesion
a 
 1 (2.3)       Old lacunar infarct  1 (5)  
    Striatocapsular infarct  1 (2.3)       Chronic subcortical infarct  1 (5)  
    Lesion  1 (2.3)  Reference to symptoms   
‘Stroke’        Silent lacunar infarct  4 (20)  
    Subcortical stroke  1 (2.3)  
Non-specific/no reference to 
lesion   
    Deep ischaemic stroke  1 (2.3)      Lesion  1 (5)  
Non-specific/no reference to lesion       No reference to lesion  1 (5)  
    Focal hyperintensity on DWI  1 (2.3)    
    No reference to lesion  1 (2.3)    
a 
On both computed tomography and magnetic resonance imaging 
MCA, middle cerebral artery; DWI, diffusion-weighted imaging  
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Table 4.3 Description of site (A) and size (B) for acute and old lacunar lesions on imaging 
 
A. Acute lacunar lesions  n (%) 
 Site defined 18 (42) 
   General description  
       Areas supplied by deep perforants  7 (38.9) 
       Subcortical MCA territory 1 (5.56) 
   Specific territories  
       Supratentorial white matter 1 (5.56) 
       CR, BG, CS, IC or other deep white matter regions 1 (5.56) 
       BG and subcortical white matter 1 (5.56) 
       Deep white matter or brainstem 1 (5.56) 
       IC, thalamus, BG, CR, pons and CS 1 (5.56) 
       Lentiform nucleus 1 (5.56) 
       Thalamus, capsule, protuberance and mesencephalon 1 (5.56) 
       Subcortical, i.e. CR, IC and BG 1 (5.56) 
       CR, BG, thalamus and caudate nucleus 1 (5.56) 
       IC, CR, CS, CN, P, GP, thalamus, midbrain, pons and medulla  1 (5.56) 
   
 Old lacunar lesions (n=4) n (%) 
 Site defined 4 (20) 
    Territory supplied by deep/superficial small perforating arteries 1 (25) 
    Deep in the brain 1 (25) 
    Frontal, parietooccipital, temporal, BG and infratentorial regions
a
 1 (25) 
    IC, thalamus, BG, CR, pons and CS 1 (25) 
a
As used for white matter hyperintensities  
MCA, middle cerebral artery; CR, corona radiata; BG, basal ganglia; CS, centum semiovale; IC, internal 
capsule; CN, caudate nucleus; P, putamen; GP, globus pallidus
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Table 4.3 continued 
B. 
  
Acute lesions, n 
(%) 
Old lesions, n (%) 
 Size defined 21 (49) 9 (45) 
 Minimum size stated
a
 4 (9) 6 (30) 
 Maximum size stated
b
 19 (44) 8 (40) 
 aAcute lesions, values 3-5mm; old lesions, range 10-20mm 
 bAcute lesions, values 2-, 3-, 5mm; old lesions, range 10-20mm 
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Table 4.4 Clinical terminology and descriptions used for lacunar stroke 
 
A.   n (%) 
 Lacunar stroke/syndrome/infarction 28 (75.7%) 
 Lacunar, large vessel cervical or intracranial atherosclerosis 1 (2.7%) 
 Ischaemic stroke 2 (5.4%) 
 Subcortical MCA territory infarction/lacunar syndrome 1 (2.7%) 
 Subcortical stroke/lesion/infarction 3 (8.1%) 
 
Acute focal symptoms e.g. hemiparesis or acute aphasia, diagnosed according 
to ICD-9 
1 (2.7%) 
 Pure sensory stroke 1 (2.7%) 
 Cerebrovascular attack 1 (2.7%) 
   
   n (%) 
B. Lacunar syndrome (with or without description of each of the 5 classical 
syndromes)  
14 (56) 
 Lacunar syndrome with reference to imaging findings 5 (20) 
 Symptoms specific to condition under investigation  1 (4) 
 Non-specific  
    Acute focal deficit confirmed by an associated lesion on CT or MRI 1 (4) 
    Focal neurological symptoms 1 (4) 
    Minor focal cerebrovascular events 1 (4) 
    Ischaemic stroke 1 (4) 
 
   Syndrome associated with lacunar infarction in the deep white matter or 
brainstem 
1 (4) 
MCA, middle cerebral artery; ICD, International Classification of Diseases; CT, computerized 
tomography; MRI, magnetic resonance imaging 
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 amongst SVD researchers 
Chapter 5. Wide variation in definition, detection and description of 
lacunar lesions amongst researchers in cerebral small vessel 
disease 
5.1. Introduction 
Lacunar stroke accounts for about 25% of ischaemic stroke (Bamford et al. 1991). On 
brain imaging, lacunar lesions form part of a spectrum of radiological features of 
cerebral SVD. Lacunar and other SVD lesions may have overlapping appearances, e.g. 
recent, small, lacunar infarcts may be difficult to distinguish from WML without DWI or 
prior imaging; and old lacunar cavities may resemble EPVS. Some lacunar infarcts may 
never cavitate, and instead resemble a WML indefinitely (Potter et al. 2010b), making 
cavitation an unreliable marker for prior lacunar infarction. 
A recent survey of 13 neuropathology laboratories showed wide variation in how 
lacunar infarcts and SVD features were defined (Pantoni et al. 2006). A literature review 
showed wide variation in reporting of lacunar-related lesions on imaging (Potter et al. 
2010c). Variations in terminology have complicated research in other related areas such 
as vascular dementia (Chui et al. 2000, Erkinjuntti et al. 1997, Leys and Pasquier 1998, 
Pohjasvaara et al. 2000, Román et al. 1993). Radiological criteria for vascular dementia, 
especially those applying to small vessels, are also variable (van Straaten et al. 2003).
 
 
Variations in imaging definitions of lacunar lesions, difficulties in their detection, and 
variation in lesion classification, once identified, may be hampering lacunar stroke 
research.  
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 amongst SVD researchers 
5.2. Aims 
We used an online survey (SurveyMonkey
TM
; SurveyMonkey.com, Portland, Oregon, 
USA; R. Finley) to assess how researchers interested in cerebral SVD (1) use 
terminology and definitions for lacunar lesions and (2) detect and describe lacunar 
lesions. 
5.3. Methods 
We set up an online survey to send to researchers with an interest in cerebral SVD. We 
asked questions about participant discipline, whether they had previously published on 
lacunar stroke, and, where relevant, whether there had been involvement of a radiologist 
in reading of images in any previous publications.  
To assess definitions of lacunar lesions, we asked participants to select a single answer 
from a list of several options for (1) size of lacunar lesions, (2) site of lacunar lesions 
and (3) definition of EPVS. 
To assess detection and description of lacunar lesions, we used 10 case-based examples 
of brain CT and MRI. MRI sequences used in the case-based examples included axial 
T2, FLAIR and DWI (indicated on the images themselves). We provided a size marker 
on the image, or description of lesion size, in each case. We included a ‘comments box’ 
for all questions to allow queries, difficulties, further explanations and other relevant 
comments to be noted by participants. In the case-based examples, we assessed lesion 
detection and description, tested effects of lesion appearance (cavitation, size, location), 
presence of concomitant WML, and effect of providing prior imaging on lesion 
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detection. We deliberately chose images which allowed us to test one or several of these 
features, and included varying amounts of relevant prior information. We also assessed 
differentiation of lacunes from EPVS. For case-based examples of old lacunar lesions, 
we showed MRI T2 and FLAIR sequences (while withholding the DWI-positive 
imaging from the time of acute lacunar stroke presentation), provided a history of 
symptoms in the relevant hemisphere from the time of original presentation, and 
indicated that no haemorrhage was visible on GRE imaging. To assess degree of 
certainty in lesion detection, we asked participants to indicate if they thought the lesion 
was present: ‘yes, definitely’, ‘yes, probably’, ‘yes, possibly’, or ’no’. 
We identified SVD researchers from a literature review of lacunar lesion definitions 
from three journals related to stroke (Stroke, Journal of Neurology, Cerebrovascular 
Diseases) and from prior knowledge amongst our stroke research group (e.g. previous 
collaboration, discussion at stroke research meetings). We tested the survey in our 
dedicated stroke research group prior to the final, modified version being sent 'live'. A 
web link to the survey was sent to 147 SVD researchers. We indicated in the covering 
email message that the survey would take approximately 10-15 minutes to complete, that 
partially completed surveys could not be saved, and that all responses would be 
anonymous (Appendix 6). We allowed three weeks for completion initially, and sent two 
further reminders, extending the deadline for completion of the survey by a further two 
weeks each time. We also encouraged sending of the survey link to other interested 
colleagues.  
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5.3.1. Analysis 
We assessed the number of participants completing each question, their discipline, and 
previous publication on lacunar stroke (including involvement of a radiologist). For 
definitions of lacunar lesions and EPVS, we assessed the number of participants 
selecting each of the definitions provided. In the case-based examples, we assessed 
effects of lesion appearances (cavitation, site, size), concomitant WML and provision of 
prior imaging on lacunar lesion detection/description, and differentiation of lacunes from 
EPVS. We also downloaded an abbreviated summary of the results from the 
SurveyMonkey
TM 
site (Appendix 7, including survey images). 
5.4. Results 
Fifty-six people responded to the survey, of whom 46/56 (82%) completed all 10 case-
based questions, and 44/56 (79%) completed the entire survey (case-based and non-case-
based questions). The majority of participants were neurologists (25/44, 57%). Other 
disciplines were stroke physicians (12/44, 27%), neuroradiologists (6/44, 14%) and a 
care of the elderly physician (1/44, 2%). Most respondents (37/44, 84.1%) had published 
articles on SVD, most with involvement of a radiologist (27/37, 73%).  
5.4.1. Definitions of lacunar lesions and EPVS 
For definition of site of lacunar lesions, most (43/44, 97.7%) respondents selected 
‘territory of deep perforating arteries – brainstem, BG and white matter’ (Table 5.1). 
Definitions selected for size of acute and old lacunar lesions were more varied: for 
‘acute lacunar infarct’; 17/44 (38.6%) selected 3-20mm and 9/44 (20.5%) selected 3-
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25mm (Table 5.1), and for ’old lacunar infarct’, 27 (61.4%) selected 3-15mm (one 
participant selected 3-25mm). Numbers selecting each size category (3-15mm, 3-20mm, 
3-25mm) were similar for both ‘old lacunar infarct’ and ‘lacune’.  
For EPVS definition, most (27/44, 61.4%) selected ‘small, round or linear lesions along 
the course of penetrating arteries with intensity close to CSF’ (Table 5.1). Definitions we 
provided which did not include specific size criteria were selected more often than those 
which did (32/44, 72.7%, vs 11/44, 25%, respectively; Table 5.1). 
5.4.2. Effect of lacunar lesion appearance (cavitation and size), concomitant 
WML and prior imaging on old lacunar lesion detection and description 
There was a strong tendency to identify CSF-containing cavities as lacunar infarcts. 
Thus, cavitated lesions were identified as lacunar stroke lesions with certainty by 29/46 
(63%) participants (Figure 8A). In the presence of concomitant WML, cavitated lesions 
were much more likely to be identified as lacunar stroke lesions than non-cavitated 
lesions (29/46, 63% vs 4/51, 7.8%, respectively, Figure 8A, B; χ2 p=<0.001), even if 
baseline FLAIR images were provided for comparison (Figure 8C). Indeed, when shown 
a CT scan with a cavity of CSF density in the thalamus (without information on whether 
the original presenting lesion was a haemorrhage or infarct), most respondents selected 
‘lacunar infarct’ (25/56, 44.6%, Figure 9). Non-cavitated lesions were only identified as 
lacunar stroke lesions when large and in the absence of other WML (33/50, 66%, Figure 
8D). 
 
Chapter 5 Varied imaging definitions/detection of lacunar lesions 74 
 amongst SVD researchers 
5.4.3. Differentiation between lacunes and EPVS 
Prominent EPVS were more likely to be mistaken for lacunar infarcts than correctly 
identified as EPVS. Most participants counted EPVS as lacunes (e.g. 21/47, 44.7%, 
selecting ‘>5 lacunes’ when shown the example in Figure 10).  
5.4.4. Effect of lacunar lesion site  
Lesion description varied with lesion site, being greatest for a lacunar lesion located in 
the brainstem. From a list of multiple terms provided, 20/56 (35.7%) opted to provide an 
alternative description for the brainstem lesion, many of which implied an underlying 
mechanism (Figure 11).  
5.5. Discussion  
In an online survey of SVD researchers, we found marked variation in definitions, 
detection and description of lacunar lesions, with even more variation in terminology 
when describing posterior fossa lesions. Most agreed on definitions for lacunar lesion 
site and EPVS but there was less agreement for lacunar lesion size. There was wide 
variation in lesion recognition and classification. Cavitated lesions of any size were 
detected with the highest degree of confidence, but were described using multiple terms, 
including ‘lacunar infarct’ and ‘lacunar stroke’ (even without information about possible 
previous haemorrhage or relevant symptoms). Detection of non-cavitated lacunar 
infarcts in the presence of WML, and differentiation of lacunes from EPVS, was poor.  
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The main strengths of our study were the use of a structured survey designed to assess 
multiple aspects of lacunar lesion description and detection. We tested the survey 
amongst local stroke researchers to improve the design and relevance of the survey prior 
to its distribution. The images were carefully chosen to allow us to test specific features 
that might influence lacunar lesion detection and description. We included images 
demonstrating various SVD features which we expect to be representative of the type of 
imaging being assessed by other lacunar stroke research groups. By specifically 
identifying researchers with an interest in cerebral SVD, we gathered opinions which are 
likely to be most relevant to lacunar stroke research. 
Our study has limitations. Only a third of those invited to participate took part. The 
reasons for non-participation and any differences between participants/non-participants 
are unknown as the responses were anonymous. Not all participants completed the entire 
survey. Forty-four people completed the entire survey, so our data represents only a 
fraction of opinions; however, most respondents were interested in SVD, therefore we 
feel the responses were sufficient in both detail and quality to demonstrate the 
substantial lack of harmony for definitions and detection of lacunar lesions, even 
amongst interested experts. Most respondents were neurologists, with only a few 
neuroradiologists and one stroke physician; however neurologists have contributed the 
highest proportion of the lacunar stroke literature. In most cases, we allowed only a 
single answer, but participants were able to add further comments using a ‘comments 
box’. 
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We found marked variation in terminology for lacunar lesions, particularly for those in 
the brainstem, and a worrying tendency to infer causation rather than simply to describe 
the imaging appearance. Similar heterogeneity was found in a study of neuropathology 
laboratories (Pantoni et al. 2006). There was interchangeable use of the terms ‘lacune’, 
‘lacunar infarct’ and ‘lacunar stroke’ for all lacunar lesions, whether recent or old, 
symptomatic or asymptomatic. This implies a similar etiology for each lesion, which 
may not be true (Wardlaw 2008). Identification of old lacunar lesions was best for 
cavitated lesions, but since only a fifth of symptomatic lacunar infarcts cavitate,
 
cavitation is an unreliable marker for prior lacunar infarction (Potter et al. 2010b). 
Misclassification of old lacunar infarcts as WML, combined with variation in 
terminology, may be contributing to current sources of controversy in epidemiological, 
etiology and risk factor studies of lacunar stroke (Davis and Donnan 2004, Futrell 2004, 
Jackson and Sudlow 2005, Lammie and Wardlaw 1999, Lee et al. 2005a, Leys et al. 
1999, Norrving 2004, Read et al. 1998, Wardlaw et al. 2009). 
In conclusion, detection and description of lacunar lesions on imaging varies widely, 
with under-recognition particularly of old, non-cavitated lacunar lesions. A consensus in 
lacunar lesion definition - with more consistent and accurate use of the several terms 
currently in use for lacunar lesions, accurate lesion description and avoidance of 
assumptions about underlying cause – is urgently needed. 
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5.6. Tables  
Table 5.1 Definitions of lacunar lesions and enlarged perivascular spaces (single answer  
allowed; n=44 except where indicated) 
 
"What do you consider the best definition of 
size for the following lacunar lesions?" 
3-15mm 3-20mm 3-25mm Unsure 
Acute lacunar infarct, n (%) 13 (29.5) 17 (38.6) 9 (20.5) 4 (9.1) 
Old lacunar infarct, n (%) 27 (61.4) 12 (27.3) 1 (2.3) 3 (6.8) 
Lacune, n (%)
a
 24 (55.8) 9 (20.9) 1 (2.3) 7 (16.3) 
a
 n=43     
 
 
"What do you consider the best definition regarding site of lacunar lesions?" n (%) 
Territory of deep perforating arteries - brainstem, basal ganglia (caudate nucleus, lentiform 
nucleus, internal capsule, thalamus) and white matter (corona radiata, centrum semiovale) 
43 
(97.7) 
Subcortical MCA territory 0 (0) 
Clinically relevant areas 0 (0) 
Deep white matter of brain and/or brainstem 1 (2.3) 
Deep in the brain 0 (0) 
MCA, middle cerebral artery  
 
 
"What do you consider the best definition of enlarged perivascular (Virchow-Robin) spaces?"  n (%) 
≤2mm, round or linear lesions along the course of penetrating arteries with intensity close to CSF 
7 (15.9) 
≤2mm, round or linear lesions at point of entry of MCA lenticulostriate arteries into basal 
ganglia, with intensity close to CSF 
4 (9.1) 
Small, round or linear lesions along the course of penetrating arteries, with intensity close to CSF 
27 
(61.4) 
Small, round or linear, lesions at point of entry of MCA lenticulostriate arteries into basal 
ganglia, with intensity close to CSF 
5 (11.4) 
Uncertain 1 (2.3) 
CSF, cerebrospinal fluid; MCA, middle cerebral artery 
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5.7. Figures  
Figure 8 Effect of cavitation and white matter lesions (WML) on detection of old lacunar lesions. 




B. Non-cavitated lesion with WML ("Is there a lesion in the right hemisphere consistent with a lacunar infarct 2 years 
previously?"; n=51) 
  
C. Non-cavitated lesion with WML, but provision of baseline fluid-attenuated inversion recovery (FLAIR) imaging in 
survey ("Is there a lesion in the left cerebral hemisphere consistent with a lacunar infarct?; n=48) 
 
 
D. Non-cavitated but large lesion, with no WML ("Is there a lesion in the right hemisphere consistent with a lacunar 
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Figure 9 Effect of lesion appearance on lacunar lesion description 
 





  n (%) 
 
Lacunar infarct 25 (44.6) 
 
Lacunar stroke 3 (5.4) 
 
Subcortical infarct 3 (5.4) 
 
Subcortical stroke 0 (0) 
 
Small, deep infarct 4 (7.1) 
 
Small, deep stroke 3 (5.4) 
 
Lacune 14 (25) 
 
Black hole 3 (5.4) 
 
White matter lesion 1 (1.8) 
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Figure 10 Differentiation of lacunes from enlarged perivascular spaces (data shown for 47 
respondents) 
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Figure 11 Effect of site of lacunar lesions on descriptions used 
"Which term you consider most appropriate for this acute lesion in a patient with a 17-hour history of 





  n (%) 
 
Lacunar infarct 23 (41.1) 
 
Lacunar stroke 1 (1.8) 
 
Subcortical infarct 1 (1.8) 
 
Subcortical stroke 1 (1.8) 
 
Small, deep infarct 9 (16.1) 
 




Black hole 1 (1.8) 
 
White matter lesion 0 (0) 
 
Other* 20 (35.7) 
   
*Other 
Pontine infarct (n=6)   
Probable infarct - lacune 
Branch artery infarct 
Branch artery disease 
Pontine paramedian infarct (n=3) 
Pontine branch infarct 
Hyperintense vascular lesion in brainstem 
Ischaemic lacunar stroke 
Pontine perforator stroke 
Left pontine ischaemic lesion 
Brain or pontine infarction in paramedian territory, not lacunar 
Lacunar stroke due to proximal perforator occlusion, suggesting large artery disease/embolism as the 
cause 
Probably progressive subacute pontine infarct, given only rim of high DWI signal 
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Section two Neuroimaging of associated features of cerebral small vessel 
disease 
Chapter 6. Lack of a relationship between carotid artery stenosis and 
ipsilateral white matter lesions suggests emboli do not cause 
white matter lesions 
6.1. Introduction 
WML, often termed ‘leukoaraiosis’ (Hachinski et al. 1987), are commonly seen on brain 
MRI, and are generally considered a marker of tissue damage from cerebral SVD. The 
precise cause of WML is unknown (Pantoni and Garcia 1997), but they are associated 
with increasing age, hypertension, diabetes, other vascular risk factors (Jeerakathil et al. 
2004a), and markers of carotid atheroma such as intima media thickening and carotid 
plaques (Bots et al. 1993, Romero et al. 2009). Two studies have shown an apparent 
association between increasing degrees of carotid stenosis and WML (Romero et al. 
2009, Saba et al. 2009), which has led to the suggestion that WML (and, by association, 
lacunar ischaemic stroke) may be caused by atherothromboemboli.  
Amongst all studies that have assessed the relationship between carotid artery stenosis 
and WML, most have examined whole brain rather than hemispheric WML, using 
several methods of carotid stenosis measurement: tightest stenosis (Bogousslavsky et al. 
1987, Lindgren et al. 1994, Manolio 1999, Romero et al. 2009); right carotid artery 
stenosis only (Bots et al. 1993); or stenosis graded basis according to presence of 
unilateral and/or bilateral carotid disease (Adachi et al. 1997, Fazekas et al. 1988, 
 
Chapter 6 Lack of a relationship between carotid stenosis and ipsilateral WMLs 83 
Schmidt et al. 1992). Three studies have considered each hemisphere/carotid artery as 
separate units, with each patient contributing two pairs of scores, but two did not control 
for WML burden in the opposite hemisphere (Altaf et al. 2008, Saba et al. 2009), and the 
third, although adjusting for interdependence of right and left hemispheres, used CT to 
assess WML, which is less sensitive than MRI (Streifler et al. 1995). A single study of 
20 patients assessed the relationship between carotid stenosis asymmetry and WML 
asymmetry (Herholz et al. 1990). Amongst all 12 previous studies, two (Romero et al. 
2009, Saba et al. 2009) (n= 2118 patients) found an association between carotid stenosis 
and WML, and 10 (Adachi et al. 1997, Altaf et al. 2008, Bogousslavsky et al. 1987, Bots 
et al. 1993, Fazekas et al. 1988, Herholz et al. 1990, Lindgren et al. 1994, Manolio et al. 
1999, Schmidt et al. 1992, Streifler et al. 1995) (n=5725) did not (Table 6.1). In addition 
to methodological differences (including methods of WML and stenosis measurement), 
these conflicting results may be attributed to whether or not studies accounted for 
associations with multiple overlapping risk factors, including age, as carotid stenosis and 
WML may both be associated with some other third variable, rather than directly with 
each other.  
6.2. Aims 
We hypothesized that if atherothromboemboli cause WML, then more WML would be 
expected to occur in the cerebral hemisphere distal to increasing degrees of carotid 
stenosis. In this study, we aimed to assess, in two large, separate, prospective cohorts of 
ischaemic stroke patients, the associations 1) between asymmetric carotid stenosis and 
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asymmetric WML and 2) between degree of carotid stenosis and ipsilateral hemispheric 
WML, while controlling for WML burden in the opposite hemisphere.  
6.3. Methods 
6.3.1. Patient recruitment 
We recruited patients from the ESS and the MSS as described above. Briefly, the ESS 
consisted of prospectively recruited consecutive patients with stroke, admitted or seen as 
outpatients at a large academic teaching hospital, between 2002 and 2005; the MSS 
consisted of prospectively recruited consecutive patients, seen at the same hospital, with 
acute lacunar stroke, and control patients with mild cortical stroke, between 2005 and 
2007. In this study, we included only patients with acute ischaemic stroke, where 
symptoms persisted >24 hours.  
6.3.2. Clinical assessment, assessment of risk factors and investigations 
Patients in both studies were assessed by an experienced stroke physician, who recorded 
baseline demographics, NIHSS score, and vascular risk factors. Hypertension and 
diabetes mellitus were defined as previous diagnosis of, or on current treatment for, 
hypertension or diabetes, respectively. In both studies, patients were assigned an OCSP 
classification (Bamford et al. 1991), which was modified following radiological 
assessment. Patients underwent routine stroke investigations, including brain CT or 
MRI, and carotid Doppler ultrasound. All patients from the MSS, and some from the 
ESS, had brain MRI instead of, or in addition to, CT. All patients included in the current 
study had MRI. Written informed consent was obtained from all patients (or guardians 
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of patients) in both studies. Both studies were approved by the Local Research Ethics 
Committee.  
6.3.3. Brain and carotid imaging 
Patients had carotid Doppler ultrasound of both carotid arteries using a 7.5 MHz linear 
transducer. Ultrasound was performed blinded to other imaging results, but not to 
clinical presentation. Carotid artery stenosis was defined according to the North 
American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria (NASCET 
Steering Committee 1991). The carotid artery contralateral to the side of symptoms was 
defined as symptomatic, and the artery ipsilateral to side of symptoms as asymptomatic.  
6.3.4. Brain imaging and imaging classification 
Brain MRI at 1.5T included axial diffusion- and T2WI, and axial FLAIR and other 
sequences as described above. Recent infarcts were defined as hyperintense on DWI, 
hypointense on the apparent diffusion coefficient map and either normal or hyperintense 
to brain on FLAIR/ T2WI, but less hyperintense than cerebrospinal fluid on T2WI. Brain 
MRI in each study was assessed by a neuroradiologist, who was aware of the side of 
acute stroke symptoms but blinded to other clinical and imaging data, including the 
presence of carotid disease. The studies were read at non-overlapping time points. The 
reader of the second study was unaware of the hypothesis being tested and was blinded 
to results of the first study. Each neuroradiologist (JMW, GMP) rated hemispheric 
WML on FLAIR and/or T2WI using the Fazekas scale (Fazekas et al. 1987), scoring 0-3 
for deep and periventricular WML (where 0=none and 3=severe). To assess total 
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hemispheric WML, we combined scores in the hemispheric deep and periventricular 
regions. The less experienced neuroradiologist was trained in WML rating using a 
validated test set of 20 MRI scans demonstrating a full range of WML. 
6.3.5. Analysis 
We assessed the association between carotid stenosis (≥50% NASCET) asymmetry and 
WML asymmetry. We then assessed the association between degree of carotid stenosis 
(measured as a continuous variable) and WML score in the ipsilateral hemisphere, firstly 
without, then with, adjustment for potential confounders (age, diabetes and 
hypertension); we controlled for the opposite hemisphere by analysing left versus right , 
and symptomatic versus asymptomatic, sides for each patient. In the multivariate model, 
we dichotomised scores for overall (periventricular plus deep) WML (0, 0.5, 1.0 versus 
1.5, 2.0, 2.5, 3.0, after halving periventricular and deep WML scores) and for 
periventricular and deep WML (0-1 vs 2-3). All statistical analyses were carried out 
using Minitab Statistical Software Version 15 (Minitab, Inc., State College, PA, USA).  
6.4. Results 
In the ESS, 253 acute stroke patients had brain MRI and carotid Doppler ultrasound, of 
whom 250 had imaging adequate for WML assessment. An additional three patients 
with primary intracranial haemorrhage were excluded, leaving 247 patients (mean age 
69 ± 13 years). In the MSS, 253 patients with acute ischaemic stroke had brain MRI and 
carotid ultrasound (mean age 68 ± 11 years). Vascular risk factors and stroke severity 
were similar in both studies, with a low overall stroke severity score in both (Table 6.2). 
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A final OCSP classification (clinical plus imaging) of lacunar ischaemic stroke was 
present in 80 (32%) of patients in the ESS, vs 129 (51%) in the MSS. Median 
periventricular and deep WML scores were 1 (interquartile range 1-2) in both studies. 
Carotid stenosis on at least one side of ≥50% NASCET was present in 36 (15%) and 
≥70% in 27 (11%) patients in the ESS, and 29 (11%) and 15 (6%) patients in the MSS 
(respectively).  
Carotid stenosis was asymmetric in 28 (11%) and 26 (10%) patients in the ESS and MSS 
respectively (Table 6.3); of these, across both studies, only four had asymmetric WML 
(WML score higher distal to stenosed side in three and distal to the non-stenosed side in 
one). WML were asymmetric between hemispheres in 22 (9%) and 11 (4%) patients in 
the ESS and MSS, respectively; of these, across both studies, only four had asymmetric 
carotid stenosis (stenosis more severe proximal to the side with higher WML score in 
three, and to the side with lower WML score in one). Combining patients from both 
studies, there was no association between carotid stenosis asymmetry and WML 
asymmetry (OR 1.15, 95% CI 0.39 to 3.41). 
Amongst 1000 hemispheres (over stenosis ranging from 0% to 100%), there was no 
association in either study between WML and ipsilateral carotid stenosis, whether 
symptomatic or not (Figure 12). This finding of a lack of an association was unchanged 
in multivariate analysis adjusted for potential confounders (Table 6.4). Increasing age 
was associated with periventricular, deep and overall WML in both studies, whether 
considering carotid stenosis as left and right (p<0.001 for periventricular and deep WML 
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and for overall WMH; Table 6.4), or as symptomatic and asymptomatic (p<0.001 for 
periventricular and deep WML and for overall WMH; Table 6.4).  
6.5. Discussion 
In this study of two large, separate cohorts of acute ischaemic stroke patients, there was 
no association between carotid stenosis asymmetry and WML asymmetry (OR 1.15, 
95% CI 0.39 to 3.41). No association was found between increasing degrees of carotid 
artery stenosis and ipsilateral hemispheric WML, with or without adjustment for 
vascular risk factors. WML were strongly associated with increasing age in both studies 
(p<0.001). 
The main strengths of this study were the inclusion of two separate, prospectively 
collected cohorts of stroke patients with similar baseline patient characteristics, totalling 
500 patients, where brain appearances were assessed on MRI. Data collection methods 
were similar and comprehensive in each study and the same methods of brain and 
carotid artery imaging were used in all patients. Brain MRI was assessed by two 
independent neuroradiologists and both studies included patients with a full range of 
carotid stenosis and WML. We assessed the association between asymmetric carotid 
stenosis and asymmetric WML on a per patient basis and found no association. We 
performed detailed analysis of the relationship between hemispheric WML and 
ipsilateral carotid artery stenosis, while controlling for the opposite cerebral hemisphere 
WML load by considering each of the two artery-hemisphere units per patient as both 
right versus left, and symptomatic versus asymptomatic.  
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There were limitations to our study. The assessment of WML by a different 
neuroradiologist in each study might have led to inconsistencies, and could be 
considered a weakness; however, both neuroradiologists performed image reading to an 
internal standard using a validated test set. We made no adjustment for cardiac or aortic 
arch sources of emboli, but as these would not have any predilection for a particular 
hemisphere, this is unlikely to have any significant influence on our assessment of 
hemispheric WML distal to ipsilateral carotid stenosis. The inclusion of some patients 
with either high grade stenosis or carotid artery occlusion may have acted as a 
confounding factor due to the possibility of hypoperfusion-related WML (Fazekas et al. 
1988), but the number of these was low in both studies. As relatively few patients had 
asymmetric stenosis (11% in the ESS, 10% in the MSS), we cannot fully exclude a 
direct association between WML and carotid stenosis; however, these frequencies of 
asymmetry for carotid stenosis are typical of hospital-admitted stroke patients and WML 
are generally symmetrical, so if an association between carotid stenosis and WML does 
exist, it is likely to be weak, indirect and occur via a co-association with a shared third 
factor. We considered combining the two datasets and analyzing them as one study, but 
we felt that it would be more correct to keep them separate as they were performed as 
separate studies and there were some differences in methodology. However, as both 
studies have independently arrived at the same conclusion, we do not feel that 
combining the data would have made a material difference. 
Carotid artery stenosis is associated with cortical ischaemic stroke and transient 
ischaemic attack. Several studies suggest that carotid stenosis is infrequent in lacunar 
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stroke and may be coincidental (Mead et al. 2002), despite which, emboli are still 
regarded as a cause of lacunar stroke and WML. Amongst 12 previous studies (n=7843) 
assessing stenosis versus WML, two (n=2118) found an association between increasing 
stenosis and increasing global WML and 10 (n=5725) did not show any such association 
(Table 6.1). The populations in the studies are rather variable, only some adjusting for 
some risk factors or age, so it is possible that any association between stenosis and 
WML is actually due to co-association with a third factor which was not adjusted for. 
Three previous studies assessed the specific relationship between increasing degrees of 
carotid artery stenosis and ipsilateral hemispheric WML (n=1395) (Altaf et al. 2008, 
Saba et al. 2009, Streifler et al. 1995), but two relied on CT, which is less sensitive to 
WML (Saba et al. 2009, Streifler et al. 1995) (the rest used MRI), and the other was 
rather small (Altaf et al. 2008). Our results are in agreement with Herholz et al (Herholz 
et al. 1990), who assessed asymmetric WML versus asymmetric carotid stenosis, but in 
only 20 patients. Our multivariate results are in agreement with Altaf et al (Altaf et al. 
2008), although they did not consider carotid artery/hemisphere units in relation to 
symptoms as we have done. Adding our 500 patients to these data means that there are 
now 11 studies, totaling 6225 patients, which have not shown any association between 
WML and carotid stenosis, including four which examined individual artery/hemisphere 
units; of these, ours is the only study to account for the opposite artery/hemisphere unit 
by considering left versus right, and symptomatic versus asymptomatic, sides.  
In conclusion, in this study of two large cohorts of patients with ischaemic stroke, we 
found no link between degree of carotid stenosis and ipsilateral hemispheric WML, 
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whether the carotid stenosis was symptomatic or not. The totality of existing data would 
suggest that there is now substantial evidence that emboli have little role in the 
formation of WML (or by association, with most lacunar ischaemic stroke) and that any 
suggestion of an association in previous studies between embolic sources (e.g. atrial 
fibrillation or carotid disease) and WML may simply have been due to a third mediating 
factor, such as age or hypertension. Future studies should therefore focus on determining 
what causes the intrinsic small vessel pathological changes that appear to underlie most 
WML. Until the precise mechanisms underlying WML are elucidated, current therapies 
directed towards WML will likely remain focused on control of vascular risk factors. 
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6.6. Tables 
Table 6.1 Previous studies investigating association between carotid artery stenosis measured by Doppler ultrasound* and white matter  
lesions (WML) (table continues on following page) 
 








        
Unilateral/highest % carotid stenosis (either side) vs global WML    
Romero et al. 
2009 
1971 Framingham Offspring Cohort 
(prospective epidemiologic study 





WML volume related to 
stenosis ≥50% after adjustment 
for vascular risk factors (OR 
2.35, 95% CI 1.08-5.13) 
Positive 
Manolio et al. 
1999 
3502 Cardiovascular Health Study 
(cross-sectional study of men 
and women ≥65 years) 




WML associated with 






77 Randomly selected patients ≥35 
years with no history of focal 
brain lesions 




No relationship between WML 




et al. 1987 
31 Patients with 
leukoencephalopathy and 







Patients with WML less often 
had ≥50% stenosis‡ or 
occlusion vs controls (p<0.05) 
OR not given 
Negative 
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Table 6.1 continued    








Right % carotid stenosis vs global WML    
Bots et al. 
1993 
111 Randomly selected patients aged 
65 to 85 years from Rotterdam 
Scan Study (prospective follow-
up of people aged ≥55 years 
investigating incidence of chronic 
disabling diseases) 




No difference in prevalence of 
minimal, or moderate to severe, 
stenosis§ (right carotid artery) 
between groups with/without 
WML 
Negative 
      
Unilateral/highest and/or bilateral stenosis vs global WML    
Schmidt et al. 
1992 
234 133 consecutive stroke patients 
and 101 normal volunteers 





No relationship between WML 
and stenosis|| in multivariate 
analysis adjusted for vascular risk 
factors  
Negative 
Adachi et al. 
1997 
323 Patients with cerebrovascular 
disease, neurological disease, 
diabetes, ischaemic heart disease 




Periventricular No relationship between severity 
of periventricular WML and 
stenosis# 
Negative 
Fazekas et al. 
1988 
52 Volunteers in prospective field 
study on incidence of 





Higher grade stenosis** not 
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Table 6.1 continued  








Unilateral % carotid stenosis vs ipsilateral hemispheric WML, each patient contributing two hemisphere-artery units  
Altaf et al. 
2008 
178 Recent anterior circulation TIA, 
minor strokes, and amaurosis 






WML volume not related to 




Saba et al. 
2009 
147 Consecutively registered 
patients ≥65 years undergoing 
CT of brain and carotid arteries 





Association between WML and 
carotid stenosis class, adjusted 
for age and vascular risk factors 
(OR 1.365, 95% CI 1.073-1.737, 
p=<0.05) 
Positive 
Streifler et al. 
1995 
1197 Patients enrolled in NASCET 
with recent ischaemic 
symptoms and no cardiac 
source of embolism 
CT Visual rating 
scale 
Periventricular WML not related to degree of 
ipsilateral stenosis*** (OR 
[severe vs mild stenosis] 1.08, 
95% CI 0.73-1.62; p=0.952) 
Negative 
Carotid stenosis asymmetry vs hemispheric WML asymmetry  
Herholz et al. 
1990 
20 Patients evaluated because of 
suspected cerebrovascular 
disease  
MRI Visual rating 
scale 
Hemisphere; 
location not stated 
No correlation between 
hemispheric WML asymmetry 
and stenosis asymmetry (τb 
=0.35; p=0.074) 
Negative 










Table 6.1 continued  
 
†Graded as 0%; 1-24%; 25-49%; 50-74%; 75-99%; and 100% stenosis  
‡Graded: normal or <50% stenosis; 50-74%; 75-99%; occluded 
§Graded normal; minimal (1-15% stenosis); moderate (16-49%); severe (≥50%) 
||Graded 0, no atherosclerotic lesion (ASL); 1, discrete ALS one side (<20%); 2, 20-50% one side or discrete ASL both; 3, 50-70% one side or 20-50% both; 4, 
>0% one side , 50-70% both, or occlusion one side; 5, ≥70% or occlusion both sides 
#Graded 1-5: 1, no lesions; 2, <30% stenosis; 3, 30-75%; 4, ≥75%; 5, occlusion; grouped as: 1, unilateral grade 2 or lower; 2, bilateral grade 2 or unilateral grade 
3; 3, bilateral grade 3 or unilateral grade 4; 4, bilateral grade 4 or above or unilateral grade 5 
**Graded 0-3: 0, no lesion; 1, unilateral <20% stenosis; 2, bilateral <20% or unilateral 20-50% stenosis; 3, bilateral 20-50% or unilateral ≥50-70% stenosis  
***Graded mild, <30% stenosis; moderate, 30-69%; severe, 70-99%; occluded; τb = tau beta statistic 
MRI, magnetic resonance imaging; CT, computed tomography; OR, odds ratio; CI, confidence interval; TIA, transient ischaemic attack; NASCET, North 
American Symptomatic Carotid Endarterectomy Trial  
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Table 6.2 Baseline clinical and imaging characteristics for Edinburgh Stroke Study (ESS) and 







Demographics*   
Age in years (± SD) 69 ± 13 68 ± 11 
Male (%) 133 (54) 165 (65) 
Previous stroke (%) 45 (18) 23 (9) 
Diabetes 25 (10) 36 (14) 
Hypertension (%) 131 (53) 154 (61) 
Previous AF (%) 40 (16) 22 (9) 
Lacunar stroke subtype 80 (32) 129 (51) 
NIHSS, median (IQR) 1 (0-3)† 2 (2-3) 
Imaging parameters   
PVL‡, median (IQR) 1 (1-2) 1 (1-2) 
DWML‡, median (IQR) 1 (1-2) 1 (1-2) 
*Shown as n (%) unless otherwise indicated  
†n=230 
‡PVL and DWML rated according to Fazekas scale 
SD, standard deviation; AF, atrial fibrillation; NIHSS, National Institutes of Health Stroke Scale; IQR, interquartile 
range; PVL, periventricular white matter lesions; DWML, deep white matter lesions 
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Table 6.3 Association between carotid stenosis asymmetry and white matter lesions (WML) 
asymmetry in the Edinburgh Stroke Study (ESS) and Mild Stroke Study (MSS) 
 
ESS   WML asymmetric WML symmetric Total 
 Stenosis asymmetric 2
a
 26 28 
 Stenosis symmetric 20 199 219 
 Total 22 225 247 
 
a
 WML score higher distal to stenosed side in both 
     
     
MSS   WML asymmetric WML symmetric Total 
 Stenosis asymmetric 2
b
 24 26 
 Stenosis symmetric 9 218 227 
 Total 11 242 253 
 
b
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Table 6.4 Association between hemispheric white matter lesions (WML) and carotid artery stenosis adjusted for vascular risk factors for  
symptomatic/asymptomatic hemispheres, shown for the Edinburgh Stroke Study (ESS) and Mild Stroke Study (MSS) 
 
  Symptomatic hemisphere WML Asymptomatic hemisphere WML 
 ESS MSS ESS MSS 
 OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P 
Increasing age 1.08 (1.05, 1.11) 0.000 1.11 (1.08, 1.14) 0.000 1.08 (1.06, 1.11) 0.000 1.11 (1.08, 1.15) 0.000 
Diabetes 0.83 (0.33, 2.06) 0.685 0.91 (0.40, 2.04) 0.811 0.94 (0.37, 2.35) 0.888 0.78 (0.34, 1.76) 0.544 
Hypertension 1.50 (0.85, 2.65) 0.162 1.01 (0.55, 1.86) 0.968 1.40 (0.79, 2.46) 0.250 0.96 (0.52, 1.79) 0.904 
Carotid artery stenosis (%) 1.00 (0.99, 1.01) 0.865 1.01 (1.00, 1.03) 0.117 0.99 (0.98, 1.01)  0.418 0.99 (0.98, 1.01) 0.476 
OR, odds ratio; CI, confidence interval 
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6.7. Figures 
 
Figure 12 Relationship between hemispheric white matter lesion (WML) and ipsilateral carotid 
stenosis (% NASCET) in the ESS (Study 1) and the MSS (Study 2), showing 
symptomatic versus asymptomatic sides. 
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Chapter 7. Are enlarged perivascular spaces associated with white 
matter hyperintensities and lacunar stroke? 
7.1. Introduction 
Perivascular spaces (PVS), or Virchow-Robin spaces, surround the walls of arteries, 
arterioles, veins and venules as they course from the subarachnoid space through the 
brain parenchyma (Kwee and Kwee 2007). PVS are commonly seen on brain MRI but 
are frequently ignored or considered normal.  
The pathophysiology of EPVS in unclear, but they may be part of the spectrum of age-
related SVD, previous studies having shown an association with lacunar stroke 
(Adachi et al. 2000, Doubal et al. 2010), WMH (Doubal et al. 2010), CADASIL 
(Cumurciuc et al. 2006) and vascular dementia (Patankar et al. 2005). Similarly, the 
diagnostic and prognostic significance of EPVS are not fully known at present. EPVS 
appear in small numbers in all age groups, but their frequency increases with 
advancing age, in association with worse cognition in otherwise normal older subjects 
(MacLullich et al. 2004) and patients with diabetes (Ferguson et al. 2003), and in 
several disease states, including depression at older ages (Patankar et al. 2007), 
multiple sclerosis (Wuerfel et al. 2008), myotonic dystrophy (Di Costanza et al. 2001) 
and Parkinson’s disease (Laitinen et al. 2000).  
7.2. Aims 
In this study, we tested the association of EPVS with WMH and lacunar stroke subtype 
in an independent cohort of ischaemic stroke patients. 
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7.3. Methods 
7.3.1 Patient recruitment, clinical assessment, assessment of risk factors and 
investigations 
We recruited patients from the ESS as described above. Briefly, patients were 
diagnosed and subtyped by a stroke physician using the OCSP classification into 
LACS, PACS, TACS and POCS (Bamford et al. 1991). Initial clinical classification 
was modified by radiological assessment. Patient demographics and risk factors were 
recorded, including age, history of diabetes, hypertension and previous clinical 
presentation with TIA or stroke (Jackson et al. 2008). In the current study we included 
only those patients with acute stroke who underwent MRI. The ESS was approved by 
the Local Research Ethics Committee and all patients (or their relatives) gave written 
informed consent. 
7.3.2. Brain imaging and imaging classification 
Patients underwent 1.5T MRI (GE Signa LX EchoSpeed scanner, Milwaukee, WI, 
USA) as described above. Images were reviewed by a neuroradiologist (GMP) who 
was blinded to all clinical details except for age and sex (present on MR images). 
Location and size of recent infarcts were recorded. Recent infarcts were defined as 
hyperintense on DWI/hypointense on the apparent diffusion coefficient map, and either 
normal or hyperintense to normal brain on FLAIR/T2 imaging (less hyperintense than 
cerebrospinal fluid on T2). Acute lacunar infarcts were defined as round or ovoid 
lesions measuring ≤20mm in maximal diameter in the white matter, BG or brainstem. 
EPVS (defined as ≤2mm round or linear CSF-isointense lesions along the course of 
 
Chapter 7 Are EPVS associated with WMH and lacunar stroke? 102 
penetrating arteries, T2-hyperintense and T1/FLAIR-hypointense) were rated on T2 
imaging (with all sequences available) in the BG and CS using a local rating scale from 
0-4, where 0=none, 1=1-10, 2=11-20, 3=21-40 and 4=>40 EPVS (MacLullich et al. 
2004). Total EPVS scores were calculated by combining CS EPVS (CS-EPVS) and 
BG EPVS (BG-EPVS) scores to give a score of 0-8. Periventricular and deep WMH 
were rated 0-3 using the Fazekas method (Fazekas et al. 1987). The neuroradiologist 
was familiarised with the WMH rating scale using a local validated test set of images. 
We recorded presence of old infarcts (using all sequences) and rated deep and 
superficial cerebral atrophy from 0-3 using a validated scale, where 0=none and 
3=severe (Farrell et al. 2009).  
7.3.3. Analysis 
Total EPVS were normally distributed and were analysed using multiple linear 
regression. We assessed univariate associations of EPVS using the Pearson correlation 
for age, the Student’s t-test for dichotomised variables (previous stroke, diabetes, old 
infarcts and presence of lacunar stroke subtype) and linear regression for WMH. We 
used multiple regression to assess effects of explanatory variables (age, previous 
stroke, hypertension, diabetes, periventricular WMH, deep WMH, old infarcts, atrophy 
and lacunar stroke subtype) in predicting number of total EPVS. We assessed 
univariate and multivariate associations of BG- and CS-EPVS. BG- and CS-EPVS 
were not normally distributed and were dichotomised as 0-1 vs 2-4 to permit binary 
logistic regression. We dichotomised scores for WMH (0-1 vs 2-3) and for atrophy 
(combining superficial and deep atrophy scores to give a score 0-6, then dichotomising 
as 0-3 vs 4-6). Patients with both PACS and TACS were considered as cortical stroke. 
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All analyses were performed using Minitab Statistical Software Version 15 (Minitab, 
Inc., State College, PA, USA).  
7.4. Results 
We recruited 298 patients with a mean age of 68 years (Table 7.1). Eighty-nine 
(29.9%) patients were diagnosed with LACS, 113 (37.9%) with PACS, 20 (6.7%) with 
TACS and 69 (23.2%) with POCS. Clinical diagnosis was uncertain in seven (2.3%). 
Mean total EPVS score was 4, and the median score for periventricular WMH and 
deep WMH was 1; a higher atrophy category was present in 61 (20.5%) patients (Table 
7.1). 
7.4.1. Associations of total EPVS 
Total EPVS were associated with increasing age, hypertension, periventricular WMH 
and deep WMH (all p<0.001), atrophy (p=0.001) and old infarcts (p=0.04; Table 7.2). 
In multivariate analysis after adjustment for vascular risk factors and periventricular 
WMH, only age (p=0.01) and deep WMH (p=0.005) remained significantly and 
independently associated with total EPVS; previous stroke also showed a significant 
association (Table 7.2).  
7.4.2. Associations of BG- EPVS 
On univariate analysis, BG-EPVS were associated with age, periventricular WMH, 
deep WMH, CS-EPVS and atrophy (all p=<0.001, Table 7.3). On multivariable 
analysis, only age (p=0.001), CS-EPVS (p<0.001) and atrophy (p=0.03) remained 
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significant. There was also a significant association between BG-EPVS and lacunar 
stroke subtype (p=0.04; Table 7.3). 
7.4.3. Associations of CS-EPVS 
On univariate analysis, CS-EPVS were associated with age (p=0.002), periventricular 
WMH (p=0.01) and BG-EPVS (p=<0.001); only BG-EPVS showed a significant 
association with CS-EPVS in multivariate analysis (p=<0.001), correcting for all other 
explanatory variables in the table (Table 7.4). 
7.5. Discussion 
Amongst 298 patients with ischaemic stroke, total EPVS were associated with age, 
deep WMH and previous stroke on multivariate analysis after adjustment for vascular 
risk factors and periventricular WMH. In multivariate analysis, BG-EPVS were 
associated with lacunar stroke subtype, increasing age, CS-EPVS and atrophy.  
There were strengths in our study. We used a cohort of prospectively recruited patients 
with acute ischaemic stroke who were carefully assigned an OCSP subtype by an 
experienced stroke physician using a combination of clinical and radiological 
assessment. All patients underwent standardised brain MRI. We used a large cohort of 
patients, enabling us to assess several possible explanatory variables. We assessed 
EPVS associations using both combined (BG- and CS-EPVS) as well by separate BG 
and CS locations, which enabled us to compare EPVS associations between these sites. 
EPVS were assessed using a rating scale previously shown to have high intrarater 
agreement (MacLullich et al. 2004) and which allowed us to record a full range of 
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EPVS, from none to >40. We performed multivariate analysis in order to correct for as 
many confounding factors as possible. 
Limitations to our study include the use of a single image rater. However, 
‘recalibration’ using a test set of images was performed during rating in order to try 
and minimise intra-rater variability.  
At present, the diagnostic and prognostic significance of EPVS are not fully known. 
Our findings of an association between BG-EPVS and WMH are similar to findings by 
Doubal et al (2010), although our patient cohorts were slightly different. Our findings 
of an association with age and WMH are also in agreement with Rouhl et al (Rouhl et 
al. 2008), who found association between BG-EPVS and age, hypertension, 
asymptomatic lacunar infarcts, and WMH. However, these associations were 
investigated in patients with a first lacunar stroke, rather than in a cohort including all 
stroke subtypes. 
The causes for EPVS are unclear. Blood-brain barrier dysfunction may play a role in 
the aetiology of lacunar stroke (Wardlaw et al. 2009) and in patients with multiple 
sclerosis, in which EPVS become more visible with development of active 
inflammation and subside again as inflammatory activity wanes (Wuerfel et al. 2008). 
EPVS are conduits for drainage of interstitial fluid from the brain (Abbott 2004, 
Warlow et al. 1992), so it is highly relevant if they alter in visibility with inflammation, 
given that SVD may have an inflammatory component. EPVS are also more frequent 
compared to healthy controls in CADASIL (Cumurciuc 2006) where there is altered 
vessel wall permeability and extravasation of plasma proteins into the PVS (Poirier et 
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al. 1983). It seems plausible that blood-brain barrier dysfunction may also play a role, 
as yet undefined, in the formation of EPVS. 
Another hypothesis for the aetiology of EPVS includes ex-vacuo dilatation secondary 
to shrinkage of cerebral tissue after demyelination and axonal loss. In our study, we 
found an association between BG-EPVS and atrophy, but not between total or CS- 
EPVS and atrophy. However, no association between atrophy and EPVS was 
demonstrated in previous studies of patients with ischaemic stroke (Doubal et al. 2010) 
or multiple sclerosis (Wuerfel et al. 2008). 
In conclusion, our study, showing an association between total EPVS and WMH, and 
between BG-EPVS and lacunar stroke, provides further evidence that EPVS may be a 
further imaging marker for cerebral SVD. Our findings should be confirmed in larger 
studies with similar patients. Given the growing evidence that EPVS are not as benign 
as once thought and may be part of the spectrum of SVD, EPVS should not be ignored, 
but included in the overall imaging assessment of cerebral SVD. 
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7.6. Tables 
Table 7.1 Baseline characteristics of study subjects (n=298) 
Characteristic  
Mean age in years (SD) 68.4 (13.3) 
Previous TIA n (%) 51 (17.1) 
Previous stroke n (%) 79 (26.5) 
Hypertension n (%) 156 (52.3) 
Diabetes n (%) 27 (9.1) 
Lacunar stroke subtype n (%) 89 (29.9) 
Deep WMH Fazekas score, median (IQR) 1 (1-2) 
Periventricular WMH Fazekas score, median (IQR) 2 (1-2) 
Atrophy n (%) 61 (20.5) 
Old infarcts n (%) 89 (29.9) 
Mean total EPVS score (SD) 4 (1.7) 
SD, standard deviation; TIA, transient ischaemic attack; WMH, white 
matter hyperintensities; IQR, interquartile range; EPVS, enlarged 
perivascular spaces 
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Table 7.2 Univariate (A) and multivariate (B) associations with total (basal ganglia and 
centrum semiovale) enlarged perivascular spaces (EPVS)  
 
A. Variable Statistic used and test score p value 
 Age Pearson coefficient 0.422 <0.001* 
 
Previous stroke t-test difference in EPVS score 0.033  
(-0.393 to 0.460) 
0.88 
 
Hypertension t-test difference in EPVS score -0.676  
(-1.049 to -0.302) 
<0.001* 
 
Diabetes t-test difference in EPVS score 0.356  
(-0.294 to 1.005) 
0.27 
 Periventricular WMH Linear regression adj r squared 24.8% <0.001* 
 Deep WMH Linear regression adj r squared 22.6% <0.001* 
 Atrophy Linear regression adj r squared 3.4% 0.001* 
 
Old infarcts t-test difference in EPVS score 0.4  
(0.02 to 0.779) 
0.04* 
 
Lacunar stroke subtype (compared 
with cortical stroke) 
t-test difference in EPVS score 0.16 0.48 
 
*Significant at p<0.05; WMH, white matter hyperintensities 
B. Variable Beta coefficient p value 
 Age 0.02 0.01* 
 Previous stroke -0.27 0.006* 
 Hypertension 0.25 0.15 
 Diabetes -0.31 0.31 
 Periventricular WMH 0.31 0.08 
 Deep WMH 0.44 0.005* 
 Old infarcts -0.01 0.97 
 Atrophy -0.003 0.42 
 
Lacunar stroke subtype 
(compared with cortical stroke) 
0.15 0.42 
 *Significant at p<0.05; WMH, white matter hyperintensities 
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Multivariate OR (95% 
CI)  
Age <0.001 1.08 (1.05-1.10)* 0.001 1.06 (1.02-1.09)* 
Hypertension 0.015 1.78 (1.12-2.82)* 0.84 0.94 (0.50-1.76) 
Diabetes 0.3 0.65 (0.29-1.46) 0.48 0.68 (0.24-1.98) 
Deep WMH <0.001 3.00 (2.19-4.11)* 0.22 1.43 (0.81-2.54) 
Periventricular WMH <0.001 3.48 (2.53-4.80)* 0.08 1.73 (0.95-3.15) 
Old infarcts 0.05 1.59 (1.00-2.54) 0.4 0.76 (0.40-1.45) 
CS-EPVS <0.001 3.00 (2.21-4.07)* <0.001 3.27 (2.20-4.85)* 
Atrophy <0.001 3.64 (1.95-6.81)* 0.03 2.72 (1.08-6.84)* 
Lacunar stroke subtype (compared 
with cortical stroke) 
0.26 1.36 (0.79-2.34) 0.04 2.08 (1.04-4.17)* 
*Significant at p<0.05     
OR, odds ratio per unit increase in the explanatory variable; CI, confidence interval; WMH, white matter hyperintensities; CS-
EPVS, centrum semiovale enlarged perivascular spaces 
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Univariate OR (95% 
CI)  Multivariate p value 
Multivariate OR (95% 
CI)  
Age 0.002 1.03 (1.01-1.05)* 0.76 1.00 (0.98-1.03) 
Hypertension 0.13 1.5 (0.89-2.52) 0.69 1.13 (0.63-2.01) 
Diabetes 0.62 1.27 (0.49-3.28) 0.39 1.58 (0.56-4.46) 
Deep WMH 0.07 1.29 (0.98-1.7) 0.29 0.75 (0.44-1.29) 
Periventricular WMH 0.01 1.46 (1.1-1.93)* 0.72 1.11 (0.63-1.97) 
Old infarcts 0.31 1.32 (0.77-2.24) 0.53 1.22 (0.66-2.23) 
BG-EPVS <0.001 2.56 (1.76-3.74)* <0.001 2.96 (1.87-4.69)* 
Atrophy 0.98 1.01 (0.53-1.91) 0.17 0.55 (0.24-1.30) 
Lacunar stroke subtype (compared 
with cortical stroke) 
0.47 0.8 (0.44-1.46) 0.25 0.69 (0.37-1.29) 
*Significant at p<0.05     
OR, odds ratio per unit increase in the explanatory variable; CI, confidence interval; WMH, white matter hyperintensities; BG-
EPVS, basal ganglia enlarged perivascular spaces 
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Chapter 8. Quantification of enlarged perivascular spaces (EPVS): 
development and observer variability of an EPVS rating scale 
8.1. Introduction 
EPVS surround the walls of arteries, arterioles, veins and venules as they course from 
the subarachnoid space through the brain parenchyma (Kwee and Kwee 2007). EPVS 
are normally microscopic and are thought to be visualised on T2-weighted brain MRI 
only when enlarged. Previous studies have suggested that EPVS may act as drainage 
pathways in the brain (Abbott 2004, Esiri and Gay 1990, Warlow et al. 1992), and when 
enlarged, may represent interstitial fluid trapped in the subpial or interpial space of the 
brain (Ozturk and Aydingoz 2002). 
At present, the diagnostic and prognostic significance of EPVS are not fully known. 
Although EPVS appear in small numbers in all age groups, their frequency increases 
with advancing age, in association with worse cognition in otherwise normal older 
subjects (MacLullich et al. 2004) and patients with diabetes (Ferguson et al. 2003), and 
in several disease states including CADASIL (Cumurcuic 2006), depression at older 
ages (Patankar et al. 2007), multiple sclerosis (Wuerful 2008), myotonic dystrophy (Di 
Costanza et al. 2001) and Parkinson’s disease (Laitinen et al. 2000). EPVS are also part 
of the spectrum of age-related SVD, previous studies having shown an association with 
lacunar stroke (Adachi et al. 2000, Doubal et al. 2010), WML (Doubal et al. 2010) and 
vascular dementia (Patankar et al. 2005).  
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Since the recognition of WML on cross sectional imaging in the 1980s, multiple WML 
rating scales have been developed (Fazekas et al. 2002), but EPVS are not included in 
any of these. Several EPVS rating scales have been described (Adachi et al. 2000, Di 
Costanza et al. 2001, Groeschel et al. 2006, Heier et al. 1989, MacLullich et al. 2004, 
Patankar et al. 2005, Rouhl et al. 2008), but these appeared limited in either the 
anatomical location or range of EPVS that they describe, or in their method of assessing 
frequency and severity. Knowledge of the observer variability of EPVS rating scales is 
essential if the diagnostic and prognostic significance of EPVS are to be investigated 
effectively. Previous testing of a local EPVS rating scale (MacLullich et al. 2004) 
showed good intrarater agreement for BG-EPVS and moderate agreement for centrum 
CS-EPVS. 
8.2. Aims 
We aimed to develop an improved scale and test its observer agreement. 
8.3. Methods 
8.3.1. Review of previously published EPVS rating scales and selection of a 
scale for revision 
We searched for and reviewed previously published EPVS rating scales (Adachi et al. 
2000, Di Costanza et al. 2001, Groeschel et al. 2006, Heier et al. 1989, MacLullich et al. 
2004, Patankar et al. 2005, Rouhl et al. 2008; Table 8.1). A neuroradiologist (GMP) 
applied each scale on two occasions to a test set of 20 standard T2-weighted MR scans, 
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from older subjects with and without stroke symptoms, that had been selected to 
represent a range of WML, noting the ease of use and time required to become familiar 
with each scale. The scale used by MacLullich et al (MacLullich et al. 2004) appeared 
most comprehensive and easy to use and was selected for further revisions in an attempt 
to create an easy to use, comprehensive EPVS rating scale. 
8.3.2. Development and testing of a revised EPVS rating scale 
Regions to be assessed: We retained BG and CS regions (included in all but one of the 
previously published scales; Table 8.1) and added the midbrain (MB) (included in one 
previous scale; Table 8.1) as these are three major sites for EPVS (Kwee and Kwee 
2007). We removed the hippocampus because of its variable visualisation on axial 
images and because hippocampal EPVS may be confused with hippocampal fissural 
cysts, currently thought to be normal variants. As most people will demonstrate EPVS in 
the anterior perforated substance (Groeschel et al. 2006), EPVS in this region are 
unlikely to be a reliable indicator of EPVS frequency or severity; we therefore chose not 
to add this to the revised scale. We did not separate EPVS into sub-regions in the BG (as 
done by Patankar et al (Patankar et al. 2005), as this was found to be both difficult and 
time-consuming; or in the CS (as done by Rouhl et al; Rouhl et al. 2008). We tested 
effects on rating consistency of using pre-defined slices and regions, e.g. for BG-EPVS, 
using the slice showing the maximal BG area, and for CS-EPVS, regions defined by pre-
defined gyri and sulci, but since none of these methods led to an improvement in 
consistency, they were not incorporated into the revised scale. 
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Method of rating: We retained the frequency and range of EPVS used by MacLullich et 
al
 
(MacLullich et al. 2004) as follows: 0=no EPVS, 1=1-10 EPVS, 2=11-20 EPVS, 
3=21-40 EPVS, 4=>40 EPVS (Figure 13; Appendix 8). These categories are similar to 
those used by Rouhl et al. previously (Rouhl et al. 2008) and best reflect the possible 
frequency and range of EPVS, unlike previous scales in which EPVS range and 
frequency are limited (Adachi et al. 2000, Heier et al. 1989, Patankar 2005) or in which 
every individual EPVS requires to be counted (Di Costanza et al. 2001). Unlike two 
previous studies (Di Costanza et al. 2001, Heier et al. 1989), we did not include size 
criteria due to difficulties in distinguishing between EPVS measuring <2mm and 2-
3mm. We used frequency and range of EPVS in preference to dichotomisation by 
appearance (dilated vs non-dilated; Groeschel et al. 2006, since we considered this a 
more sensitive and accurate method of EPVS assessment. Although excluded in one 
previous scale (Rouhl et al. 2008), we chose to include EPVS surrounded by a FLAIR-
hyperintense rim, since although the exact nature of these is unclear, they are likely to 
form part of the same spectrum of cerebral SVD.  
EPVS rating scale user guide: Prior to testing of the revised rating scale, we constructed 
a ‘user guide’ with detailed definitions, descriptions and clear examples 
(http://www.sbirc.ed.ac.uk/documents/epvs-rating-scale-user-guide.pdf; Appendix 9). 
EPVS were defined as small, sharply delineated structures of CSF intensity measuring 
≤2mm following the course of perforating vessels. We provided examples for each 
rating category and for each region, gave instructions on slice selection, and highlighted 
potential difficulties, such as differences in EPVS visibility and presence of WML. 
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Following observer testing in the present study, we added further instructions to avoid 
the residual sources of observer disagreement.  
Assessment of observer variability of the revised EPVS rating scale: Two different 
neuroradiologists (ZM, JMW), blinded to the other’s ratings, tested the modified EPVS 
rating scale by each rating 60 T2-weighted MR scans (with T1-weighted, FLAIR, and 
GRE imaging also available) on two separate occasions. Images were reviewed by each 
rater at least one week apart and in a random order (using a web-based random number 
service, RANDOM.ORG) on each occasion. MRI scans were selected from a local 
hospital-based stroke registry (the ESS, Jackson et al. 2008; www.dcn.ed.ac.uk/ess/) and 
a cohort of older community-dwelling well people (the Lothian Birth Cohort 1936 
Study; Deary et al. 2007) and assessed digitally using the national Kodak Picture 
Archiving and Communication System. The 60 MRI scans included a full range of 
EPVS and demonstrated varying background brain appearances, including WML and 
lacunes.  
8.3.3. Analysis 
We quantified observer agreement using the unweighted kappa (κ) statistic for EPVS 
grades after dichotomizing the five potential categories into categories 0-2 versus 3-4. 
Analyses were performed using the Statistical Package for the Social
 
Sciences Version 
14 (SPSS Inc., Chicago, IL, USA). Confidence intervals for κ and median scores for 
BG- and CS-EPVS were calculated using Minitab Statistical Software Version 15 
(Minitab, Inc., State College, PA, USA).  
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8.4. Results 
 
8.4.1. Intra- and interrater agreement for the modified EPVS rating scale 
Between the first and second ratings, there was a trend towards higher BG- and CS-
EPVS ratings for rater 1 (median scores 2 for BG-EPVS and CS-EPVS vs 3 and 2.5, 
respectively, on repeat rating) and a trend towards lower rating by rater 2 (median scores 
for BG-EPVS and CS-EPVS of 3 and 2, respectively, vs 2.5 and 2 on repeat rating; 
Table 8.2). 
Intrarater agreement was similar in all locations, being good for CS- and MB-EPVS (κ 
range, 0.60 to 0.72) and highest for BG-EPVS (κ 0.73, 0.86 for rater 1, 2, respectively; 
table 8.2). Interrater agreement was moderate for CS- and MB-EPVS on both ratings (κ 
range 0.41 to 0.58) and highest for BG-EPVS (κ 0.86, initial rating; Table 8.2).  
8.4.2. Sources of discrepancy using the modified EPVS rating scale 
On close review of sources of discrepancy, it was clear that most disagreements were 
due to very small but visible EPVS, extensive WML or presence of multiple lacunes 
(Table 8.3; Figure 14). Very small EPVS could be discriminated by their intensity lower 
than CSF and we decided that these should not be counted as true EPVS. WML, 
especially when extensive and confluent, accounted for disagreements in the CS as the 
WML obscured EPVS. Lacunes contributed to disagreements in the BG region (Table 
8.3). Disagreement also occurred when there was asymmetry in background brain 
parenchyma (due to a previous unilateral total anterior circulation infarction), and where 
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EPVS were asymmetrical (Table 8.3). EPVS with a surrounding FLAIR-hyperintense 
rim did not contribute to intra- or interrater disagreement.  
8.5. Discussion 
We reviewed existing EPVS visual rating scales, identified omissions or ambiguities in 
each, and used this combined knowledge to design improvements to one existing scale 
that already most closely met requirements for a comprehensive easy-to-use scale. Two 
other radiologists then tested this revised scale on 60 MRI scans chosen to demonstrate a 
full range of EPVS frequencies, backed by a comprehensive user guide with further 
modifications to help avoid residual sources of observer variation.  
Using this revised scale, two observers showed similar intrarater agreement for BG-, 
CS- and MB EPVS (MB-EPVS) ranging from good to very good kappa values. 
Interrater agreement was moderate for CS- and MB-EPVS on both ratings although very 
good for BG-EPVS on the initial rating. Disagreements were mainly due to the counting 
of very small but just visible EPVS, which were a recognised source of difficulty prior 
to rating. Other main causes for disagreement were the presence of numerous 
background WML particularly when confluent and lacunes (in the CS and BG regions, 
respectively). 
Strengths of our study included the deliberate selection of a large sample of cases 
illustrating all grades of EPVS and a range of background appearances. We developed 
our existing EPVS rating scale after reviewing and testing existing scales; the current 
scale is very quick to apply and includes the three main anatomical regions where EPVS 
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are found. We wrote a user guide for the rating scale, including instructions on slice 
selection, potential difficulties in EPVS rating and imaging examples for each EPVS 
category (http://www.sbirc.ed.ac.uk/documents/epvs-rating-scale-user-guide.pdf). We 
used routine structural MRI for EPVS assessment rather than specialised sequences. 
Each observer performed ratings at least one week apart blind to prior ratings and in a 
random order on each occasion, minimising effects of recall. Observer variability was 
tested for dichotomized EPVS; however, the scale we have devised also records EPVS 
frequencies over a total of five levels, which allows the opportunity for testing EPVS 
associations more closely if required.  
There were limitations to our study. We did not assess atrophy, which may have an 
influence on EPVS size, but this was not the purpose of this study and the scale we have 
devised does not rate EPVS size. The scale was tested by two experienced 
neuroradiologists, but brain imaging in many research studies is performed by non-
radiologists (Potter et al. 2010c) and many raters will be less experienced in reviewing 
MRI scans and in rating EPVS. We hope the inclusion of a user guide, with detailed 
imaging examples for each rating category, will help improve observer variability. We 
included EPVS with a surrounding FLAIR-hyperintense rim, even though the exact 
nature of these is unclear, but these were not a source of intra- or interrater 
disagreement. 
Further work on ways of improving observer agreement about EPVS is needed, 
including training observers in the rating of EPVS. The use, and further development, of 
the EPVS rating scale may help future studies to answer outstanding questions about the 
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diagnostic and prognostic value of EPVS and will enable study comparisons and meta-
analyses. Although we have developed and tested a visual rating scale, automated EPVS 
measurement methods may be possible with improved image processing algorithms in 
future, as has already occurred for WML rating (Jeerakathil et al. 2004a).
 
 
In conclusion, assessment of EPVS can be standardised to at least a moderate to good 
level of interrater agreement with a modified rating scale that takes account of all prior 
rating scales and improvements that we implemented following testing. Further 
modifications should include additional ways to deal with very small EPVS and 
concomitant WML and lacunes to reduce their effect on EPVS assessment variability.  
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8.6. Tables 
Table 8.1 Summary of existing enlarged perivascular spaces (EPVS) scales 
 
Study Subjects MRI technique Locations 
assessed 
Description of rating method Observer variability  
Rouhl et al. 
2008 
165 patients with 
first ever lacunar 
stroke 
1.5T axial T2WI and 
FLAIR 
CS, BG Low=<20 EPVS, moderate=20-50 EPVS, 
high=>50 EPVS 
Interobserver Cohen's kappas: 
BG-VRs, 0.64; CSO-VRs, 
0.57; L-VRs, 0.72 
Groeschel et 
al. 2006 
125 healthy subjects 
aged 0.5-30 years; 




3D structural images 
using T1W 3D 
FLASH; clinical 
subjects: 1.5T, axial 
T2 TSE/SPIR and 
FLAIR, sagittal T2, 
coronal T1 IR-TSE  
Supratentorial 
white matter 
Dilated = focal expansion, either irregular 
or ectatic); non-dilated = smooth and 
regular morphology 
NA 
Patankar et al. 
2005 




1.5T axial FLAIR, 
T1W IR, variable 
echo, FSE, high-






CS: 0=none, 1=<5 per side, 2->5 on one or 
both sides; basal ganglia: 0=only either 
side and <5 either side, 2=>5 SI on either 
side or any in lentiform nucleus, 2=any in 
caudate nucleus on either side; subinsular: 
0=none, 1=<5 either side, 2=>5 on one or 
both sides 
Intrarater BG, 0.89-1.00; CS, 
0.78/0.82; subinsular, 0.89, 
0.91; mesencephalon 0.84, 
0.94; interobserver BG 0.91, 
0.98; CS 0.84; subinsular 
0.90; mesencephalon 0.82 
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Table 8.1 continued 
Study Subjects MRI technique Locations 
assessed 
Description of rating method Observer variability  
MacLullich 
et al. 2004 
97 healthy men 1.5T structural 




0=none, 1=<10, 2=11-20, 3=21-40, 
4=>40 
Intrarater Cohen’s kappas: 0.88 for 
BG; 0.78 for CS 
Di Costanza 
et al. 2001 
41 adults with 
myotonic dystrophy 
0.5T sagittal T1, axial 
PD and T2W SE 
Lenticulostriate, 
high convexity 
Number multiplied by size category, 
where size 1=<2mm, 2=2-3mm and 
3=>3mm 
NA 
Adachi et al. 
2000 
171 consecutive 
patients admitted with 
acute cerebral infarcts 
1.5T T2WI, T1WI 
and PD 
BG Grade 0, no lesions; grade 1, 1-5 
lesions; grade 2, 6-10 lesions; grade 3, 
>10 lesions 
NA 










1 (mild)=<2mm, 2 (moderate)=2-
3mm, 3 (marked)=>3mm 
NA 
MRI, magnetic resonance imaging; T2W, T2-weighted; FLAIR, fluid attenuated inversion recovery; CS, centrum semiovale; BG, basal ganglia; BG-VRs, basal 
ganglia Virchow-Robin spaces; CSO-VRs, centrum semiovale Virchow-Robin spaces; L-VRs, linear Virchow-Robin spaces; T1W, T1-weighted; FLASH, fast 
low-angle shot; TSE, turbo spin echo; SPIR, spectral presaturation with inversion recovery; IR-TSE, inversion recovery turbo spin echo; TW1 IR, T1-weighted 
inversion recovery; FSE, fast spin echo; SI, substantia innominata; FSE T2, fast spin echo T2; T2WI, T2-weighted imaging; T1W, T1-weighted imaging; PD, 
proton density; T2W, T2-weighted SE, T2-weighted spin echo; NA, not applicable 
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Table 8.2 Unweighted κ scores and proportional agreement for intrarater (A) and interrater agreement (B) in the centrum semiovale, basal 




  Intrarater agreement 
 
 Rater 1   Rater 2  
 
Region Kappa (95% CI) 
Proportional agreement 
(%, 95% CI)   
Kappa (95% CI) 
Proportional agreement 
(%, 95% CI) 
 
Centrum semiovale 0.61 (0.51, 0.93) 80 (67.7, 89.2)  0.6 (0.4, 0.8) 80 (67.7, 89.2) 
 
Basal ganglia 0.73 (0.56, 0.9) 86.7 (75.4, 94.1)  0.86 (0.72, 0.99) 93.3 (83.8, 98.2) 
 
Midbrain 0.62 (0.32, 0.92) 91.7 (81.6, 97.2)  0.72 (0.51, 0.93) 90 (79.5, 96.2) 
 
 
     
B. 
 Interrater agreement 
  First rating   Repeat rating 
 
  Kappa (95% CI) 
Proportional agreement 
(%, 95% CI) 
  Kappa (95% CI) 
Proportional agreement 
(%, 95% CI) 
 
Centrum semiovale 0.58 (0.39, 0.77) 95 (86.1, 99)  0.57 (0.36, 0.77) 78.3 (65.8, 87.9) 
 
Basal ganglia 0.86 (0.73, 0.99) 93.3 (83.8, 98.2)  0.57 (0.36, 0.77) 83.3 (71.5, 91.7) 
 
Midbrain 0.53 (0.13, 0.27) 85 (73.4, 92.9)   0.41 (0.12, 0.70) 83.3 (71.5, 91.7) 
           CI, confidence interval
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Table 8.3 Details of cases causing disagreement for intrarater (A) and interrater (B) enlarged  
perivascular spaces (EPVS) variability testing 
 
A. Region Description n (%) 





 7 (35) 
  No WMH present
b
 11 (55) 
  Movement artefact 1 (5) 
 Basal ganglia (n=8) Rating 2 vs 3, no clear cause for 
disagreement 
6 (75) 
  Unilateral TACI 1 (12.5) 
  Multiple possible lacunes bilaterally 1 (12.5) 
 
a
1-point difference in scale, n=4; 2-point difference, n=2; 3-point difference, n=1; WMH 
confluent (n=5) or scattered (n=2)  
b
1-point difference in rating in 9/10 cases 
WMH, white matter hyperintensities; TACI, total anterior circulation infarction 
  
 
B. Region Description n (%) 
 WMH present
a
 9 (42.9) 
 
Centrum semiovale 
(n=21) No WMH present
b
 11 (52.4) 
  Movement artefact 1 (4.8) 
 Basal ganglia (n=12) Rating 2 vs 3, no clear cause for disagreement 5 (41.7) 
  Unilateral TACI 1 (12.5) 
  Multiple possible lacunes
c
 6 (50) 
 a1-point different in scale, n=6; 2-point difference, n=3; WMH confluent (n=7) or scattered 
(n=2) 
b
1-point difference in rating in 10/11 cases 
c
Unilateral in 3, bilateral in 3 
WMH, white matter hyperintensities; TACI, total anterior circulation infarction 
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8.7 Figures 
 
Figure 13 Examples of enlarged perivascular spaces (EPVS) on T2-weighted magnetic 
resonance imaging.  
(A) Grade 4 enlarged perivascular space (EPVS) (>40 EPVS) in the frontal region in a 
magnified view of the centrum semiovale. (B) Grade 2 EPVS (11-20 EPVS) in the basal ganglia 
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Figure 14 Main causes for observer variability in enlarged perivascular spaces (EPVS) rating  
 
(A) Magnified view of white matter lesions in the right centrum semiovale, which may be 
scattered with EPVS still visible (left, arrows) or confluent, making EPVS rating difficult (right). 
(B) Small, poorly visualised EPVS in the centrum semiovale (left) and basal ganglia (right, 
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Chapter 9. Improving quantification of other features of cerebral small 
vessel disease: development of the Brain Observer 
MicroBleed Scale (BOMBS)  
9.1 Introduction 
In stroke medicine, the burning questions about BMB concern their diagnostic 
significance (for example, for the ante mortem diagnosis of cerebral amyloid angiopathy 
and other disorders), and whether BMB should influence the use of antithrombotic and 
thrombolytic drugs (Fiehler et al. 2007, Lovelock et al. 2010). If the diagnostic and 
prognostic significances of BMB are to be investigated and used for these purposes in 
clinical practice, then definitive research studies should fulfill a variety of prerequisites 
(Cordonnier et al. 2007), including knowledge of the effectiveness of the scales used to 
rate BMB as well as the intra- and interrater variation of the individual researchers using 
the scales. 
Previous studies have reported variable levels of interrater agreement amongst two or 
three observers (Greenberg et al. 1999, Jeerakathil et al. 2004b, Jeon et al. 2007, Kakuda 
et al. 2005, Kwa et al. 1998, Lee et al. 2004, Lee et al. 2005b, Lee et al. 2006, Lee et al. 
2007, Lemmens et al. 2007, Roob et al. 1999, Vernooj 2008,Viswanathan et al. 2006; 
Table 9.1). Studies of interrater reliability found kappa (κ) values ranging from 0.33 
(fair; Jeerakathil et al. 2004b) to 0.88 (excellent; Jeon et al. 2007, Lee et al. 2004); most 
found κ>0.7, sample sizes were small, 95% CIs were not always provided, and the 
properties of the rating scales used were not described. 
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9.2. Aims 
In view of the variation in reported interrater agreement in BMB, the potential for a 
rating scale to improve levels of agreement, and the absence of a rating scale for BMB, 
we further quantified interrater agreement about the presence, number, size, and location 
of BMB in order to develop a simple BMB classification scheme which might minimise 
observer variation. 
9.3. Methods 
9.3.1. Patient recruitment 
We studied a subset of patients from the ESS (described above; Table 9.2). Consecutive 
consenting stroke and TIA patients were recruited to the register from outpatient clinics 
and hospital admissions. In the current study we included those patients who had 
undergone at least one MRI scan with GRE sequences (n=264). If a patient had more 
than one MRI, we used the earliest scan. 
9.3.2. Brain imaging 
Patients underwent brain MRI according to the ESS protocol as described above 
(Chapter 2, Table 2.1). 
9.3.3. Brain microbleed rating 
A neuroradiologist (GMP) and a neurologist (CC), both with experience in rating BMB, 
independently assessed all MRI sequences on hard copy imaging of 264 adults, using a 
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pilot BMB rating scale, which required the reader to quantify BMB sub-divided by size 
(<5mm, 5-10mm), side of brain (left, right), and location (lobar [cortex/grey-white 
junction; subcortical white matter], deep [BG grey matter; internal and external 
capsules; thalamus], and posterior fossa [brainstem; cerebellum]) (Figure 15). All BMB 
were measured manually. Each observer was blinded to clinical data and to the other 
observer’s ratings. BMB were defined as homogeneous, round foci, <10mm diameter 
(no minimum size was specified), of low signal intensity on GRE MRI. The observers 
were aware of the main BMB mimics (Samarasekera et al. 2011). Low signal lesions on 
GRE MRI within a lesion compatible with an infarct were regarded as haemorrhagic 
transformation of infarct rather than BMB. 
Following the assessment of interrater agreement with the pilot scale, a senior 
neuroradiologist (JMW) reviewed MRI scans about which the two observers disagreed 
in their BMB ratings. We developed the Brain Observer MicroBleed Scale (BOMBS) to 
account for some of the common sources of disagreement and other major problems 
encountered (Appendix 10). We re-evaluated agreement between the same two 
observers using BOMBS, in a different set of patients undergoing identical MRI 
sequences and parameters, to quantify BMB sub-divided by size, side of brain, and 
location (as before), but with the addition of a further subdivision into ‘certain’ and 
‘uncertain’ BMB categories. The study population for the assessment of BOMBS was a 
series of 156 patients with stroke (different to the 264 in whom the pilot rating scale was 
tested), who had been recruited in the MSS (see above for details) and another stroke 
study requiring MRI (outpatients presenting more than 1 week after a mild stroke, in 
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whom CT scanning would not discriminate between ischaemic or haemorrhagic stroke, 
requiring MRI for stroke subtyping). 
9.3.4. Analysis 
We quantified observer agreement using the un-weighted κ statistic for nominal data 
(such as dichotomised
 
presence versus absence of ≥1 BMB), analysed in any brain 
location and in separate brain areas (lobar, deep, and posterior fossa). When using 
BOMBS, we calculated κ for BMB rated ‘certain’, and for BMB rated ‘certain’ or 
‘uncertain’. Intraclass correlation coefficients were calculated for the overall numbers of 
BMB. When exploring interobserver reliability in measurements of BMB size, we 
restricted our analysis to MRI scans on which both raters had observed ‘definite’ BMB 
in the same brain location. All analyses were performed the Statistical Package for the 
Social
 
Sciences Version 13 (SPSS Inc., Chicago, IL, USA), except CIs for κ
 
which were 
calculated using Confidence Interval Analysis software (Bryant 2000).  
9.4. Results 
Agreement about the presence/absence of ≥1 BMB in any location in the brain was 
moderate (κ 0.44, 95% CI 0.32 to 0.56), but it appeared to be better in deep and posterior 
fossa locations, when compared to lobar areas (Table 9.1). Intraclass correlation 
coefficient for the overall number of BMB was of 0.91 (95% CI 0.88 to 0.93). The two 
observers disagreed about the presence of ≥1 BMB on 65 MRI scans. When these 
disagreements were reviewed by a third observer (JMW), most were found to occur 
where there was doubt about whether there was one BMB on a scan or none. The main 
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causes for disagreement were common BMB mimics such as vascular flow voids 
(cortical and perforator vessels), irregularly-shaped lesions, lesions too pale to be 
confident about them being a BMB, partial volume artifacts from the petrous temporal 
bone or orbit, and variable signal dropout (Figure 16). 
We revised the pilot rating scale on the basis of the causes of the observed 
disagreements to develop the BOMBS (Appendix 10). Interrater agreement about the 
presence/absence of ≥1 BMB improved using BOMBS, when the analysis was restricted 
to ‘certain’ BMB, but remained similar to the pilot rating scale when considering 
‘certain’ and ‘uncertain’ BMB (Table 9.2). No significant differences in interrater 
reliability were discernible between brain locations using BOMBS (Table 9.2). 
Intraclass correlation coefficient for the overall number of certain BMB was of 0.93 
(95% CI 0.91 to 0.95). There were 27 definite BMB observed by both raters in the same 
brain location, 25 of which were rated in the same size category (93%, 95% CI 77 to 
98); two BMB were considered to be ≥5 mm by observer A, but <5 mm by observer B. 
9.5. Discussion 
We have shown that the assessment of BMB on GRE MRI in patients with stroke and/or 
TIA is not straightforward using a simple pilot rating scale, with only moderate levels of 
interrater agreement comparable to previous studies. BOMBS (Appendix 10) improved 
interrater reliability when all brain locations were analysed together, and particularly in 
lobar locations, which had been identified in our pilot study as a difficult part of the 
brain to rate (Table 9.2). Although the consideration of BMB mimics is widely 
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recognised as being important, observer variation persists, even when mimics are 
carefully thought about during MR scan review. BOMBS had its main effect by 
differentiating ‘certain’ BMB from ‘uncertain’ BMB – uncertainty about BMB may be 
an important problem, because it applied to between one third and one half of BMB in 
this study (Table 9.2). 
BMB maximum diameters in prior research have varied from 2-5mm, to ≤7mm and 
≤10mm (Fiehler et al. 2007). In this study, we found few BMB >5mm in diameter, and 
we found only two disagreements about BMB size, but further studies are needed of 
observer agreement in BMB size categorisation and of the pathological substrates for 
BMB of varying sizes, in different patient populations. 
We found good agreement about the total number of BMB. It is quite possible that the 
number of BMB may influence their prognostic significance (Fiehler et al. 2007), but 
this is not beyond doubt. On both these counts, continuing to collect the total number of 
BMB rated by any observer – rather than subdividing a rating scale into no/few/many 
BMB – will contribute to improving agreement about BMB number, as well as 
determining what the numerical thresholds for BMB prognostic/therapeutic significance 
are. Furthermore, studying observers’ certainty in relation to their ratings of the 
presence/absence of BMB as well as the number and size of BMB seen, will help 
understand whether small/uncertain BMB are more likely to be counted in patients with 
multiple certain BMB than those with a solitary certain BMB or multiple uncertain 
BMB. Patterns of rater behavior were evident in our study (Table 9.2). 
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Although studies have described the interrater reliability of BMB ratings (Table 9.1), we 
sought to improve agreement as our primary objective. We used κ and our study design 
fulfilled the assumptions inherent in the κ statistic; the subjects
 
under study and the 
observers were independent, and the
 
categories in the scale were independent, mutually 
exclusive,
 
and exhaustive (Cohen 1960). The design of BOMBS benefited from the 
lessons gleaned using the pilot scale and independent review of the scans about which 
the observers disagreed. This study also benefited from using consistent imaging 
parameters and the same range of sequences (including GRE in all), and blinding of each 
observer to the other’s ratings. 
The main weakness of this study was that these findings have not yet been validated in 
larger cohorts, in other disease groups, and amongst other observers; we encourage other 
researchers to do so, to explore the generalisability of BOMBS. The influence of 
practice effects in our observers cannot be ruled out, but prior even to their ratings using 
the pilot rating scale, both had experience of interpreting BMB on MRI. The prevalence 
of BMB appeared to drop when BOMBS was validated, which was likely to have been 
related to the patients whose MRI scans were used to test BOMBS being younger and 
having milder strokes than those whose MRIs were used for the pilot rating scale; a 
systematic review has found BMB prevalence to be lower in these groups (Cordonnier et 
al. 2007). An artifact of the κ statistic is that it is affected in complex ways by the 
prevalence of the abnormality under study, but a drop in BMB prevalence from 20-40% 
to 18-25% was unlikely to have significantly biased the observers or affected the 
properties of the κ statistic. 
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The BOMBS dichotomisation of BMB into ‘certain’ and ‘uncertain’ was intended to 
improve agreement about the existence of certain BMB. Prioritising the identification of 
certain BMB would result in improved specificity (at the expense of sensitivity), by 
identifying BMB more reliably, which could improve the internal and external validities 
of research projects and encourage more reliable identification of BMB should they 
become relevant in clinical practice. Investigators could also explore the robustness of 
their study findings using sensitivity analyses (by restricting analyses to either ‘certain’ 
BMB, or ‘certain’ and ‘uncertain’ BMB, which would improve sensitivity at the expense 
of specificity). This dichotomisation also permits the identification of a separate group 
of MRIs with ‘uncertain’ BMB to further understand why and how observers disagree 
about BMB and follow-up such patients to determine if these ‘uncertain’ BMB mature 
into ‘certain’ BMB. 
Our findings should be regarded
 
as a baseline measure of observer agreement for future 
studies using BOMBS.
 
Further work on ways of improving observer agreement about 
BMB is needed, and training observers to recognise certain and uncertain BMB, as well 
as their mimics, is an obvious priority. BOMBS will also enable others to study 
agreement about BMB size, number, brain location, and diagnostic certainty, as well as 
exploring the influence of these factors on the diagnostic and prognostic utilities of 
BMB. 
Because the clinical implications of BMB remain to be established, there is still an 
opportunity to improve the reliability of BMB assessments by the use (and further 
development) of the BOMBS rating scale, so that adequately-powered, well designed 
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studies will be able to answer the outstanding clinical concerns about the diagnostic and 
prognostic value of BMB, and whether they should influence the prescription of 
antiplatelet, anticoagulant, or thrombolytic drugs. The use of a standard scale for BMB 
is also essential for future studies, to enable comparisons and meta-analyses. 
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9.6. Tables 















agreement (95% CI 
where available) 
Lee et al. 2006 2 125 ICH 66% Total number of BMB Spearman 
correlation 
0.81 
Greenberg et al. 
1999 
2 32 Lobar ICH NS Total number of BMB Intraclass 
correlation 
0.97 
Viswanathan et al. 
2006 
2 20 CADASIL 35% Total number of BMB Intraclass 
correlation 
0.96 
Lee et al. 2004 2 102 Stroke and HTN 65% Grade of BMB (4 
grades) 
Kappa 0.88 (0.81 to 0.95) 
Jeon et al. 2007 2 63 ICH 68% Presence or absence of 
BMB 
Kappa 0.88 
Lee et al. 2005b 2 143 ICH vs control 97% vs 56% NS Kappa 0.87 
Lee et al. 2005b 2 26 ICH NS NS Kappa 0.86 
Kakuda et al. 2005 2 70 Ischaemic 
stroke treated 
with IV t-PA 
16% Presence or absence of 
BMB 
Kappa  0.77 (0.55 to 0.99) 
Greenberg et al. 
1999 
2 15 Lobar ICH NS Presence or absence of 
new BMB 
Kappa 0.73 
Lemmens et al. 
2007 
2 342 TIA or 
ischaemic 
stroke 
26% Presence or absence of 
BMB 
Kappa 0.71 (0.59 to 0.82) 
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agreement (95% CI 
where available) 
Kwa et al. 1998 2 221 Mixed 14% NS Kappa 0.6 
Roob et al. 1999 3 280 ‘Healthy’ 6% Presence or absence of 
BMB 
Kappa 0.40 to 0.65 
Jeerakathil et al. 
2004b 
3 222 ‘Healthy’ 5% Presence or absence of 
BMB 
Kappa 0.33 to 0.57 
Vernooij et al. 2008 2 300 ‘Healthy’ 24% Presence or absence of 
BMB 
Kappa 0.85 
MRI, magnetic resonance imaging; CI, confidence interval; ICH, intracerebral haemorrhage; CADASIL, cerebral autosomal dominant arteriopathy with 
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Table 9.2 Characteristics of the study populations and interrater agreement (simple [unweighted] kappa statistic) about the presence of ≥1 
brain microbleed (BMB) in separate brain areas or in any brain location using the pilot rating scale and using the Brain Observer 
MicroBleed Scale (BOMBS) 
 Pilot population (n=264) BOMBS population (n=156) 
Median age (IQR) 72 (60-78) 66 (56-75) 
Ischaemic stroke  235 (90%) 151 (97%) 
Intracerebral haemorrhage 10 (4%) 5 (3%) 
Transient ischaemic attack 15 (6%) 0 
History of stroke or transient ischaemic 
attack  
79 (30%) 22 (14%) 
History of treated hypertension 135 (51%)  81 (52%) 
Pilot rating scale BOMBS rating scale 
 Certain & uncertain BMB Certain BMB 
 
Observer A Observer B 
Kappas  
0 vs ≥1 
BMB 
(95% CI) 
Observer A Observer B 
Kappas  
0 vs ≥1 
BMB 
(95% CI) 
Observer A Observer B 
Kappas  
0 vs ≥1 
BMB 
(95% CI) 
Patients with ≥1 
BMB (%; 95% CI) 
105 
40 (34 to 46) 
54 
20 (16 to 26) 
28 
18 (13 to 25) 
39 
25 (19 to 32) 
18 
12 (7 to 18) 
21 
14 (9 to 20) 
Number of lesions 



















Median number of 
lesions per patient 
(IQR) 












Patients with ≥1 
BMB (%; 95% CI) 
71 
27 (22 to 33) 
39 
15 (11 to 20) 
16 
10 (6 to 16) 
24 
15 (11 to 22) 
12 
8 (5 to 13) 
13 
8 (5 to 14) 
Number of lesions 
on all scans 
 






Median number of 
lesions per patient 
(IQR) 
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Table 9.2 continued 
Patients with ≥1 
BMB (%; 95% CI) 
50 
19 (15 to 24) 
30 
11 (8 to 16) 
17 
11 (7 to 17) 
22 
14 (10 to 20) 
9 
6 (3 to 11) 
12 
8 (5 to 13) 
Number of lesions 
on all scans 
 





Median number of 
lesions per patient 
(IQR) 













Patients with ≥1 
BMB (%; 95% CI) 
23 
9 (6 to 13) 
18 
7 (4 to 11) 
5 
3 (1 to 7) 
6 
4 (2 to 8) 
3 
2 (1 to 6) 
6 
4 (2 to 8) 
Number of lesions 
on all scans 












Median number of 
lesions per patient 
(IQR) 












IQR, interquartile range; CI, confidence interval
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9.7. Figures 
Figure 15 Diagram to illustrate lobar and deep regions of brain superimposed on axial gradient 
echo MRI brain 
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Figure 16 Examples of certain and uncertain brain microbleeds (BMB) and BMB mimics.  
(A) Axial gradient echo (GRE) showing a certain BMB in the right thalamus (arrow). (B) 
Uncertain BMB, with a pale gray lesion in the right thalamus (arrow). (C) and (D) Small cortical 
vessels in the left parietal lobe (short arrows) on T2-weighted (C) and GRE imaging (D) 
mimicking BMB in a patient with an old right frontal cortical infarct (long arrows). (E) and (F) 
BMB mimics on GRE imaging due to partial volume artefact from right orbit (E) and left 
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Chapter 10. Discussion  
In my investigation of ‘clinical-imaging dissociation’ in acute ischaemic stroke, I found 
that 23% of patients presenting with a PACS had an acute lacunar infarct on MRI with 
DWI, and 16% of patients presenting with a LACS had an acute cortical infarct. In 
multivariate analysis adjusted for potential confounders, diabetes was the main factor 
associated with ‘clinical-imaging dissociation’. In patients with an acute lacunar infarct 
on DWI, proximity of the lacunar infarct to the cortex, increasing age, diabetes and left 
hemisphere location were associated in multivariate analysis with ‘clinical-imaging 
dissociation’, but not lesion size, multiple acute infarcts, time to scanning, WML, brain 
atrophy or history of prior stroke.  
In my analysis of the proportion of acute, symptomatic lacunar infarcts undergoing 
cavitation, a fifth of patients with acute lacunar ischaemic stroke showed definite lacunar 
infarct cavitation on follow-up imaging at a median of 227 days after onset of stroke; in 
a ‘pure’ subgroup with an infarct on baseline MRI with DWI and follow-up MRI, 
definite cavitation occurred in 15% of lacunar infarcts. Definite cavitation was 
associated with increasing time to follow-up imaging in univariate and multivariate 
analysis, but not with increasing age, stroke severity, lesion size or location, or other 
features of cerebral SVD, including presence of other lacunes at the time of baseline 
imaging.  
I investigated completeness of reporting of lacunar lesions in the lacunar stroke literature 
and found marked variation in terminology and descriptions of imaging definitions of 
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lacunar lesions. An imaging definition was provided in 26 (60%) studies of acute, and 8 
(40%) of old, lacunar lesions. Definitions were heterogeneous and often incomplete. The 
terms ‘lacunar infarct’ and ‘lacunar stroke’ were used for all types of lesion, whether 
acute and old, symptomatic or asymptomatic. A minority attempted to seek relevant 
prior symptoms for old lacunar lesions. Clinical terminology varied widely, with a 
clinical stroke definition being provided in only half of studies. Only a third of studies 
using MRI included DWI. Non-radiologists interpreted images in most cases.  
I assessed definition and detection of lacunar lesions on imaging in an online survey of 
SVD researchers and found marked variation in definitions and descriptions of lacunar 
lesions, with marked variation in terminology when describing posterior fossa lesions. 
Most participants agreed on definitions for lacunar lesion site and for EPVS. There was 
wide variation in lesion recognition and classification. Cavitated lesions of any size were 
detected with the highest degree of confidence, but were described using multiple terms. 
Detection of non-cavitated lacunar infarcts in the presence of WML was limited, and 
differentiation of lacunes from EPVS was poor.  
In my investigation of the relationship between carotid stenosis and ipsilateral WML, I 
found no association between carotid stenosis asymmetry and WML asymmetry, or 
between increasing degrees of carotid artery stenosis and ipsilateral hemispheric WML, 
either with or without adjustment for vascular risk factors. In both studies, WML were 
strongly associated with increasing age, in agreement with previous studies.  
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In my examination of clinical and imaging associations of EPVS in patients with acute 
ischaemic stroke, I found that total EPVS were associated with age and deep WML. BG-
EPVS were associated with age, CS-EPVS, cerebral atrophy and lacunar stroke subtype.  
In order to develop a visual rating scale for EPVS, I reviewed existing EPVS rating 
scales, identified omissions or ambiguities in each, and used this information to make 
improvements to one existing scale. I assessed observer variability of the revised scale in 
60 MRI scans chosen to demonstrate a full range of EPVS frequencies and designed a 
user guide with further modifications to help avoid residual sources of observer 
variation. Two observers showed similar intrarater agreement for BG-, CS- and MB-
EPVS, ranging from good to very good kappa values. Interrater agreement was moderate 
for CS- and MB-EPVS on both ratings, although very good for BG-EPVS on the initial 
rating. Disagreements were mainly due to the counting of very small, but just visible, 
EPVS, and the presence of background WML and lacunes (in the CS and BG regions, 
respectively).  
Using a pilot rating scale for BMB (the Brain Observer MicroBleed Scale, BOMBS), I 
found that the assessment of BMB in patients with stroke and/or TIA is not 
straightforward, with only moderate levels of interrater agreement, comparable to 
previous studies. BOMBS improved interrater reliability when all brain locations were 
analysed together, and particularly in lobar locations, which had been identified in our 
pilot study as a difficult part of the brain to rate. BOMBS had its main effect by 
differentiating ‘certain’ BMB from ‘uncertain’ BMB. Observer variation persisted even 
when BMB mimics were considered during BMB rating.  
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There are strengths of this work. In several studies, we used patients from two large 
cohorts of ischaemic stroke patients recruited prospectively to an academic teaching 
hospital. In both studies, patients were carefully subtyped by a stroke physician, taking 
account of clinical syndrome and brain imaging, using the OCSP classification system. 
The use of large cohorts enabled us to assess several possible explanatory variables, 
where relevant, and to use multivariate analysis to correct for confounding factors. 
Patients had standard structural MRI brain imaging on the same scanner using the same 
protocol, which included GRE and DWI. ESS and MSS MRI scans were reviewed 
systematically according to a structured proforma, with assessment of SVD lesions 
according to detailed, pre-defined definitions and using all available sequences in order 
to distinguish as accurately as possible between the often overlapping features of SVD. 
MRI scans for each study (ESS, MSS) were assessed by independent raters blinded to all 
clinical details (except age and sex) and to each other’s ratings. The neuroradiologist 
who rated the ESS MRI scans was aware at the time of rating of the hypothesis 
regarding influence of lacunar lesion site on clinical presentation, but was unaware of 
other hypotheses to be tested subsequently (WML vs carotid stenosis, EPVS 
associations, particularly the association with WMH and lacunar stroke subtype), thus 
eliminating evaluation bias. Rating scores for WML and EPVS were collected on a ‘per 
hemisphere’ as well as on a whole brain basis, and EPVS scores according to relevant 
major anatomical regions, enabling detailed analyses to be carried out. For assessment of 
lacunar infarct cavitation, we proposed our own definitions for ‘partial’ and ‘definite’ 
cavitation after careful assessment of imaging findings. Where possible, we used 
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validated scales in the image assessment proforma, enabling better cross-comparison 
with similar studies. In order to try and improve observer rating consistency, the less 
experienced rater was trained in WML and atrophy assessment using a test set of 
previously validated images, and provided with guidance on EPVS rating. Both raters 
carried out regular ‘recalibration’ during reading of images using the test set of images. 
In all patients who had carotid Doppler ultrasound, the examination was performed by 
dedicated neurovascular sonographers, with dual-reporting of stenoses measuring >50% 
NASCET, thus optimising consistency of assessment. In our studies assessing 
definitions of lacunar lesions, we assessed multiple aspects of definitions and 
terminology for different lesions types, including both clinical and radiological aspects, 
to enable a wider overall impression of potential problems relating to lacunar stroke 
research. We chose to survey interested experts in SVD disease in order to gain insight 
into current practice amongst relevant researchers. In our assessment of the relationship 
between carotid artery stenosis and WML, we overcame methodological limitations 
noted in previous studies. In designing new scales for rating EPVS and BMB, we used 
raters with previous experience in EPVS and BMB rating to allow informed 
modifications to both scales, and, recognising the inherent, commonly encountered 
difficulties in EPVS and BMB rating, designed a comprehensive user guide for each 
(both available online) as a potential aid to other interested researchers. For testing the 
revised EPVS scale, we deliberately selected images which demonstrated an appropriate 
range of severity/frequency of EPVS, and we fulfilled the assumptions inherent in the 
use of the κ statistic when testing each scale.  
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Limitations of this work include potential selection bias of patients in the ESS with an 
MRI. Although this subset was used in several studies, the potential influence of 
selection bias was most pertinent in our study of clinical-imaging dissociation, due to a 
possible overrepresentation of patients who were more difficult to subtype; however, 
this does not negate our observation that lacunar lesion location was associated with 
clinical-imaging dissociation. Additionally, median time from stroke onset to MRI was 
19 days, i.e. outwith the time period considered optimal for DWI, and only 64% patients 
had a diffusion-positive infarct. However, a previous study showed that DWI may be 
useful up to several weeks after stroke onset (Keir et al. 2004). Images in the ESS and 
MSS were assessed by a single neuroradiologist on a single occasion, precluding 
assessment of intra- or interobserver reliability, which may have had a negative 
influence on the reliability of our results. However, we attempted to improve 
consistency in rating for WML by incorporating training on a test set of images 
demonstrating a full range of WML; for atrophy by using a validated scale including a 
template of images; and for EPVS by using a template of examples with rating 
instructions. Additionally, ‘recalibration’ was carried out by both raters during 
assessment of images, and raters used all sequences available in order to identify SVD 
features as accurately as possible, aware of areas of particular difficulty such as 
distinguishing EPVS from old, cavitated lacunes. In our study of lacunar lesion 
definitions, we collected a relatively small sample of data from the lacunar stroke 
literature; however, this does not negate our finding of marked variation in definitions of 
lacunar lesions and related methodologies, and variation is likely to have increased, 
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rather than decreased, with the inclusion of further articles. In our survey of imaging 
definitions and detection of lacunar lesions, only a third of those invited to participate 
took part, so our data represents only a fraction of opinions. However, most respondents 
were interested in SVD, therefore the responses received were probably sufficient to 
demonstrate the substantial lack of harmony for definitions used for, and generally poor 
detection of, lacunar lesions on imaging. The main limitation pertaining to our studies of 
observer agreement in rating EPVS and BMB is a lack of validation of our findings in 
larger cohorts, in other disease groups, and amongst other observers, including observers 
with less rating experience.  
There are important implications of clinical-imaging dissociation, which has also been 
assessed in a recent study (Arboix et al. 2010), for research into epidemiology, 
pathophysiology and treatment of lacunar stroke. In research which relies heavily on 
clinical presentation alone, results may be affected by 'noise' caused by clinical-imaging 
dissociation of between 10 and 20% patients with mild stroke. Studies which do not use 
high sensitivity imaging - including those where MRI is used, but does not include DWI 
- are also likely to be affected. The effect on clinical-imaging dissociation of using 
imaging which is less sensitive (CT) and potentially more sensitive (Montiel et al. 2010) 
have not been assessed. The debate over mechanisms of lacunar stroke - up to 20% are 
said to be associated with cardiac and large artery atherothromboembolism (Davis and 
Donnan 2004, Futrell 2004, Kazui et al. 2001, Norrving 2004), rather than intrinsic SVD 
- could be explained by clinical-imaging dissociation. Large primary and secondary 
prevention trials of ischaemic stroke testing aspirin, cholesterol-lowering drugs and 
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antihypertensives, have relied heavily on clinical classification and CT (CAPRIE 
Steering Committee 1996); ‘noise’ from clinical-imaging dissociation may have 
impeded the demonstration of any difference in treatment effects between stroke 
subtypes, if one existed. Future epidemiology, pathophysiology and treatment of lacunar 
stroke should aim to subtype patients as accurately as possible.  
Varied definitions and poor detection of lacunar lesions on imaging have important 
implications for all studies of cerebral SVD, including studies of lacunar stroke and 
WML. The overlapping appearances of lacunes and EPVS is well known (Román 2002), 
although in our literature review, only a minority of articles on lacunar stroke provided 
information on how the distinction between lacunar and EPVS was achieved; and when 
shown appropriate MRI sequences, SVD researchers mistook EPVS for lacunes, despite 
agreeing on an appropriate definition for EPVS. Less well-known is the significant 
problem of misclassification of non-cavitated symptomatic lacunar infarcts as WML. 
We found that only 1/5 of acute, symptomatic lacunar infarcts progressed to cavities. In 
our subsequent survey of researchers with an interest SVD, cavitated lacunar lesions of 
any size were detected with the highest degree of confidence, and detection of non-
cavitated lacunar infarcts was poor, especially in the presence of other WML. In studies 
which only count lacunes as old lacunar infarcts (Romero et al. 2010, Srikanth et al. 
2010, Vermeer 2007), the true burden of lacunar disease may be underestimated by as 
much as five times: up to 4/5 of symptomatic lacunar infarcts may resemble, and be 
misidentified as, WML at any time up to approximately five years after stroke, possibly 
longer. In all lacunar stroke and WML studies, misclassification of overlapping imaging 
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features may lead to detection of statistically significant associations where none exist, 
or to the failure to detect statistical associations where they do. The proportion of acute 
symptomatic lacunar infarcts undergoing cavitation should be confirmed in larger 
prospective studies of acute lacunar stroke using fixed, pre-determined follow-up time 
points. We found marked variation in imaging definitions for all types of lacunar lesion 
in the literature and amongst interested experts. Although similar problems have 
previously been demonstrated amongst neuropathologists (Pantoni et al. 2006), the 
extent of the problem in relation to the neuroimaging of cerebral SVD – both in the 
current literature, and amongst current SVD researchers (likely to be involved in 
publishing future SVD studies) - has, until now, not been clearly documented. Ideally, a 
consensus in the imaging definitions for all radiological markers of cerebral SVD should 
be reached by interested radiologists and clinicians. A set of representative images (e.g. 
of acute to old, partially to fully cavitated lacunar infarcts, lacunes, and other features of 
SVD, alone or in combination) could be provided, with definitions and descriptions 
made available for training purposes on relevant websites. A harmonised approach may 
help improve accuracy of results in all future cerebral SVD studies and to resolve some 
of the current controversies in the field of cerebral SVD, particularly with regard to the 
aetiology of lacunar stroke and WML. Current terms in common use (for which 
underlying aetiology and associations are often automatically assumed, e.g. ‘lacunar 
infarction’) may be better replaced by a more general term such as ‘small vessel change’ 
incorporating a purely radiological description of the lesion (using all MRI sequences, 
where relevant) including site/size and an indication as to whether there has been 
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correlation with relevant clinical symptoms. However, accurate clinico-radiological 
correlation can be problematic, even when medical records are available, and may be 
difficult to overcome. Furthermore, even with radiological training, some difficulties in 
accurate lesion classification may persist, such as differentiation of EPVS from small, 
cavitated lesions, particularly with CT alone; these may have to be accepted as an 
inherent limitation in the imaging assessment of cerebral SVD. Ultimately, a full 
appreciation of cerebral lesions in lacunar stroke can only be reached at the 
neuropathological level, although this is currently limited due to relatively low mortality 
in the acute stage of cerebral SVD, difficulties related to dissection of very small 
vessels, and the significant problem of attempting to correlate late-stage findings with 
clinical symptoms, if present. Newer approaches aiming at improving radiological-
neuropathological correlation may help to partly overcome some of these (Grinberg et 
al. 2009).  
The recognition of WML on cross sectional imaging in the last three decades, 
particularly on MRI, has led to a plethora of pathophysiology, epidemiology and 
pathophysiology studies of WML. We used standard structural MRI to investigate the 
relationship between WML and carotid stenosis, and found no association. Our results 
have also been substantiated in a recent similar study (Grüter et al. 2010). Existing data, 
including our data, would suggest that there is now substantial evidence that emboli 
have little role in the formation of WML (or, by association, with most lacunar 
ischaemic stroke) and that any suggestion of an association in previous studies between 
embolic sources (e.g. atrial fibrillation or carotid disease) and WML may simply have 
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been due to a third mediating factor, such as age or hypertension. Future studies should 
focus on determining what causes the intrinsic small vessel pathological changes that 
appear to underlie most WML. The role of newer imaging methods such as 
multiparametric (Muñoz Maniega et al. 2010) and multimodal (Nitkunen et al. 2008) 
MRI in the investigation of WML have yet to be fully determined. Direct visualisation 
of thrombus in small vessels on ultra high field MRI (Kloppenborg et al. 2010) may also 
help in unraveling the pathophysiology underlying cerebral SVD; however, the 
practicability and safety of this technique remains to be assessed. The totality of existing 
data would suggest that there is now substantial evidence that emboli have little role in 
the formation of WML (or by association, with most lacunar ischaemic stroke) and that 
any suggestion of an association in previous studies between embolic sources (e.g. atrial 
fibrillation or carotid disease) and WML may simply have been due to a third mediating 
factor, such as age or hypertension. Future studies should therefore focus on determining 
what causes the intrinsic small vessel pathological changes that appear to underlie most 
WML. There is growing evidence that cerebral SVD occurs in the context of a much 
broader vasculopathy (Thompson and Hakim 2009).  
At present, the cause and associations of EPVS are unclear, but they may be part of the 
spectrum of SVD (Doubal et al. 2010). In our study, we found an association between 
total EPVS and WML, and between BG-EPVS and lacunar stroke, providing further 
evidence that EPVS may be a further imaging marker for cerebral SVD. Blood-brain 
barrier dysfunction may play a role in the aetiology of lacunar stroke (Wardlaw et al. 
2009) and in patients with MS, in which EPVS become more visible with development 
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of active inflammation and subside again as inflammatory activity wanes (Wuerfel et al. 
2008). EPVS are conduits for drainage of interstitial fluid from the brain (Abbott et al. 
2004, Weller et al. 1992), so it is highly relevant if they alter in visibility with 
inflammation, given that SVD may have an inflammatory component. EPVS are also 
more frequent compared to healthy controls in CADASIL (Cumurciuc et al. 2006), 
where there is altered vessel wall permeability and extravasation of plasma proteins into 
the perivascular spaces (Poirier et al. 1983). It seems plausible that blood-brain barrier 
dysfunction may also play a role, as yet undefined, in the formation of EPVS. The use of 
EPVS as a surrogate marker for disease progression and in treatment trials has not yet 
been assessed. Recent work indicates that leakage of intravenously injected contrast into 
CSF predates progression of WML in patients with mild stroke (Valdés Hernández et al. 
2010). Future studies should assess the association between leakage of contrast into the 
CSF with both EPVS severity and progression of EPVS severity in stroke patients, and 
with the development and progression of cavitation in acute, symptomatic lacunar 
infarction. Questions about the utility of EPVS for predicting future stroke, and for 
predicting progression of other imaging features of SVD (including EPVS themselves), 
remain unanswered. The association we found between EPVS and WMH/lacunar stroke 
subtype should be confirmed in larger studies. 
BMB have also emerged as a potential radiological marker of cerebral SVD in recent 
years (Wardlaw et al. 2006, Cordonnier et al. 2007). At present, the pathophysiology, 
diagnostic and prognostic significance of BMB are unclear; one of the key questions 
about BMB, regarding whether presence of BMB should influence prescription of 
 
Chapter 10 Discussion  153 
 
antiplatelet, anticoagulant, or thrombolytic drugs, has recently been investigated 
(Lovelock et al. 2010). Reliable methods for assessing and rating imaging markers of 
cerebral SVD are essential to pathophysiology, diagnostic and prognostic studies. We 
developed new rating scales for both EPVS and BMB, and created a comprehensive user 
guide for each. A similar rating scale to BOMBS has recently been developed (Gregoire 
et al. 2009), in which BMB are categorised as ‘certain’ and ‘uncertain’ (as for BOMBS), 
but in which lobar BMB are also subdivided according to individual lobar anatomy. We 
are not aware of any other attempts to develop an EPVS rating scale at present. There is 
still an opportunity to improve the reliability of EPVS and BMB assessment by the use, 
and further development, of both rating scales. Further modifications to the EPVS rating 
scale should include additional ways to deal with very small EPVS and concomitant 
WML and lacunes. It is conceivable that further advances in MRI technology might lead 
to newer and better ways of identifying EPVS. The influence of variations in MRI 
parameters (Gregoire et al. 2010), and of use of more sensitive techniques such as 
susceptibility-weighted imaging (Wolf et al. 2010), on detection of BMB are beginning 
to be addressed. Our development of EPVS and BMB scales, and the further 
development of these, will hopefully act as a basis for all future studies of EPVS and 
BMB and enable better cross-comparison between studies. Training observers in how to 
rate EPVS and BMB should help to minimise observer variability and should be 
considered in all future EPVS and BMB studies.  
In conclusion, neuroimaging is essential for investigating cerebral SVD. In this work, we 
highlight the need for sensitive cross sectional imaging in subtyping of patients with 
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acute ischaemic stroke; for a consensus approach to all imaging features of cerebral 
SVD, including EPVS and BMB; for appropriate training in the wide range of 
overlapping appearances of imaging markers of cerebral SVD; and the need for further 
studies in cerebral SVD, particularly those aimed at elucidating underlying 
pathophysiology. The rating scales we have developed for EPVS and BMB (features to 
emerge more recently as imaging markers of cerebral SVD) will hopefully act as a basis 
for future investigations of their diagnostic and prognostic significance. Neuroimaging 
has significant advantages over the once neuropathology-centred investigative approach 
to cerebral SVD: with ongoing technological advances, neuroimaging will remain an 
essential means of investigating cerebral SVD in the future.  
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Appendix 1. ESS clinical data collection forms (in-patient, out-patient) 
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Appendix 2 Outpatient data collection form 
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Appendix 3. Edinburgh Stroke Study and Mild Stroke Study imaging 
classification  
 
Patient ID:  _________________   Date/time of MRI:  __________________                     
 
Sequences done:   DWI/T2/FLAIR/GRE/T1/other 
 
Relevant lesion present (age and location)  Yes/No 
 
Sequence on which lesion present:   DWI   Yes/No     FLAIR/T2 - Yes/No     
Side of brain:   Left/Right  
 
Lacunar (size, mm _____ ) MCA cortical   Other cortical 
Internal capsule   Small temporal   Anterior ACA  
Internal border zone   Small parietal     Posterior ACA  
Centrum semiovale   Basal ganglia    Anterior PCA   
Extends to cortical margin  Subcortical    Posterior PCA  
Thalamus    Anterior half peripheral MCA   Anterior border zone  
Lentiform nucleus  Posterior half peripheral MCA Posterior border zone  
Brainstem  
        
Old lesion(s) present      Yes/No 
 
 Lesion 1  Lesion 2  Lesion 3 
 
Left/Right   Side   Side  Side  
Lac/Cortical/Posterior   Location  Location  Location  
Infarct/Haemorrhage   Type   Type   Type    
 
White matter lesion (WML) rating        
      Overall  Left   Right 
 
Periventricular WML  Fazekas 0/1//2/3  ⁭  ⁭  
Deep WML  Fazekas 0/1//2/3 ⁭  ⁭ 
               
   De Leeuw n <3mm   ⁭ ⁭  ⁭ 
            De Leeuw n 3-10mm   ⁭  ⁭ 
De Leeuw n ≥10mm   ⁭  ⁭  
 
Enlarged perivascular spaces  Basal ganglia 0-4  Centrum semiovale 0-4  
 
Atrophy   Deep atrophy          None/Mild/Moderate/Severe
    Superficial atrophy    None/Mild/Moderate/Severe 
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Appendix 4. Mild Stroke Study clinical data collection form 
Patient name  _______________  DOB  ___/___/___   Sex M    F  
 
CN number   ________________  Date of assessment for study  ___/___/___ 
 
PMH   
 
TIA    
Stroke   (left /right  /both /infarct /haem /cortical /lacunar )  
Ischaemic heart disease   (angina  /MI /angioplasty /CABG )  
Peripheral Vascular Disease (or symptoms of)    
Diabetes mellitus    (diagnosed at presentation )  
Hypertension  Atrial fibrillation   
Hyperlipidaemia   
LVSD            
Structural heart disease  
 
Social and family history 
  
Family history of stroke   
Cigarette smoker  (ex-<12 months , ex >12 months , never ) 
Alcohol use   Units per week ______Previous alcohol excess       
Independent prior to stroke  
 
Details of presenting stroke 
 
Date and time of symptom onset ____/_____/_____ - ___.____  
Duration of symptoms ______ days or persisting 
Date patient seen by stroke service ____/____/____ 
Side of body/vision affected  Left   Right  
Weakness  (face , arm , leg  )  
Sensory abnormality  (face , arm , leg  ) 
Posterior circulation symptoms    
Dysphasia      Neglect    Visual field loss    
Right  Left  Handed 
NIHSS score at assessment _______ and estimated worst ________ 
 
Investigations at time of presenting stroke 
 
Total cholesterol ______   
Blood glucose ______ 
ECG - sinus    Atrial fibrillation  LVH  
Carotid Doppler/ MRA  Left ICA stenosis _____% Right ICA stenosis _____% 
Echocardiology abnormality    If so, complete free text 
Blood pressure ____/____ mmHg 
 
 
 Appendices 188 
 
Medications at time of stroke    Medications at time of MRI permeability scan 
 
Aspirin     Aspirin  
Dipyridamole    Dipyridamole  
Clopidogrel      Clopidogrel   
Warfarin     Warfarin  
Diuretic     Diuretic  
ACE inhibitor    ACE inhibitor  
Angiotensin II R antagonist   Angiotensin II R antagonist  
Beta blocker     Beta blocker  
Other antihypertensive   Other antihypertensive  
Oral hypoglycaemic     Oral hypoglycaemic   
Insulin      Insulin   
Statin     Statin  




Clinical classification     Lacunar   Cortical   
Imaging classification     Lacunar   Cortical   
Final clinical and imaging classification   Lacunar   Cortical   POCS  
 
Free text comments 
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Appendix 5. Data extraction form for reporting of lacunar-related lesions 
 
Lacunar lesion definition  
    




RefMan database      ID       Year      
Volume/Issue/Page  
Title    
1st author     Last author       
Corresponding author  
Corresponding author department/institution/city       
Country            Continent   
Other departments in authorship        Y/N     
If yes, number/type:     Neurology/stroke/medicine/neuroradiology/geriatrics/psychiatry/other 
 
Article type  Original article/correspondence/comment/case report/review/other  
 
Radiologist(s) in authorship       Y/N          
 
If yes, type Neuroradiologist/general radiologist         




Conclusions    
 
Subjects 
      
Subject type  Hospital/community/unclear 
If hospital, IP or OP IP/OP/both/unclear   
If community, type Healthy/diseased     If diseased, type   
Clinical stroke Y/N Type (first ever/recurrent, etc) stated Y/N   
If yes, type  First ever/recurrent  
If clinical stroke, type:  Stroke alone/stroke + dementia/stroke + cardiovascular/stroke + other  
If dementia, type stated Y/N    
If yes, type  Vascular/Alzheimer’s/other  
 
Imaging-related data – readers 
 
Number readers stated   Y/N If yes, number    
Blinding of readers stated Y/N    
Type of readers stated  Y/N  
If yes, type   Neuroradiologist/radiologist/neurologist/stroke phys/general phys/psychiatrist/other  
If yes, grade stated  Y/N  
If yes, state    
 




Clinical term(s) stated  Y/N If yes, term(s) used   
Clinical definition stated Y/N 
If yes, clinical definition   
Refs given*          Y/N      Refs only   Y/N                
 
Primary aim of paper wrt age of lacunar lesion      
 
Acute/non-acute/both   (complete relevant sections below) 
 
Acute lacunar lesions relevant           Y/N 
 
Term(s) used  
 Imaging definition stated         Y/N      
If yes, imaging definition   Refs given*     Y/N       If yes, refs only          Y/N   
Type of imaging                CT/MRI/both   If MRI, sequences stated in full  Y/N 
MRI, magnet strength stated   Y/N  If yes, magnet strength  
If MRI, sequences done DWI/T1/T2/FLAIR/PD/GRE/other   
If MRI, description of sequences used for diagnosis        Y/N     If yes, sequences used    
Reference to MR signal/CT attenuation        Y/N  If yes, state   
Sites stated       Y/N             If yes, state    
Timing of scan wrt symptoms stated    Y/N     If yes, state     
Size stated   Y/N        
Minimal size stated      Y/N      If yes, state       mm    
Maximum size stated Y/N  If yes, state  mm     
Shape stated  Y/N  If yes, state  
 
Non-acute lacunar lesions relevant  Y/N 
 
Term(s) used  
Imaging definition stated    Y/N              If yes, imaging definition    
Refs given*         Y/N                If yes, refs only         Y/N   
Type of imaging  CT/MRI/both  
If MRI, sequences stated in full  Y/N  
If MRI, magnet strength stated    Y/N   If yes, magnet strength  
If MRI, sequences done   DWI/T1/T2/FLAIR/PD/GRE/other   
If MRI, description of sequences used for diagnosis Y/N  
If yes, sequences used  
Reference to MR signal/CT attenuation                Y/N If yes, state  
Sites stated        Y/N              
If yes, state 
Relationship to symptoms stated    Y/N    
If yes, interval stated     Y/N  If yes, interval     
Size stated  Y/N  
Minimal size stated      Y/N      If yes, state       mm    
Maximum size stated Y/N  If yes, state    mm     
Shape stated  Y/N  If yes, state  
 




Distinction of lacunes from EPVS stated anywhere in paper     Y/N        




 author/year/journal – add up to 3 for each)   
   
Clinical    
Acute 
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Subject: Survey of imaging definitions of lacunar infarcts - Dr G Potter/Professor J Wardlaw, The 




We are interested in finding out more about how people define and interpret the appearance of lacunar 
infarcts on CT and MR imaging.  We are particularly interested in the views of those with a research 
interest in cerebral small vessel disease, but also those of other neurologists, stroke physicians and 
neuroradiologists, who may be involved in the clinical care of patients with lacunar stroke.   
  
You have received this because you have published on some aspect of lacunar stroke, or possibly because 
you belong to a neurology, stroke physician, neuroradiology or other relevant organisation.  
  
We hope you will take the 15 minutes to complete our survey, which includes 9 clinical cases with 
imaging.  Please note that if you choose to participate, the survey needs to be completed in one session, as 
partially completed versions cannot be saved. 
  
The information you provide to us is completely anonymous and goes automatically into a database for 
analysis.  If you would like to receive the final results of the survey once available, please contact Dr 
Gillian Potter (gillian.potter@ed.ac.uk).  Please note that the survey results may be presented at scientific 
meetings and/or submitted for publication in the scientific literature. 
  
To complete the survey, please use the following link: 
http://www.surveymonkey.com/s.aspx?sm=T8r6sLfC2HEaGAPNxNBIow_3d_3d.  
 
Please submit your responses by Friday 16th October, 2009.  
 
If you are aware of any colleagues who may also be interested in participating in this survey, we would be 
grateful if you could forward this information to them. If you have any other queries about the survey, 
please contact Dr Gillian Potter. 
  
Thank you again for your participation. 
 
 Kind regards, 
  
Dr Gillian Potter 
Neuroradiology Specialist Registrar & Clinical Research Fellow, The University of Edinburgh 
  
Professor Joanna Wardlaw 
Professor of Neuroradiology & SINAPSE Director, The University of Edinburgh 
  
SINAPSE - Scottish Imaging Network, A Platform for Scientific Excellence (www.sinapse.ac.uk) - is a 
pooling initiative between the Universities of Aberdeen , Dundee, Edinburgh, Glasgow, St Andrews and 
Stirling, funded by the Scottish Funding Council and the Chief Scientist Office of the Scottish Government. 
GP is funded by the NHS Lothian R&D Office 
 
 Appendices 193 
 
Appendix 7. Lacunar definition online survey: SurveyMonkey
TM
 downloaded results 
Case 1. Please indicate which term you consider most appropriate for the lesion circled in YELLOW in 
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Case 2. Which term you consider most appropriate for this acute lesion? 
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Case 3. Is there any evidence of an acute lacunar infarction in the LEFT hemisphere? (DWI/ADC – 
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Case 5. Is there a lesion in the left hemisphere consistent with a lacunar infarct 18 months previously?   
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Case 6. Is there a lesion in the LEFT cerebral hemisphere of the bottom row of scans consistent with a 
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Case 10. Is there a lesion in the right hemisphere consistent with a lacunar infarct 18 months previously?  
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Question 12. Definitions of site for lacunar lesions 
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Question 14. Participant discipline 
 
Question 15. Research interest in small vessel disease 
 
Question 16. Publications on lacunar infarction 
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Appendix 8. Enlarged perivascular spaces rating scale 
 
     Rating  Number of EPVS Description 
Basal ganglia and centrum semiovale 0  No EPVS  None 
     1   1-10 EPVS  Mild 
     2   11-20 EPVS   Moderate 
     3  21-40 EPVS   Frequent 
     4  >40 EPVS  Severe 
 
Midbrain    0   No EPVS visible  Absent 
     1   EPVS visible  Present 
 
Notes: 
Review both sides of the brain for EPVS, but use the highest number from 1 side only 
Review all relevant slices, but use the slice with the highest number of EPVS  
In cases where rating is difficult (e.g. due to movement, extensive WMH or uncertainty due to variations 
in EPVS visibility), select the closest category 
In cases of marked asymmetry (rare), record the score for the side of the brain with more EPVS  
For basal ganglia EPVS, do not include EPVS in the anterior perforated substance  
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Appendix 9. Enlarged perivascular spaces rating scale user guide  
Available at: http://www.sbirc.ed.ac.uk/documents/epvs-rating-scale-user-guide.pdf 
 
Enlarged perivascular spaces (EPVS): a visual rating scale and user guide 
Gillian Potter, Zoe Morris & Joanna Wardlaw 
Section 1 Introduction        
Section 2 EPVS on brain MRI        
A. Definition        
B. Visualisation of EPVS on MRI     
C. Location of EPVS      
D. Description of EPVS in each anatomical area 
a. Basal ganglia (BG)     
b. Centrum semiovale (CS)  
c. Midbrain       
Section 3 Potential difficulties in EPVS rating     
   A. Difficulties due to differences in EPVS visibility 
   B. Difficulties rating due to white matter hyperintensities 
   C. Varying number of EPVS on different slices 
   D. ‘Double counting’ of linear EPVS 
   E. Poor scan quality, including movement 
   F. Asymmetry in background brain appearances 
   G. Asymmetry in EPVS 
   H. Focally dilated EPVS 
   I. Differentiating between the most severe categories CS-EPVS 
   J. Variations in lesion load between cohorts 
Section 4: The EPVS rating scale        
A. Rating categories & descriptions     
B. Imaging examples of rating categories     
a. Basal ganglia       
b. Centrum semiovale      
c. Midbrain       
References           
Conclusion      
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Section 1. Introduction 
 
Enlarged perivascular spaces (EPVS, sometimes called Virchow-Robin spaces) surround the walls of 
vessels as they course from the subarachnoid space through the brain parenchyma.
1 
EPVS appear in all age 
groups, but are only visualised clearly on T2-weighted brain magnetic resonance imaging (MRI) when 
enlarged.  
Several EPVS rating scales have been described,
2-7
 but these are either limited in their anatomical location, 
in the range of EPVS that they describe, or in their method of assessing severity. Additionally, some scales 
were tested using specific MRI sequences rather than standard structural brain MRI. We reviewed existing 
EPVS visual rating scales,
2-8
 identified omissions or ambiguities in each, and used this combined 
knowledge to design improvements to one existing scale
8
 that already most closely met requirements for a 
comprehensive easy to use scale. We then tested this revised scale on 60 MRI scans chosen to demonstrate 
a full range of EPVS frequencies and designed a comprehensive user guide. Using the revised scale and 
the user guide, two observers showed similar intra-rater agreement for BG-, CS- and midbrain EPVS 
ranging from good to very good kappa values. Inter-rater agreement was moderate for CS- and MB-EPVS 
on both ratings although very good for BG-EPVS on the initial rating. Disagreements were mainly due to 
the counting of very small but just visible EPVS, which were a recognised source of difficulty prior to 
rating. Other main causes for disagreement were the presence of background white matter hyperintensities 
(WMH), particularly when confluent, and lacunes (in the CS and BG regions, respectively). The user 
guide was subsequently modified to help avoid residual sources of observer variation. 
This revised EPVS rating scale includes the 3 major anatomical regions where EPVS are found: basal 
ganglia (BG), centrum semiovale (CS) and midbrain.
1
 The development of a validated rating scale, 
including a user guide with illustrations, will hopefully minimise interobserver variation in studies of 
EPVS, enable cross-comparison between research groups and facilitate meta-analysis of EPVS studies.  
Section 2. EPVS on brain MRI 
A. Definition  
EPVS may be defined on MRI as ‘small, sharply delineated structures of cerebrospinal fluid (CSF) 
intensity (or close to CSF intensity) measuring <3mm following the course of perforating vessels’. 
B. Visualisation of EPVS on MRI 
EPVS are most easily seen on T2-weighted imaging (T2WI), and may be distinguished from cavitated 
lacunes which contain CSF by the latter’s large size (>3mm) and shape (spheroid; Fig 1); these features 
are often easier to see by reviewing adjacent slices. 
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Figure 1. Differentiating true EPVS (arrowhead) from lacunes containing CSF (thin and block arrows) in 
the basal ganglia using size and shape criteria 
 
Although often described as hypointense structures on T1 and FLAIR, many EPVS will not be visible 
unless severe (Fig 2).  
Figure 2. A. Sagittal T1 imaging showing severe EPVS in the basal ganglia (arrows). B. Axial T2 and 
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If EPVS are not identified on T2 images, it is very unlikely that they will be identified on other routine 
sequences. Thus, T2 images should always be reviewed first. 
Although others have excluded EPVS with surrounding FLAIR hyperintensity when rating EPVS (Fig 3), 
these have been included in the current scale 
Figure 3. Axial FLAIR MRI showing EPVS surrounded by white matter hyperintensities (WMH) in the 
centrum semiovale (A, arrows) and basal ganglia (B, arrows; different patient to A). EPVS without 
surrounding WMH are also visible in both regions (arrowheads). 
 
C. Location of EPVS 
EPVS are found throughout the brain, and are subpial spaces surrounding the perforating arteries, 
arterioles, veins and venules of the brain. 
For EPVS rating, there are three primary areas to be considered: basal ganglia, centrum semiovale and 
midbrain. EPVS in these areas have been kept separate in the rating scale as it is possible that they may 
have different underlying pathophysiology.  
For the basal ganglia, this will normally involve reviewing at least 3 slices, for the midbrain, 1- 2, and for 
the centrum semiovale, at least 3 slices.  
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Each anatomical area will now be described in more detail. 
Description of EPVS in each anatomical area 
a. Basal ganglia EPVS 
EPVS are seen in the basal ganglia along the paths of the perforating lenticulostriate arteries (arising from 
the middle cerebral artery), which enter the brain parenchyma inferiorly through the anterior perforated 
substance at the level of the anterior commissure, before coursing superiorly through the basal ganglia. 
However, EPVS in relation to perforating arteries in the insular cortex should be included in the basal 
ganglia EPVS rating. Structures to be reviewed in basal ganglia rating are shown in the following 
diagram: 
 
On standard axial T2MR imaging, EPVS in the basal ganglia most commonly appear as rounded foci of 
high signal (Fig 4). In the insular cortex, EPVS often appear as short linear structures due to different 
orientation of vessels (Fig 5). 
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Figure 5. Linear EPVS following the course of perforating arteries in the insular cortex (arrows) 
 
Inferior to the basal ganglia, at the level of the anterior perforated substance (or substantia innominata) 
most normal people will demonstrate EPVS (Fig 6). Rating of EPVS in the basal ganglia should therefore 
be done above this level: EPVS at the level of the anterior commissure should be excluded from the 
overall rating. 
Figure 6. A. EPVS at the level of the anterior perforated substance (thin arrows), on the slice immediately 
above the upper midbrain (left image), and below the basal ganglia (circled, right image) 
 
 B. Magnified view showing EPVS at the level of the anterior perforated substance, where the anterior 
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b. Centrum semiovale EPVS 
EPVS are seen in the centrum semiovale along the paths of the perforating medullary arteries as they enter 
the cortical gray matter over the high convexities and extend into the white matter. On standard axial 
T2MR imaging, EPVS in the centrum semiovale may have 3 different appearances depending on location 
scan orientation and perforator vessel orientation (Fig 7).   
Figure 7. Varied configuration of EPVS in the centrum semiovale close to the vertex, with a combination 
of rounded (arrowheads), short linear (block arrow) and long linear (arrows) configurations 
 
More inferiorly in the centrum semiovale, EPVS are frequently seen as linear, rather than rounded 
structures (Fig 8). Some scales separate EPVS in the centrum semiovale into round/oval and linear (Rouhl, 
2008); in this scale, only 1 rating is given to EPVS in the centrum semiovale. 
Figure 8. EPVS (arrows) visualised as linear structures in the centrum semiovale at the level of the bodies 
of the lateral ventricles (V) 
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c. Midbrain EPVS 
At the junction of the midbrain and pons (Fig 9), EPVS may be seen in relation to perforating arteries 
arising from the short paramedian (perforating) branches of the basilar artery.  On standard axial T2MR 
imaging, EPVS in the midbrain normally appear as rounded foci of high signal. Normally, at least 2 slices 
should be reviewed when assessing midbrain EPVS. 
Figure 9. A. Level of pons. B. Midbrain (at pons-midbrain junction), the third major site at which EPVS 
are seen. C. Slice above pons. A magnified view of the midbrain is also shown, demonstrating lower 
midbrain EPVS (arrowheads) 
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Section 3. Potential difficulties in EPVS rating 
A. Variations in EPVS visibility 
With current MRI scanners, some EPVS may be seen as faint, indistinct high signal structures in the basal 
ganglia, centrum semiovale and midbrain rather than clear, very high – near-CSF signal – structures (Fig 
10, 11). A general impression of the region being rated should be used to choose a category, using the 
‘whole picture’ and matching as closely as possible with the categories provided.  
Figure 10. Multiple tiny EPVS visualised in the centrum semiovale, in a patient with additional 
movement artefact. 
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B. Background WMH 
Where there are extensive WMHs, EPVS may be difficult to rate. In such cases, an estimate must be made 
of the closest rating category, using the appearance of non-involved white matter (where visible), and 
cortical gray matter. Review of all slices, including those at the vertex may be useful, where uninvolved 
white matter, and cortical gray matter, may be more easily visible (Fig 12). Some EPVS may also remain 
visible despite the presence of extensive WMH. Where WMH are non-confluent, rating may be more 
straightforward (Fig 13); in such cases, non-affected parenchyma should be used, and review of gray 
matter may also help. 
Figure 12. Extensive deep WMH in the centrum semiovale, extending to the vertex. Appearances closer 
to the vertex (magnified image, bottom right image) suggest only mild EPVS  
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Figure 13.Non-confluent WMHs 
 
C. Varying number of EPVS on different slices 
The number of EPVS may vary depending on the slice selected. For example, in some patients, fewer 
EPVS will be visualised in the centrum semiovale at the level of the vertex compared to slices below this 
(Fig 14). After reviewing all relevant slices for the anatomical area being assessed, the highest number of 
EPVS should be recorded. 
Figure 14. Axial T2-weighted images slices demonstrating varying numbers of EPVS at different levels 
of centrum semiovale, with fewer EPVS visible closer to the vertex (right image) 
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D. ‘Double counting’ of linear EPVS 
Care should be taken to try to avoid counting linear EPVS twice, particularly in the centrum semiovale 
(Fig 15). Review of slices closer to the vertex – where EPVS are more often punctuate, rather than linear – 
may help in form an initial impression of the closest rating category. In all areas, review of adjacent slices 
can help reduce this potential problem. 
Figure 15. Illustration of potential pitfall of double-counting EPVS in the centrum semiovale 
 
E. Poor scan quality, including movement 
In some cases, EPVS rating may be made more difficult due to limited scan quality, particularly in 
patients with mild/moderate EPVS (Fig 16A) rather than frequent/ severe EPVS (Fig 16B). In such cases, 
an estimate of the closing rating category should be made. 
Figure 16. Limited MRI scan quality due to movement, making assessment of small structures more 
difficult, particularly where EPVS are mild (A) rather than frequent (B) 
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F. Asymmetry in background brain appearances 
When background brain parenchyma is asymmetric due to the presence of another lesion, e.g. infarction 
(Fig 17A), EPVS should be rated on the other side where possible, or an estimate made of the closest 
category. Lacunes (fully, partially or non-cavitated) in the basal ganglia may also lead to difficulties in 
rating (Fig 17B); again, an estimate must be made of the closest category. 
Figure 17. A. Asymmetry of background brain parenchyma due to an infarct in the right parieto-occipital 
lobe on T2-weighted MRI (arrow). B. Fully cavitated (short arrow), partially cavitated (thick arrow) and 
probably non-cavitated (arrowhead) lacunar lesions in the basal ganglia on T2 and FLAIR MRI. The exact 
nature of the lesion indicated by the long arrow is less certain - this could represent a cavitated lacune or 
EPVS with surrounding WMH 
 
G. Asymmetry in EPVS 
In some patients, EPVS may show significant asymmetry (Fig 18). In such cases, the side with the higher 
number should be counted 
Figure 18. Marked asymmetry in EPVS, with a higher number of EPVS in the posterior cerebral artery 
territory on the right side (arrows) 
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H. Focally dilated EPVS 
In some patients, focally dilated EPVS will be seen amongst uniformly dilated EPVS (Fig 19). The rating 
scale does not specifically take account of these. 
Figure 19. Focally dilated EPVS (arrows) amongst uniformly dilated EPVS 
 
I. Differentiating between the most severe categories of centrum semiovale EPVS 
In many patient cohorts, the number of patients exhibiting the highest numbers/most severe degrees of 
EPVS in the centrum semiovale will be limited. Experience in rating the highest degrees of EPVS will 
thus be limited for the majority of people performing EPVS rating. 
J. Variations in lesion load between cohorts 
Rating of EPVS may vary with lesion load, as found in observer reliability testing for WMH,
9
 therefore 
intermittent review of the full range of EPVS which may be encountered in patients – as demonstrated in 
this guide – is advised in order to help raters ‘recalibrate’. Differences in MRI parameters may also 
contribute to observer differences, although this is a parameter which may be difficult to alter in the 
majority of cases. 
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Section 4. The EPVS scale 
A. Rating categories & descriptions for each anatomical area 
     Rating  Number of EPVS Description 
Basal ganglia and centrum semiovale 0  No EPVS  None 
     1   1-10 EPVS  Mild 
     2   11-20 EPVS   Moderate 
     3  21-40 EPVS   Frequent 
     4  >40 EPVS  Severe 
 
Midbrain    0   No EPVS visible  Not present 
     1   EPVS visible  Present 
 
Notes: 
Review both sides of the brain for EPVS, but use the highest number from 1 side only 
Review all relevant slices, but use the slice with the highest number of EPVS  
In cases where rating is difficult (e.g. due to movement, extensive WMH or uncertainty due to variations 
in EPVS visibility), select the closest category 
In cases of marked asymmetry (rare), record the score for the side of the brain with more EPVS  






 Appendices 220 
 
Imaging examples for rating categories 
a. Basal ganglia 
1-10 EPVS – category 1 (one example) 
  
11-20 EPVS – category 2 
Example 1 of 2 
  
Example 2 of 2 
  
 
 Appendices 221 
 
Basal ganglia 
20-40 EPVS – category 3  
Example 1 of 2 
  
Example 2 of 2 
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>40 EPVS – category 4 
Example 1 of 2 
  
Example 2 of 2 
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b. Centrum semiovale 
1-10 EPVS – category 1 
  
11-20 EPVS – category 2 
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11-20 EPVS – category 2 
Example 2 of 2 
  
20-40 EPVS – category 3 
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>40 EPVS – category 4 
Example 1 of 2 
  
Example 2 of 2 
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c.  Midbrain 
EPVS visible – category 1  
 
Conclusion 
Because the clinical implications of EPVS remain to be established, there is still an opportunity to 
improve the reliability of EPVS assessment by the use of the EPVS rating scale, so that adequately 
powered, well designed studies will be able to answer the outstanding clinical concerns about their 
diagnostic and prognostic value within the spectrum of cerebral small vessel disease, and whether EPVS 
should influence patient management. Although we have developed and tested a visual rating scale, 
automated EPVS measurement methods may be possible with improved image processing algorithms in 
future. 
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Appendix 10. The Brain Observer MicroBleed Scale 
Available at: http://www.sbirc.ed.ac.uk/documents/bombs-2008.pdf 
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Appendix 11. The Brain Observer MicroBleed Scale user guide  
Available at: http://www.sbirc.ed.ac.uk/documents/bombs-userguide.pdf 
A rating scale for brain microbleeds 
The Brain Observer MicroBleed Scale [BOMBS]
1
 is a classification system devised to improve levels of 
interrater agreement about the presence, number, size and location of brain microbleeds (BMB). The use 
of a standard rating scale will hopefully minimise interobserver variation, enable cross-comparison 
between research groups and facilitate meta-analysis of BMB studies.  
The BOMBS scale was developed after testing of an initial pilot scale by two observers highlighted 
several common difficulties in rating BMB, leading to interobserver variation. Ways of minimizing these 
difficulties were then incorporated into a revised scale – BOMBS – which improved interrater agreement. 
Brain microbleeds are most easily identified on haem-sensitive MRI sequences, also known as T2* or 
gradient echo (GRE). However, BMB may also be visible on T2-weighted images, especially if they are 
numerous. T2-weighted images are particularly useful for demonstrating flow voids in cortical vessels, 
which can mimic BMB (see later). If there are no BMB evident on the GRE images, it is unlikely that they 
will be identified on other routine sequences, although all images should be reviewed as standard practice.  
The BOMBS rating scale is shown on the next page. This is followed by a more detailed description of the 
main sections, including a diagram of the 7 anatomical locations which must be viewed for each scan. 
Finally, there are examples of ‘certain’ and ‘uncertain’ BMB and examples of common BMB mimics. 
 
1 Cordonnier C, Potter GM, Jackson CA, Doubal F, Keir S, Sudlow CLM, Wardlaw JM, Al-Shahi Salman 
R. Improving interrater agreement about brain microbleeds: development of the Brain Observer 
MicroBleed Scale (BOMBS). Stroke 2009;40:94-99.
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Description of BOMBS 
The top section of the scale (yellow) consists of a flow chart, highlighting the two main situations in 
which common problems should be reviewed: 1. If there are only a few BMB, then particular care should 
be taken over mimics, and 2. If the lesion is in a location where ‘BMB mimics’ are common - basal 




 Appendices 232 
 
There are 7 locations which must be assessed on both sides of the brain. Descriptions of 3 of these 
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Locations to be assessed in BOMBS (excluding cerebellum and brainstem) 
See Figure 15. 
Finally, BMB should be rated as ‘certain’ and ‘uncertain’ for each side of the brain, in the appropriate row 
for rating size (<5mm, 5-10mm). Examples of BMB and their common mimics are shown on the 




Deep Caudate (C), lentiform nucleus (L), thalamus (T) 
Internal (I) & external capsules (E) 
Lobar Cortex (grey matter) 
 








Locations with BMB:  Cortex/grey-white matter junction (both sides) 
Internal capsule/external capsule (white arrow) 
Thalamus (black arrows)  
 














Locations: Cortex/grey-white matter junction (both sides; not all labelled) 
Deep white matter (white arrows) 
 

















  GRE               T2 
Location: Left upper pons (long arrow) 
 
Note: There are also BMB mimics on this scan - from partial volume artifact (short black arrow) and small 














    GRE               T2 
Location: Right cerebellum (arrow) 















Here, there is a pale unilateral low signal lesion in the right internal capsule. In this case, no CT was 
available to check for asymmetric calcification. This lesion would be rated as ‘uncertain’. 
 
 
Here, the lesion is smaller and even paler than in the previous case and would therefore be rated as 
‘uncertain’. 
 
Remember that when there are 1-2 BMB, rating may be more difficult. 
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Examples of common ‘BMB mimics’ 
1. Basal ganglia calcification  
 
In this case, axial non-contrast CT (right) confirms the presence of bilateral basal calcification, mimicking 
BMB on gradient echo MRI (left) 
 
2. Cortical vessels 
 
In this case, the circled ‘BMB’ (magnified image on right) is due to a sulcal vessel seen in cross section - 
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3. Partial volume artefact 
A. From petrous temporal bone 
    
Note the small apparent ‘pale’ BMB in the left temporal lobe (arrows) – these are due to partial volume 
from the petrous temporal bone and therefore not BMB.  
 
B. From orbit 
 
Similarly, this ‘pale BMB’ in the right medial frontal lobe (arrow) is due to partial volume artifact from 
the orbit, which lies immediately inferior to this slice. 
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Conclusions 
Because the clinical implications of BMB remain to be established, there is still an opportunity to improve 
the reliability of BMB assessment by the use (and further development) of the BOMBS rating scale, so 
that adequately powered, well designed studies will be able to answer the outstanding clinical concerns 
about their diagnostic and prognostic value, and whether presence of BMB should influence the 
prescription of antiplatelet, anticoagulant, or thrombolytic drugs.  
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Appendix 12. Publications 
Improving Interrater Agreement About Brain Microbleeds
Development of the Brain Observer MicroBleed Scale (BOMBS)
Charlotte Cordonnier, PhD; Gillian M. Potter, FRCR; Caroline A. Jackson, MSc;
Fergus Doubal, MRCP; Sarah Keir, MD; Cathie L.M. Sudlow, DPhil;
Joanna M. Wardlaw, FMedSci; Rustam Al-Shahi Salman, PhD
Background and Purpose—If the diagnostic and prognostic significance of brain microbleeds (BMBs) are to be
investigated and used for these purposes in clinical practice, observer variation in BMB assessment must be minimized.
Methods—Two doctors used a pilot rating scale to describe the number and distribution of BMBs (round, low-signal
lesions, 10 mm diameter on gradient echo MRI) among 264 adults with stroke or TIA. They were blinded to clinical
data and their counterpart’s ratings. Disagreements were adjudicated by a third observer, who informed the development
of a new Brain Observer MicroBleed Scale (BOMBS), which was tested in a separate cohort of 156 adults with stroke.
Results—In the pilot study, agreement about the presence of 1 BMB in any location was moderate (0.44; 95% CI,
0.32–0.56), but agreement was worse in lobar locations (0.44; 95% CI, 0.30–0.58) than in deep (0.62; 95% CI,
0.48–0.76) or posterior fossa locations (0.66; 95% CI, 0.47–0.84). Using BOMBS, agreement about the presence
of 1 BMB improved in any location (0.68; 95% CI, 0.49–0.86) and in lobar locations (0.78; 95% CI,
0.60–0.97).
Conclusion—Interrater reliability concerning the presence of BMBs was moderate to good, and could be improved with
the use of the BOMBS rating scale, which takes into account the main sources of interrater disagreement identified by
our pilot scale. (Stroke. 2009;40:94-99.)
Key Words: brain microbleed  rating scale  interrater reliability  classification  stroke
In stroke medicine, the burning questions about brainmicrobleeds (BMBs) concern their diagnostic significance
(for example, for the ante mortem diagnosis of cerebral
amyloid angiopathy and other disorders) and whether BMBs
should influence the use of antithrombotic and thrombolytic
drugs.1 If the diagnostic and prognostic significances of
BMBs are to be investigated and used for these purposes in
clinical practice, then definitive research studies should fulfill
a variety of prerequisites,2 including knowledge of the use-
fulness of the scales used to rate BMBs as well as the
intrarater and interrater variation of the individual researchers
using the scales.
Previous studies have reported variable levels of inter-
rater agreement among 2 or 3 observers (Table 1).3–15
Studies of interrater reliability found kappa values ranging
from 0.33 (fair)3 to 0.88 (excellent);10,11 however, most
found 0.7, but sample sizes were small, 95% CIs were
not always provided, and the properties of the rating scales
used were not described.
In view of the variation in reported interrater agreement,
the potential for a rating scale to improve levels of agreement,
and the absence of a rating scale for BMBs, we further
quantified interrater agreement about the presence, number,
size, and location of BMBs to develop a simple BMB
classification scheme that might minimize observer variation.
Subjects and Methods
Study Population
We studied a subset of patients from a hospital-based stroke register
(the Edinburgh Stroke Study, http://www.dcn.ed.ac.uk/ess/)16 (Table
2). Consecutive consenting stroke and transient ischemic attack
(TIA) patients were recruited to the register from outpatient clinics
and hospital admissions (total n2160). In the current study we
included those patients who had undergone at least 1 MRI scan with
gradient echo (GRE) sequences (n264). If a patient had 1 MRI,
then we used the earliest scan.
MRI Protocols
MRIs were performed on a GE Signa LX 1.5-Tesla machine with
22-mT m1 maximum strength gradients using the manufacturer-
supplied quadrature birdcage head coil. Diagnostic MR imaging
included (all axial sequences): diffusion-weighted (TR, 9999; TE,
98.8; matrix, 128128; FoV, 2424; slice thickness, 5 mm; slice
gap, 1 mm; NEX, 1 [where TR indicates relaxation time; TE, echo
time; FoV, field of view; NEX, number of excitations]); T2-weighted
(TR, 6300; TE, 107; matrix, 256256; FoV, 2418; slice thickness,
Received May 26, 2008; accepted June 10, 2008.
From Department of Neurology and Stroke Unit (C.C.), Lille University Hospital, France; Division of Clinical Neurosciences (C.C., G.M.P., C.A.J.,
F.D., S.K., C.L.M.S., J.M.W., R.A.S.S.), University of Edinburgh, UK.
Correspondence to Rustam Al-Shahi Salman, Bramwell Dott Building, Division of Clinical Neurosciences, Western General Hospital, Edinburgh EH4
2XU, UK. E-mail Rustam.Al-Shahi@ed.ac.uk
© 2008 American Heart Association, Inc.
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5 mm; slice gap, 1.5 mm; NEX, 2); fluid-attenuated inversion
recovery (TR, 9002; TE, 147; matrix, 256256; FoV, 2424; slice
thickness, 5 mm; slice gap, 1.5 mm; NEX, 1); and GRE (T2*; TR,
620; TE, 15; flip angle, 20; FoV, 2418; matrix, 256192; slice
thickness, 5 mm; slice gap, 1 mm; NEX, 2).
Brain Microbleed Rating
A neuroradiologist (G.M.P.) and a neurologist (C.C.), both with
experience in rating BMBs, independently assessed all MRI se-
quences on cut film, belonging to all 264 adults, using a pilot BMB
rating scale, which required the reader to quantify BMBs subdivided
by size (5 mm, 5–10 mm), side of brain (left, right), and location
(lobar [cortex/gray–white junction; subcortical white matter], deep
[basal ganglia grey matter; internal and external capsules; thalamus],
and posterior fossa [brain stem; cerebellum]; Figure 1). All BMBs
were measured manually. Each observer was blinded to clinical data
and to the other observer’s ratings. BMBs were defined as homoge-
neous, round foci, 10 mm diameter (no minimum size was
specified), of low signal intensity on GRE T2*-weighted MRI. The
observers were aware of the main BMB mimics. Low-signal lesions
on GRE T2* within a lesion compatible with an infarct were
regarded as hemorrhagic transformations rather than BMBs.
Development and Testing of the Brain Observer
MicroBleed Scale (BOMBS)
After the assessment of interrater agreement with the pilot scale, a
senior neuroradiologist (J.M.W.) reviewed MRI scans about which
the 2 observers disagreed in their BMB ratings. We developed the
Brain Observer MicroBleed Scale (BOMBS) to account for some of
the common sources of disagreement and other major problems
encountered (see Supplemental Figure I, available online at http://
stroke.ahajournals.org and www.sbirc.ed.ac.uk/imageanalysis.html).
We re-evaluated agreement between the same 2 observers using
BOMBS in a different set of patients undergoing identical MRI
sequences and parameters to quantify BMBs subdivided by size, side
of brain, and location (as before), but with the addition of a further
subdivision into “certain” and “uncertain” BMB categories. The
study population for the assessment of BOMBS was a series of
156 patients with stroke (different to the 264 in whom the pilot
rating scale was tested) who had been recruited in 2 other stroke
studies requiring MRI. Both studies recruited from the same
hospital sources as the Edinburgh Stroke Study. One study
recruited patients with lacunar or nondisabling cortical ischemic
stroke (the Mild Stroke Study); the other included outpatients
presenting 1 week after a mild stroke, in whom CT scanning
would not discriminate between ischemic or hemorrhagic stroke,
requiring MRI for stroke subtyping.
Statistical Analyses
We quantified observer agreement using the unweighted  statistic
for nominal data (such as dichotomized presence versus absence of
1 BMB) analyzed in any brain location and in separate brain areas
(lobar, deep, and posterior fossa). When using BOMBS, we calcu-
lated  for BMBs rated certain, and for BMBs rated certain or
uncertain. Intraclass correlation coefficients were calculated to as-
sess agreement between observers for the overall numbers of BMBs.
When exploring interobserver reliability in measurements of BMB
size, we restricted our analysis to MRI scans on which both raters
had observed definite BMBs in the same brain location. All analyses
were performed in SPSS version 13.0, except for confidence inter-









of BMBs Type of Analysis Statistical Test Used
Interobserver Agreement
(95% CI When Available)
Lee et al13 2 125 ICH 66% Total N of BMBs Spearman correlation 0.81
Greenberg et al6 2 32 Lobar ICH Not specified Total N of BMBs Intraclass correlation 0.97
Viswanathan et al12 2 20 CADASIL 35% Total N of BMBs Intra-class correlation 0.96
Lee et al11 2 102 Stroke and HTN 65% Grade of BMBs (4
grades)
Kappa 0.88 (0.81–0.95)
Jeon et al10 2 63 ICH 68% Presence or absence
of BMBs
Kappa 0.88
Lee et al9 2 143 ICH vs control 97% vs 56% Not specified Kappa 0.87
Lee et al8 2 26 ICH Not specified Not specified Kappa 0.86
Kakuda et al7 2 70 Ischemic stroke
treated with IV
tPA
16% Presence or absence
of BMBs
Kappa 0.77 (0.55–0.99)
Greenberg et al6 2 15 Lobar ICH Not specified Presence or absence
of new BMBs
Kappa 0.73
Lemmens et al14 2 342 TIA or ischemic
stroke
26% Presence or absence
of BMBs
Kappa 0.71 (0.59–0.82)




14% Not specified Kappa 0.6
Roob et al4 3 280 Healthy 6% Presence or absence
of BMBs
Kappa 0.40–0.65
Jeerakathil et al3 3 222 Healthy 5% Presence or absence
of BMBs
Kappa 0.33–0.57
Vernooij et al15 2 300 Healthy 24% Presence or absence
of BMBs
Kappa 0.85
Updated from Cordonnier et al Brain 2007.2
CADASIL indicates cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; HTN, arterial hypertension; ICH, intracerebral
hemorrhage; IV, intravenous; TIA, transient ischemic attack; tPA, tissue plasminogen activator.
Cordonnier et al Brain Observer MicroBleed Scale 95
 at UNIV OF EDINBURGH on June 1, 2010 stroke.ahajournals.orgDownloaded from 
vals for , which were calculated using Confidence Interval Analysis
software.17
Ethics
Ethical approval was granted by the Lothian Research
Ethics Committee.
Results
Study of Interrater Reliability Using a Pilot
Rating Scale
Agreement about the presence/absence of 1 BMB in any
location in the brain was moderate (, 0.44; 95% CI,
0.32–0.56), but it appeared to be better in deep and posterior
fossa locations when compared to lobar areas (Table 2). The
intraclass correlation coefficient for the overall number of
BMBs was 0.91 (95% CI, 0.88–0.93). The 2 observers
disagreed about the presence of 1 BMB on 65 MRI scans.
When these disagreements were reviewed by a third observer
(J.M.W.), most were found to occur when there was doubt
about whether there was 1 BMB on a scan or none. The
main causes for disagreement were common BMB mimics
such as vascular flow voids (cortical and perforator ves-
sels), irregularly shaped lesions, lesions too pale to be
confident about them being a BMB, partial volume arti-
facts from the petrous temporal bone or orbit, and variable
signal dropout (Figure 2).
Development and Testing of the BOMBS
We revised the pilot rating scale on the basis of the causes
of the observed disagreements to develop the BOMBS
(Supplemental Figure I). Interrater agreement about the
Table 2. Characteristics of the Study Populations and Interrater Agreement (simple unweighted kappa statistic) About the





Median age (IQR) 72 (60–78) 66 (56–75)
Ischaemic stroke 235 (90%) 151 (97%)
Intracerebral hemorrhage 10 (4%) 5 (3%)
TIA 15 (6%) 0
History of stroke or TIA 79 (30%) 22 (14%)
History of treated
hypertension
135 (51%) 81 (52%)
Pilot Rating Scale
BOMBS Rating Scale
Certain and Uncertain BMBs Certain BMBs
Observer A Observer B
Kappas 0 vs 1
BMB (95% CI) Observer A Observer B
Kappas 0 vs 1
BMB (95% CI) Observer A Observer B




BMB; % (95% CI)
105; 40 (34–46) 54; 20 (16–26) 0.44 (0.32–0.56) 28; 18 (13–25) 39; 25 (19–32) 0.38 (0.19–0.57) 18; 12 (7–18) 21; 14 (9–20) 0.68 (0.49–0.86)
N of lesions on all
scans
320 362 67 107 43 61
Median N of lesions
per patient (IQR)
1 (1–3) 2 (1–7.25) 2 (1–2) 1 (1–2.5) 1.5 (1–2) 2 (1–2.5)
Lobar
Patients with 1
BMB; % (95% CI)
71; 27 (22–33) 39; 15 (11–20) 0.44 (0.30–0.58) 16; 10 (6–16) 24; 15 (11–22) 0.49 (0.26–0.71) 12; 8 (5–13) 13; 8 (5–14) 0.78 (0.60–0.97)
N of lesions on all
scans
188 231 29 48 19 28
Median N of lesions
per patient (IQR)
1 (1–2) 2 (1–6.5) 1 (1–2) 1 (1–2) 1 (1–2) 1 (1–2)
Deep
Patients with 1
BMB; % (95% CI)
50; 19 (15–24) 30; 11 (8–16) 0.62 (0.48–0.76) 17; 11 (7–17) 22; 14 (10–20) 0.39 (0.14–0.63) 9; 6 (3–11) 12; 8 (5–13) 0.54 (0.25–0.83)
N of lesions on all
scans
95 88 28 43 18 19
Median N of lesions
per patient (IQR)
1 (1–2) 2 (1–4) 1 (1–1) 1 (1–2) 1 (1–1) 1 (1–1)
Posterior fossa
Patients with 1
BMB; % (95% CI)
23; 9 (6–13) 18; 7 (4–11) 0.66 (0.47–0.84) 5; 3 (1–7) 6; 4 (2–8) 0.91 (0.72–1.00) 3; 2 (1–6) 6; 4 (2–8) 0.66 (0.28–1.00)
No. of lesions on all
scans
37 43 10 16 6 14
Median N of lesions
per patient (IQR)
1 (1–2) 2 (1–4) 1 (1–2) 1 (1–4) 1 (1–2.5) 1 (1–4)
IQR indicates interquartile range; TIA, transient ischemic attack; ICH, intracerebral hemorrhage; N, number.
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presence/absence of 1 BMB improved using BOMBS
when the analysis was restricted to certain BMBs, but
remained similar to the pilot rating scale when considering
certain and uncertain BMBs (Table 2). No significant
difference in interrater reliability was discernible between
brain locations using BOMBS (Table 2). The intraclass
correlation coefficient for the overall number of certain
BMBs was 0.93 (95% CI, 0.91– 0.95). There were 27
definite BMBs observed by both raters in the same brain
location, 25 of which were rated in the same size category
(93%; 95% CI, 77–98); 2 BMBs were considered to be
5 mm by observer A, but 5 mm by observer B.
Discussion
With our simple pilot rating scale, we found that the
assessment of BMBs on GRE T2* MR images in patients
with stroke or TIA was not straightforward, with only
moderate levels of interrater agreement, comparable to
previous studies. BOMBS (Supplemental Figure I) im-
proved interrater reliability when all brain locations were
analyzed together, and particularly in lobar locations,
which were identified in our pilot study as a difficult part
of the brain to rate (Table 2). Although the consideration of
BMB mimics is widely recognized as being important,
observer variation persists, even when mimics are care-
fully thought about during MR scan review. BOMBS had
its main effect by differentiating certain from uncertain
BMBs; uncertainty about BMBs may be an important
problem, because it applied to between one-third to one-
half of BMBs in this study (Table 2).
BMB maximum diameters in previous research have var-
ied from 2 to 5 mm, to 7 mm and 10 mm.2 In this study,
using a maximum diameter of 10 mm, we found few BMBs
5 mm in diameter, and we found only 2 disagreements
about BMB size, but further studies are needed of observer
agreement in BMB size categorization and of the pathological
substrates for BMBs of varying sizes in different patient
populations.
We found good agreement about the total number of
BMBs. It is quite possible that the number of BMBs may
influence their prognostic significance,1 but this is not beyond
doubt. On both these counts, continuing to collect the total
number of BMBs rated by any observer—rather than
subdividing a rating scale into no/few/many BMBs—will
contribute to improving agreement about BMB number, as
well as determining what the numeric thresholds for BMB
prognostic/therapeutic significance are. Furthermore,
studying observers’ certainty in relation to their ratings of
the presence/absence of BMBs as well as the number and
size of BMBs seen will help in understanding whether
small/uncertain BMBs are more likely to be counted in
patients with multiple certain BMBs than those with a
solitary certain BMB or multiple uncertain BMBs.
BOMBS appeared to influence rater behavior in our study
(Table 2); for example, observer A rated more BMBs than
observer B in the pilot study, but this pattern was reversed
with BOMBS.
Although studies have described the interrater reliability of
BMB ratings (Table 1), we sought to improve agreement as
our primary objective. We used  and our study design
fulfilled the assumptions inherent in the  statistic: the
subjects undergoing study and the observers were indepen-
dent, and the categories in the scale were independent,
mutually exclusive, and exhaustive.18 The design of BOMBS
benefited from the lessons gleaned using the pilot scale and
independent review of the scans about which the observers
disagreed. This study also benefited from using consistent
imaging parameters and the same range of sequences (includ-
ing GRE T2* in all), and blinding of each observer to the
other’s ratings.
The main weakness of this study was that these findings
have not yet been validated in larger cohorts, in other disease
groups, and among other observers. We encourage other
researchers to do so to explore the generalizability of
BOMBS. The influence of practice effects in our observers
cannot be ruled out, but even before their ratings using the
pilot rating scale both had experience of interpreting BMBs
on MRI. The prevalence of BMBs appeared to decrease
when BOMBS was validated, which was likely to have
been related to the younger patients with milder strokes,
whose MRI scans were used to test BOMBS, than those
whose MRIs were used for the pilot rating scale; a
systematic review has found BMB prevalence to be lower
in these groups.2 An artifact of the  statistic is that it is
affected in complex ways by the prevalence of the abnor-
mality undergoing study, but a decrease in BMB preva-
lence from 20%– 40% to 18%–25% is unlikely to have
significantly biased the observers or affected the properties
of the  statistic.
The BOMBS dichotomization of BMBs into certain and
uncertain was intended to improve agreement about the
existence of certain BMBs. Prioritizing the identification of
certain BMBs would result in improved specificity (at the
Figure 1. Diagram to illustrate the lobar and deep regions
superimposed on a normal GRE MR brain examination. Solid
white indicates lobar cortex; black and white stripes, subcortical
white matter; black with white dots, deep caudate, lentiform,
and thalamic nuclei; white with black dots, internal and external
capsule.
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Figure 2. Examples of certain and uncertain BMBs, and BMB mimics. A, GRE T2* image showing a certain BMB in the right thalamus
(arrow) in a patient with a left thalamic hemorrhage (not labeled). B, Uncertain BMB, GRE T2* image showing a pale lesion in the right
thalamus (arrow). C and D BMB mimics. Small cortical vessels (arrows) in the left parietal lobe on GRE T2* (C) confirmed on T2 imaging
(D) in this patient with a chronic right frontal cortical infarct (not labeled). E and F, BMB mimics. GRE T2* images showing partial vol-
ume artifact from right orbit (E, arrow) and left mastoid air cells (F, arrow).
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expense of sensitivity) by identifying BMBs more reliably,
which could improve the internal and external validities of
research projects and encourage more reliable identification
of BMBs should they become relevant in clinical practice.
Investigators could also explore the robustness of their study
findings using sensitivity analyses (by restricting analyses to
either certain BMBs, or certain and uncertain BMBs, which
would improve sensitivity at the expense of specificity). This
dichotomization also permits the identification of a separate
group of MRIs with uncertain BMBs to help improve
understanding of why and how observers disagree about
BMBs, and to follow-up such patients to determine if these
uncertain BMBs mature into certain BMBs.
Our findings should be regarded as a baseline measure of
observer agreement for future studies using BOMBS. Further
work on ways of improving observer agreement about BMBs
is needed, and training observers to recognize certain and
uncertain BMBs, as well as their mimics, is an obvious
priority (Figure 2). BOMBS will also enable others to study
agreement about BMB size, number, brain location, and
diagnostic certainty, as well as exploring the influence of
these factors on the diagnostic and prognostic usefulness of
BMBs.
Because the clinical implications of BMBs remain to be
established, there is still an opportunity to improve the
reliability of BMB assessments by the use (and further
development) of the BOMBS rating scale, so that adequately
powered, well-designed studies will be able to answer the
outstanding clinical concerns about BMBs’ diagnostic and
prognostic value, and whether they should influence the
prescription of antiplatelet, anticoagulant, or thrombolytic
drugs. The use of a standard scale for BMBs is also essential
for future studies to enable comparisons and meta-analyses.
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are more likely to cause cortical symptoms. Diabetes is as-
sociated with any clinical-imaging mismatch. Stroke misclas-
sification which can arise with clinical classification alone 
should be minimized in research by verification with high-
sensitivity imaging.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Classification of acute ischemic stroke subtypes is im-
portant for categorizing patients into aetiologic and prog-
nostic subgroups in clinical trials, epidemiological and 
pathophysiological studies, and may help guide patient 
management in clinical practice  [1] . Although it is well 
established that infarcts in particular locations are asso-
ciated with specific clinical symptoms, a proportion of 
patients with acute ischemic stroke will be incorrectly 
subtyped based on clinical assessment alone.
 The Oxford Community Stroke Project (OCSP) clini-
cal classification categorizes patients based on clinical as-
sessment alone into those with a lacunar syndrome 
(LACS), a partial anterior circulation syndrome (PACS), 
 Key Words 
 Acute ischemic stroke   Stroke subtype   Infarction   
Acute stroke imaging   Diffusion-weighted imaging 
 Abstract 
 Background: Up to 20% of lacunar infarcts are clinically mis-
diagnosed as cortical infarcts and vice versa. The reasons for 
this discrepancy are unclear. We assessed clinical and imag-
ing features which might explain this ‘clinical-imaging dis-
sociation’ (C-ID).  Methods: Patients with an acute stroke syn-
drome (cortical or lacunar) underwent magnetic resonance 
imaging including diffusion-weighted imaging (DWI). We re-
corded DWI-positive infarcts and proximity to cortex for 
small subcortical infarcts. We examined factors associated 
with C-ID.  Results: 137 patients with a mild cortical or lacunar 
syndrome had an acute ischemic lesion on DWI. Of these, 
21/93 (23%) with a cortical syndrome had an acute lacunar 
infarct and 7/44 (16%) with a lacunar syndrome had an acute 
cortical infarct. From 72 patients with an acute lacunar in-
farct on DWI, lesion proximity to cortex (odds ratio (OR) 14.5, 
95% confidence interval (CI) 1.61–130.1), left hemisphere
location (OR 8.95, 95% CI 1.23–64.99) and diabetes (OR 17.1, 
95% CI 1.49–196.16) predicted C-ID. On multivariate analysis 
of all 137 patients, C-ID was associated with diabetes (OR 7.12, 
95% CI 1.86–27.2).  Conclusions: C-ID occurs in a fifth of pa-
tients with mild stroke. Lacunar infarcts lying close to cortex 
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a total anterior circulation syndrome (TACS) or a poste-
rior circulation syndrome (POCS)  [2] . PACS and TACS 
both indicate cortical stroke syndromes. The OCSP clas-
sification can predict correctly the site and size of cere-
bral infarct, if visible, on computed tomography (CT) or 
magnetic resonance (MR) brain imaging in about three 
quarters of patients  [3] . However, numerous studies dem-
onstrate that about a fifth of patients with a cortical syn-
drome clinically have an acute lacunar infarct on imag-
ing that accounts for their recent stroke symptoms; simi-
larly some patients with LACS clinically have an acute 
cortical infarct on brain imaging that accounts for their 
recent stroke symptoms  [4–15] , creating a ‘clinical-imag-
ing dissociation’ (C-ID) ( table 1 ). This dissociation is im-
portant because epidemiological studies, primary treat-
ment and secondary prevention trials in stroke have so 
far relied heavily on clinical classification so are likely to 
have incorporated ‘noise’ due to approximately one fifth 
of LACS and PACS patients being misclassified.
 Several factors may contribute to C-ID. Previous stud-
ies suggested that the side of brain affected by stroke  [3] , 
leukoaraiosis  [4] , clinical severity  [4, 13] and asymptom-
atic infarcts on imaging  [4] were associated with C-ID. 
Other contributing factors have not been assessed. De-
lays in clinical assessment may allow neurological signs 
to resolve making an accurate history difficult to obtain 
(e.g. dysarthria and dysphasia can be difficult to distin-
guish on history alone); clinical examination may be in-
sensitive to some subtle cortical signs (e.g. mild inatten-
tion) which would distinguish PACS from LACS. How-
ever, the one previous study that examined delay to 
diagnosis did not find any association with C-ID  [3] . Re-
liability of classification is affected by observer expertise 
in use of the OCSP classification, particularly in minor 
stroke  [16] . C-ID may also arise when there is failure of 
brain imaging to ascertain relevant ischemic lesions, ei-
ther because the imaging is relatively insensitive to small 
acute lesions  [17] or is performed too late to identify the 
acute lesion reliably.
Table 1. Previous studies identifying clinical-imaging dissociation (C-ID), and features examined
















Features examined in relation to C-ID
Lodder, 1994 [4] Hospital CT – 147 23 (16) 203 19 (9) Disability (OR 4.31, 95% CI 1.25–14.88)
Leukoaraiosis (non-LACS; OR 3.79,
95% CI 1.32–10.05)
Asymptomatic infarcts (non-LACS;
OR 4.13, 95% CI 1.45–11.71)
Hemisphere affected (non-LACS)
Al-Buhairi, 1998 [5] Hospital CT OCSP – – 121 4 (5) –
Pittock, 2003 [6] Hospital CT OCSP 47 2 (10) 24 3 (11) –
Wlodek, 2004 [7] Hospital CT OCSP 101 29 (29) 193 29 (15) –
Kobayashi, 2009 [8] Hospital CT OCSP 60 19 (31) 183 3 (2) –
Mead, 1999 [9] Hospital CT, MRI OCSP 180 35 (19) 395 62 (16) –
Mead, 2000 [3] Hospital CT, MRI OCSP 144 35 (24) 298 38 (13) Hemisphere affected (PACS, LACS)
Anderson, 2004 [10] Hospital, 
community
CT, MRI OCSP 69 12 (17) 75 16 (21) –
Ay, 1999 [11] Hospital DWI – 62 1 (2) – – –
Lindgren, 2000 [12] Hospital DWI – 23 2 (9) – – –
Allder, 2003 [13] Hospital DWI OCSP – – 42 6 (14) Clinical severity (χ2 18.9, p < 0.01)
Seifert, 2005 [14] Hospital DWI OCSP – – 93a 14 (15) –
Wessels, 2005 [15] Hospital DWI – 73 13 (18)b – – –
This study Hospital DWI OCSP 80 7 (16) 136 24 (25) Old infarcts (OR 3.02, 95% CI 1.06–8.59)
Diabetes (OR 7.17, 95% CI 1.86–27.71)
PACS = Partial anterior circulation syndrome; LACS = lacunar syndrome; OCSP = Oxford Community Stroke Project; OR = odds ratio; CI = confi-
dence interval; DWI = diffusion-weighted imaging; CT = computed tomography; MRI = magnetic resonance imaging. 
a Patients with subcortical or brainstem lesions <1.5 cm in diameter.
b Four with single cortical lesion, 9 with scattered or multiple lesions containing a cortical lesion.
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 Small subcortical infarcts are considered to cause their 
symptoms because their location in the subcortical white 
matter or basal ganglia effectively disconnects a larger 
section of cortex than is affected by an equivalent-sized 
lesion in the cortex ( fig. 1 ). We hypothesized that a small 
subcortical infarct lying close to the cerebral cortex could 
mimic symptoms of a mild cortical syndrome (PACS) by 
causing functional disconnection of only a small area of 
cortex compared to one of the same size lying in the peri-
ventricular white matter or basal ganglia which would 
disconnect a larger area of cortex. We also considered 
that other factors, such as previous stroke, could increase 
the proportion with C-ID, as residual features of a previ-
ous stroke could make interpretation of features due to 
the acute stroke difficult, and that common stroke risk 
factors might influence symptomatology.
 Methods 
 We included patients from a prospectively collected hospital-
based stroke register of consecutive stroke and transient ischemic 
attack (TIA) patients seen at a large academic teaching hospital 
between April 2002 and May 2005. In the present study we in-
cluded only those patients who underwent brain MR imaging 
(MRI). We performed MR when time from stroke onset was great-
er than 5–7 days or uncertain, if there was clinical uncertainty 
about the definite diagnosis of stroke (particularly in patients 
with prior stroke) or of the vascular territory involved (carotid or 
vertebrobasilar), if there was a potential underlying cause of 
stroke that required further investigation by advanced brain im-
aging, or if the patient was suitable for inclusion into other studies 
of large artery or subcortical stroke requiring brain MRI.
 All patients were assessed by an experienced stroke physician 
who took a detailed history, performed a general and neurological 
examination and recorded the National Institutes of Health Stroke 
Scale score. Patients were assigned a clinical subtype according to 
the OCSP classification based on the maximum stroke deficit as 
described previously  [1] . Lacunar and mild cortical syndromes 
(LACS and PACS, respectively) were defined according to the 
OCSP classification  [1] . LACS was defined as one of the classical 
LACSs – i.e. pure motor weakness and/or sensory loss of face and 
arm, arm and leg or all three, or ataxic hemiparesis (ipsilateral 
corticospinal and cerebellar-like dysfunction without other fea-
tures clearly localizing to the posterior circulation, including dys-
arthria-clumsy hand syndrome and homolateral ataxia and crural 
paresis) – in the absence of visual field defect or higher cerebral 
dysfunction. In patients with faciobrachial or brachiocrural motor 
and/or sensory deficits, only involvement of the whole limb was 
considered acceptable for LACS; patients with involvement of less 
than the whole limb were classified as PACS. Mild cortical stroke 
syndrome (PACS) was defined as a maximum clinical deficit of 
either: weakness or sensory loss in the face, arm or leg; loss of 
higher cerebral function (e.g. dysphasia or neglect); or weakness 
in more than one limb in the presence of loss of higher cerebral 
dysfunction or homonymous hemianopia. Isolated homonymous 
hemianopia was classified as POCS  [1] , a relatively crude grouping 
of posterior circulation cortical and lacunar lesions with clinical 
consequences which are generally less predictable because of the 
greater frequency of developmental vascular anomalies and great-
er variability of the territory supplied by individual arteries.
 All patients had MRI including diffusion-weighted imaging 
(DWI), carotid Doppler ultrasound,   electrocardiogram, blood 
tests, and other investigations as indicated. We recorded risk fac-
tors including diabetes mellitus (defined as having a previous di-
agnosis of, or being on current medication for, diabetes), hyper-
tension (defined as having a history of hypertension requiring 
medication) and prior history of stroke (i.e. clinical presentation 
with stroke). The Edinburgh Stroke Study was approved by the Lo-
cal Research Ethics Committee and all patients (or their relatives) 
gave written informed consent. Patients underwent 1.5 T MRI (GE 
Signa LX EchoSpeed scanner, Milwaukee, Wisc., USA). We col-
lected sets of axial diffusion-weighted echo planar (EP) images 
(sensitization levels b = 0 and 1,000 s/mm 2 ) with 5-mm slice thick-
ness, 1-mm slice gap, 128  ! 128 image matrix and 24  ! 24 field 
of view. Other MR parameters have been published elsewhere  [18] . 
Images were reviewed by a neuroradiologist (G.P.), blinded to all 
clinical details. Location and size of recent infarcts were recorded. 
Recent infarcts were defined as hyperintense on DWI, hypoin-
tense on the apparent diffusion coefficient map and either normal 
or hyperintense to normal brain on fluid-attenuation inversion 
 Fig. 1. Coronal T 1 -weighted MRI brain to demonstrate how the 
site of a small subcortical (lacunar) infarct could influence clini-
cal presentation. A small subcortical infarct lying in the left inter-
nal capsule, i.e. deep white matter (A), would cause functional 
disconnection of a large area of cortex (B, shaded). A peripheral 
small subcortical infarct lying close to cortex (C) would affect 





recovery (FLAIR)/T 2 -weighted imaging (less hyperintense than 
cerebrospinal fluid on T 2 ). Lacunar infarcts were defined as round 
or ovoid lesions measuring  ̂  20 mm in maximal diameter in the 
white matter, basal ganglia or brainstem. Proximity to cortex of 
recent lacunar infarcts was noted on any sequence on which the 
infarct was visible. We defined ‘close to cortex’ as the edge of the 
infarct lying within 2 mm of the cortical margin in the white mat-
ter. Infarcts were defined as cortical where there was a typical con-
figuration with involvement of cortex  8 adjacent white matter, 
and striatocapsular where located in the basal ganglia or centrum 
semiovale and measuring  6 20 mm. Uncertain lesions were 
checked with a second neuroradiologist (J.W.). A lacunar infarct 
was considered ‘appropriate’ in patients presenting with LACS; a 
lacunar infarct in the brainstem or thalamus, i.e. in the vertebro-
basilar territory, was also considered ‘appropriate’ to POCS. A 
small- or medium-sized cortical infarct was considered ‘appropri-
ate’ in PACS. We also recorded white matter hyperintensities 
(WMH) (0–3 on the Fazekas scale  [19] ); old strokes using all se-
quences; enlarged perivascular spaces (EPVS, defined as  ̂  2 mm 
round or linear isointense to cerebrospinal fluid lesions along the 
course of penetrating arteries, T 2 -hyperintense and T 1 /FLAIR-hy-
pointense) in the basal ganglia and centrum semiovale (0–4 on a 
local scale, where 0 = none and 4 =  1 40)  [20] and atrophy (0–3 on 
a validated scale, where 0 = none and 3 = severe)  [21] .
 Statistical Analysis 
 We assessed the statistical significance of differences in base-
line characteristics and brain-imaging features using Student’s t 
test for continuous variables, the Mann-Whitney test for non-
normally distributed continuous variables, and the   2 test for di-
chotomous variables. We performed multivariable analyses using 
logistic regression to determine independent factors for C-ID. In 
the logistic regression model we included all variables from uni-
variate analysis and obtained adjusted odds ratios (OR) (compar-
ing patients with C-ID versus those without) and 95% confidence 
intervals (CIs). We dichotomized scores for WMH (0–1 vs. 2–3), 
brain tissue loss (0–1 vs. 2–3) and EPVS (0–1 vs. 2–4) due to low 
frequencies. We performed analyses with Minitab Statistical Soft-
ware Version 15 (Minitab, Inc., State College, Pa., USA).
 Results 
 Amongst the 1,311 acute ischemic stroke patients re-
cruited to the Edinburgh Stroke Study, 313 underwent 
MR brain imaging, of whom 136 (43%) presented clini-
cally with PACS, 79 (25%) with LACS, 24 (8%) with TACS, 
Correct clinical-imaging association
n = 106
PACS = partial anterior circulation syndrome
LACS = lacunar syndrome
TACS = total anterior circulation syndrome
























93 PACS, 44 LACS
136 PACS 79 LACS
Excluded No diffusion-positive infarct
43 PACS, 35 LACS
313 patients MRI
Excluded 64 POCS , 24 TACS,
10 classification unknown
a




14 with acute lacunar infarct used in separate analysis (cf. table 3).
3/93 (3%) with cerebellar infarct (not shown).
11/13 multiple cortical infarcts, 2/13 cortical plus cerebellar infarcts.
 Fig. 2. Identification of patients with PACS and LACS for assessment of C-ID and imaging findings. 
 Associations of Clinical Stroke 
Misclassification 
Cerebrovasc Dis 2010;29:395–402 399
64 (21%) with POCS, and 10 (3%) with an uncertain OCSP 
classification ( fig. 2 ). Ninety-three (68%) of 136 patients 
with PACS and 44/79 (56%) patients with LACS had a dif-
fusion-positive infarct relevant to the clinical presenta-
tion ( fig. 2 ). Six (4%) patients with PACS and 3 (4%) LACS 
in whom DWI was normal had lesions on other sequenc-
es as the likely cause of symptoms. Patients undergoing 
MRI were slightly younger when compared with the 1,311 
ischemic stroke patients from which we identified our 
study population, with a higher proportion of males and 
a lower prevalence of diabetes but the proportion of
PACS and LACS were similar (online suppl. table 2, www.
karger.com/doi/10.1159/000286342).
 Sixty-nine (74%) patients presenting with PACS had 
an acute cortical infarct (all small- or medium-sized and 
considered appropriate to clinical syndrome) ( fig. 2 ), 21 
(23%) had an acute lacunar infarct ( fig. 2 ), and 3 (3%) had 
a cerebellar infarct on DWI. Of patients presenting with 
LACS, 37/44 (84%) had an acute lacunar infarct and 7 
(16%) had an acute cortical infarct. Most acute lacunar 
infarcts identified on DWI in patients presenting with 
LACS or PACS were located in the centrum semiovale 
(18/37 LACS, 20/21 PACS). Amongst patients with an 
acute infarct on DWI, 65/138 (47%) patients had old in-
farcts on imaging, the median WMH score was 1.62 
(range 0–3) and the median EPVS score was 2 (range
0–4).
 In the cohort of 137 patients with PACS and LACS and 
an acute infarct on DWI, C-ID was associated on uni-
variate analysis with diabetes (p = 0.001), increasing time 
from onset of stroke symptoms to MRI (p = 0.05), EPVS 
(p = 0.02) and old stroke lesions on brain imaging (p = 
0.02), but not with age (p = 0.69), history of previous 
stroke (p = 0.08), brain tissue loss (p = 1.0) or WMH (0.12; 
 table 2 ). On multivariate analysis, diabetes (OR 7.12, 95% 
CI 1.86–27.2; p = 0.004) was independently associated 
with C-ID. 
 Multiple acute infarcts were not associated with C-ID 
either: amongst 44 LACS, 5 (11%) had multiple DWI-pos-
itive infarcts (all lacunar lesions) and none had C-ID. 
Amongst 93 PACS, 15 (16%) had multiple DWI-positive 
infarcts, of whom 2 (13%) had C-ID (all multiple lacunar 
infarcts) and 13 (87%) were correctly associated (showing 
multiple cortical, or cortical plus cerebellar, infarcts; 
 fig. 2 ).
 We examined characteristics associated with a lacu-
nar infarct causing PACS clinical syndrome in all 72 pa-
tients with an acute lacunar infarct on DWI. Thirty-sev-
en (51%) patients presented with LACS, 21 (29%) with 
PACS, and 14 (20%) with POCS ( fig. 2 ). Lacunar infarcts 
in POCS patients were located (appropriate to symptoms) 
in the posterior circulation territory (12 brainstem, 1 
thalamus, 1 posterior border zone) and were therefore not 
considered to have C-ID. C-ID was associated in univar-





























Previous stroke, % 12 (39) 24 (23) χ2 3.03 0.08 0.14 2.38 (0.74–7.60)
Hypertension, % 23 (74) 58 (56) χ2 3.52 0.06 0.88 1.09 (0.36–3.34)
Diabetes, % 9 (29) 6 (6) χ2 11.2 0.001 0.004 7.12 (1.86–27.2)
Clinical






Mann-Whitney 5 (0–12) 0.09 0.72 1.01 (0.96–1.07)






Mann-Whitney 8 (0–14) 0.05 0.71 1.01 (0.9–1.06)
MR brain imaging characteristics
Left hemisphere, % 17 (55) 61 (58) χ2 0.07 0.79 0.49 1.44 (0.51–4.09)
WMH 2–3, %a 16 (53) 39 (37) χ2 2.62 0.12 0.85 1.12 (0.35–3.55)
EPVS 2–4, %b 19 (63) 41 (340) χ2 5.2 0.02 0.38 1.61 (0.56–4.60)
Brain tissue loss 2–3, %c 8 (28) 29 (28) χ2 <0.001 1.0 0.1 0.33 (0.09–1.24)
Old stroke lesions, % 20 (65) 45 (42) χ2 5.49 0.02 0.08 2.56 (0.89–7.36)
EPVS = Enlarged perivascular spaces; WMH = white matter hyperintensities; IQR = interquartile range; OR = odds ratio; CI = confidence interval.




iate analyses with increasing age (p = 0.03), hypertension 
(0.004), increasing delay from symptom onset to clinical 
examination (p = 0.001) and to MRI (p = 0.04) and infarct 
positioned close to cortex (p = 0.001) ( table 3 ). In multi-
variate analysis, closeness to cortex (OR 14.5, 95% CI 
1.61–130.1; p = 0.02) and older age (OR 1.16, 95% CI 1.0–
1.30; p = 0.01) remained independently associated with 
C-ID; diabetes (OR 17.1, 95% CI 1.49–195.16; p = 0.02) and 
left-hemispheric location (OR 8.95, 95% CI 1.23–64.99;
p = 0.03) were also independent associates. There was no 
difference in the size of the lacunar infarcts between 
those causing PACS and those causing LACS clinical syn-
dromes (mean 11.7  8 3.4 vs. 10.8  8 4.3 mm; p = 0.32; 
 table 3 ), nor in the size of those lacunar infarcts that were 
close to cortex and caused PACS (n = 16) or LACS
(n = 15) (mean 12.3  8 5.3 vs. 12  8 3.7 mm; p = 0.8).
 Discussion 
 In our study of acute stroke patients with PACS and 
LACS and an acute infarct on DWI, we found that 23% of 
patients presenting with PACS had an acute lacunar in-
farct, and 16% of patients presenting with LACS had an 
acute cortical infarct and no other explanation for their 
recent stroke symptoms. The main factors associated 
with C-ID amongst all patients in this study, after adjust-
ing for potential confounders, was diabetes (old stroke 
lesions and previous history of stroke were associated in 
univariate analysis only), and in patients with an acute 
lacunar infarct on imaging, proximity of the lacunar in-
farct to the cortex, older age, diabetes and left hemisphere 
location. Lesion size, multiple acute infarcts, time to 
scanning, WMH, brain atrophy and history of prior 
stroke were not associated with C-ID.
 The present study has some methodologic strengths. 
We performed a more comprehensive examination of as-
sociated features than in previous studies of C-ID. We 
identified consecutive stroke and TIA patients presenting 
to our stroke service. Patients undergoing MRI had sim-
ilar proportions of PACS and LACS to the registry cohort 
as a whole. The minor differences between patients un-
dergoing MRI and those that did not (slightly younger, 
more males, fewer with vascular risk factors) is unlikely 
to have influenced the generalizability of our results. All 
patients were very carefully examined by an experienced 
stroke physician and categorized according to strict in-
terpretation of the OCSP criteria. Images were reviewed 
systematically according to a structured proforma by a 
trained rater using validated scales.





























Previous stroke, % 6 (27) 8 (16) χ2 1.24 0.27 0.64 1.66 (0.20–13.82)
Hypertension, % 18 (82) 22 (44) χ2 8.85 0.004 0.12 3.72 (0.72–19.28)
Diabetes, % 6 (27) 4 (8) χ2 4.75 0.06 0.02 17.1 (1.49–195.16)
Clinical






Mann-Whitney –6 0.04 0.49 1.05 (0.91–1.21)






Mann-Whitney –6 0.04 0.76 0.98 (0.84–1.13)
MR brain imaging characteristics
Subcortical infarct close to cortex, % 16 (73) 15 (30) χ2 11.4 0.001 0.02 14.5 (1.61–130.1)
Infarct size, mm 11.783.4 10.884.3 Student’s t test –1.01 0.32 0.99 1.00 (0.82–1.23)
Left hemisphere location, % 15 (68) 26 (52) χ2 1.22 0.27 0.03 8.95 (1.23–64.99)
WMH 2–3, %a 12 (55) 20 (40) χ2 1.31 0.25 0.43 0.48 (0.08–2.93)
EPVS 2–4, %b 14 (64) 25 (49) χ2 0.98 0.32 0.67 1.52 (0.22–10.46)
Brain tissue loss 2–3, %c 7 (32) 9 (18) χ2 1.69 0.19 0.35 0.30 (0.02–3.75)
Old stroke lesions, % 14 (64) 23 (46) χ2 1.9 0.17 0.13 0.20 (0.02–1.65)
EPVS = Enlarged perivascular spaces; WMH = white matter hyperintensities; IQR = interquartile range; OR = odds ratio; CI = confidence interval.
1 Odds ratio (OR) per additional year of age. a On Fazekas scale. b On EPVS scale. c On brain tissue loss scale.
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 There are limitations of our study. Overall, only 
313/1,311 (24%) of patients presenting with acute stroke 
underwent MRI, which may have introduced a selection 
bias. Other factors which may have led to selection bias 
were the inclusion of patients with increasing delay, or 
uncertain time, since stroke onset, and where there was 
clinical uncertainty about stroke diagnosis. Our sample 
may therefore have included an overrepresentation of pa-
tients who were more difficult to subtype. However, this 
does not negate the observation that lacunar lesion loca-
tion was associated with C-ID. Median time from stroke 
onset to MRI of 19 days (many were outpatients, with 
mild stroke), i.e. outside the time period generally consid-
ered optimal for DWI, and only 64% (137/215) patients 
had a diffusion-positive infarct. However, a previous 
study showed no difference in the proportion with an 
acute infarct on DWI in those scanned before versus after 
4 weeks  [22] . Although several patients had DWI outside 
the optimal time period, previous work has shown that 
DWI may also be useful up to several weeks after stroke 
onset  [23] . We also cannot exclude the possibility that the 
infarct responsible for initial symptoms was no longer 
visible on DWI by the time the patient underwent brain 
imaging, and that a new, silent DWI infarct (but suffi-
ciently consistent with the infarct location as suggested 
by the symptoms and signs as to be considered as the 
acute index infarct) had appeared in this period, but this 
possibility was considered to be low and consequently not 
a significant confounding factor. We did not investigate 
underlying mechanisms as a cause of C-ID, and the study 
was not designed to test the effect of clinician experience 
on misdiagnosis, a factor identified in one previous study 
 [16] .
 Previous studies did not consider proximity of lacunar 
infarcts to cortex or diabetes as possible factors for C-ID. 
The association with diabetes may be partly explained by 
a co-association with old ‘silent’ infarcts; however, al-
though old infarcts were associated with C-ID in uni-
variate analysis, they did not remain independently as-
sociated in multivariate analysis, as found previously  [4] . 
Assigning clinical subtype may be more difficult in the 
presence of an old infarct, even if clinically silent, as signs 
from the previous infarct may confuse the clinical pic-
ture. The association of left hemisphere location and C-
ID is consistent with previous studies which found that 
left-sided lesions were more common in patients with 
PACS/non-LACS with C-ID  [4] and that right-sided le-
sions were more common in LACS presenting with C-ID 
 [3] . This may be explained by the difficulty in distin-
guishing dysarthria from dysphasia, especially if symp-
toms and signs were mild or had resolved by the time of 
assessment. We did not find an association between C-ID 
and WMH, in contrast to one previous study  [4] , possibly 
because the latter used CT, which is less sensitive to WMH 
than MR FLAIR or T 2 . We found that 11% of patients 
with LACS had multiple acute lacunar infarcts, similar to 
previous studies  [11, 14, 15] , but multiplicity of infarcts 
did not contribute to C-ID. We did not find an associa-
tion between time lapse from stroke onset to MRI and 
C-ID, in agreement with one previous study using CT  [3] . 
Ability to recall symptoms and signs may deteriorate 
with increasing time to assessment, particularly with 
speech disorders. Others have reported problems with 
very early or very late diagnosis of lacunar stroke  [24] . 
Our use of maximum deficit in assigning the OCSP sub-
type may have overcome any effect of time on stroke di-
agnosis.
 C-ID has important implications for research into ep-
idemiology, pathophysiology and treatment of lacunar 
stroke as well as for clinical practice. In research which 
relies heavily on clinical presentation alone, results may 
be affected by ‘noise’ caused by C-ID of between 10 and 
20% patients with mild stroke. Studies in which CT is 
used in conjunction with clinical classification will also 
be affected, since CT is less sensitive than DWI for small 
acute infarcts  [17] , particularly when performed soon af-
ter symptom onset, as is increasingly the case. Acute isch-
emic stroke lesions are visible on CT in  ! 20% of LACS 
and  ! 35% PACS (i.e. mild stroke) at  ! 3 h, rising to ap-
proximately 45 and 60% at 36 h  [25] . The debate over 
mechanisms of lacunar stroke – up to 20% are said to be 
associated with cardiac and large artery atherothrombo-
embolism  [26, 27] rather than intrinsic small vessel dis-
ease – could be explained by C-ID. Similarly, large pri-
mary and secondary prevention trials of ischemic stroke 
testing aspirin, cholesterol-lowering drugs and antihy-
pertensives have relied heavily on clinical classification 
and CT  [28] . ‘Noise’ from C-ID may have impeded the 
demonstration of any difference in treatment effects be-
tween stroke subtypes, if one existed. In future, where 
precise diagnosis of stroke subtype and lesion location is 
important, lesion location should be verified by sensitive 
imaging.
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Counting Cavitating Lacunes Underestimates the Burden of
Lacunar Infarction
Gillian M. Potter, MBChB, BSc (Hons), MRCP, FRCR; Fergus N. Doubal, MBChB, MRCP;
Caroline A. Jackson, MSc, PhD; Francesca M. Chappell, MSc; Cathie L. Sudlow, DPhil, FRCP;
Martin S. Dennis, MD, FRCP(E); Joanna M. Wardlaw, MD, FRCR, FRCP, FMedSci
Background and Purpose—On brain imaging, lacunes, or cerebrospinal fluid–containing cavities, are common and are
often counted in epidemiological studies as old lacunar infarcts. The proportion of symptomatic lacunar infarcts that
progress to lacunes is unknown. Noncavitating lacunar infarcts may continue to resemble white matter lesions.
Methods—We identified patients with acute lacunar stroke, with or without an acute lacunar infarct on computed
tomography or MRI, who had follow-up imaging. A neuroradiologist classified lacunar infarcts progressing to definite
or possible cavities on follow-up imaging. We tested associations between cavitation and patient-related, stroke-related,
and imaging-related features, including other features of small vessel disease.
Results—Among 90 patients (mean age 67 years), any cavitation was present on follow-up imaging in 25 (28%), and
definite cavitation in 18 (20%). Definite cavitation was associated with increasing time to follow-up imaging (median
228 days, range 54 to 1722, versus no cavitation 72 days, range 6 to 1440; P0.0003) and deep cerebral atrophy
(P0.03) but not with age, stroke severity, larger initial infarct size, or other features of small vessel disease.
Hypertension and diabetes were negatively associated with cavitation (P0.01 and 0.02, respectively).
Conclusions—Definite cavitation occurs in one fifth of symptomatic lacunar ischemic strokes, implying that most continue
to resemble white matter lesions. Epidemiology and pathophysiology studies of lacunar stroke, which have only counted
lacunes as lacunar infarcts, may have substantially underestimated by as much as 5 times the true burden of lacunar
stroke disease. (Stroke. 2010;41:267-272.)
Key Words: brain imaging  lacunar infarction  lacunes  epidemiology
Alacune is commonly defined as a small, deep, 3- to 20-mm(or in some cases, 3- to 15-mm) cerebrospinal fluid
(CSF)–containing cavity. The term lacune was first used by
Dechambre in 18381 and later in 1901 by Marie,2 who suggested
these could be attributable to infarcts. Sixty years later, Fisher
defined lacunes pathologically as infarcts, either clinically silent
or symptomatic, resulting from occlusion of a penetrating branch
of a cerebral artery.3–5 The term lacune is often used inter-
changeably with the terms lacunar infarct and lacunar stroke.
Tissue loss replaced by CSF (or near-CSF) is also known
radiologically as cerebromalacea and can affect gray or white
matter, but this term is usually applied to cortical infarcts.
Silent lacunes (on imaging or histopathology, without clear
evidence of relevant stroke symptoms) are often termed silent
lacunar infarcts or silent brain infarcts. Silent lacunes are
frequently seen in healthy older people, occur in 8% to 28% of
the general population, are associated with increasing age,
hypertension, and subtle deficits in physical and cognitive
function, and more than double the risk of stroke and dementia.6
In most studies of silent brain infarcts, there is no definitive
pathological evidence that the lesion was attributable to
infarction.
The association between clinically evident lacunar ische-
mic stroke and silent lacunes is unclear because the propor-
tions in whom the symptomatic lacunar infarct progresses to
a cavity and in whom the lesion continues to resemble a white
matter lesion are unknown. This has significant implications
for epidemiology (including risk factor) and pathogenesis
studies of lacunar infarction and cerebral small vessel disease,
in which it is common practice to count lacunes and only
consider these as silent lacunar infarcts, omitting to correlate
these with symptoms.
We investigated the proportion of symptomatic lacunar
strokes progressing to lacunes and assessed patient-related,
stroke-related, and imaging-related associations of cavitation.
Subjects and Methods
We identified patients with acute lacunar ischemic stroke, diagnosed
after clinical and radiological evaluation, with baseline and follow-up
MRI or computed tomography (CT) brain imaging, from 2 studies: a
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prospective register of consecutive stroke patients presenting to an
academic teaching hospital,7 and a prospective study of acute lacunar
stroke.8 A stroke physician assigned a classification using the Oxford-
shire Community Stroke Project Classification,9 measured the National
Institutes of Health Stroke Scale score (NIHSS), and assessed vascular
risk factors. Written consent was obtained from all patients. Both studies
were approved by the local research ethics committee.
We included patients with baseline imaging with either MRI
(diffusion-weighted imaging [DWI], T2-weighted imaging, and
fluid-attenuated inversion recovery [FLAIR]) or CT brain imaging.
We included patients with or without an acute lacunar infarct on MRI
(because the high sensitivity of magnetic resonance enabled us to
exclude as fully as possible patients with cortical infarction), but on
CT, we only included patients with a visible recent lacunar infarct in
the appropriate area for symptoms (because the low sensitivity of a
negative CT would not allow us to exclude cortical stroke, which
may give rise to lacunar-type symptoms).10 Baseline and follow-up
imaging was with either MRI (including T1-weighted, T2-weighted,
FLAIR, and gradient echo sequences) or CT (parameters published
previously).7,8 Patients with baseline DWI-positive MRI and
follow-up MRI were considered to represent a “pure” subgroup
because diagnosis was most sensitive and specific for stroke subtype.
The inclusion of the larger group in whom baseline imaging was
either CT positive or magnetic resonance negative enabled us to
increase sample size, study power, and generalizability.
A neuroradiologist (G.M.P.) recorded site and diameter of the
acute index symptomatic lacunar infarct, white matter lesions
(WML), enlarged perivascular spaces, cerebral atrophy, lacunes
(separate from index lesion), and spongiform lesions (separate from
index lesion). Acute lacunar infarcts were defined as round or ovoid
lesions of increased signal relative to white matter on DWI, FLAIR,
or T2-weighted imaging, or decreased attenuation relative to white
matter on CT, 3 to 20 mm in diameter, in the white matter, basal
ganglia, or brain stem. WMLs were rated on MRI (0 to 3 on Fazekas
scale11) or CT (0 to 2 on van Swieten scale12). Enlarged perivascular
spaces, defined as 2 mm round or linear CSF–isointense lesions
along the course of penetrating arteries, were rated on MRI in the
basal ganglia and centrum semiovale13 (0 to 4, where 0none,
110, 220, 320 to 40, and 440); atrophy was also rated
(0 to 3 on validated scale,14 where 0none and 3severe). Lacunes
were defined as round or ovoid lesions of CSF attenuation/signal
measuring 3 to 20 mm in the white matter, basal ganglia, or brain
stem; correlation with appropriate symptoms was not sought. Coding
was performed unblinded to clinical symptoms (to be certain of
correct identification of the index lesion) but blind to all other
clinical data.
At follow-up, a “definite” cavity was defined as a lesion of CSF,
or near-CSF, attenuation on CT, or of CSF signal on T2-weighted
imaging or FLAIR MRI, at the site of the index infarct (Figure 1). A
“possible” cavity was defined on FLAIR as a lesion of spongiform
appearance with areas of marked hypointensity showing early
confluence at the site of the index infarct. “Definite” (CT and MRI)
and “possible” cavitation (FLAIR only) were considered together as
“any evidence of cavitation.” In cases of uncertainty, images were
reviewed by a second experienced neuroradiologist (J.M.W.). La-
cunes developing elsewhere in the brain between baseline and
follow-up imaging were also recorded; correlation with appropriate
symptoms was not sought for these lesions.
Statistical Analysis
We calculated proportions with any evidence of, and definite, cavitation
(with 95% CIs) in the whole group, the “pure” subgroup and the
subgroup with an index infarct. We assessed statistical significance of
differences in baseline characteristics and imaging features in patients
with “definite” and any (“definite” plus “possible”) cavitation of the
index lacunar infarct in the whole group and “pure” subgroup. We used
the Student t test for continuous variables, the Mann–Whitney U test for
non-normally distributed continuous variables, and the 2 test for
dichotomous variables. We performed multivariate analysis using logis-
tic regression to determine independent predictors of cavitation, allow-
ing one variable per 5 outcome events. We obtained adjusted odds ratios
(ORs) and 95% CIs, comparing patients with “any” and “definite”
cavitation versus those without. For “any” cavitation, we used signifi-
cant variables from univariate analysis (hypertension, diabetes, time to
follow-up), and concomitant lacunes at baseline and deep atrophy,
considered more likely than other features to be associated with
cavitation; for “definite” cavitation, we included time to follow-up
(significant on univariate analysis), hypertension (significant in univar-
iate analysis for “any” cavitation), and deep atrophy. We dichotomized
scores for WMLs (Fazekas 0 to 1 versus 2 to 3; van Swieten 0 versus 1
to 2), brain tissue loss, and enlarged perivascular spaces (0 to 2 versus
3 to 4) attributable to low frequencies. We also examined the proportion
with any progression of cavitation of existing “spongiform” nonindex
lesions. All statistical analyses were performed using Minitab (Version
15; Minitab Inc).
Results
Ninety patients met our inclusion criteria. Mean age was
6712 years, 48 (53%) had a history of hypertension, 18
(20%) diabetes, and 12 (13%) a history of previous stroke. A
“pure” subgroup of 47 of 90 (52%) patients had a DWI-
positive acute lacunar infarct and follow-up MRI (Table 1); 6
had baseline MRI and follow-up CT; and 21 had baseline CT
with either CT or MRI follow-up.
Of the 74 of 90 (82%) patients with an acute index lacunar
infarct, 45 (60%) were in the centrum semiovale, 18 (24%) in the
internal capsule, 9 (12%) in the thalamus, and 3 (4%) in the brain
stem. Of the 16 of 90 MRI-negative patients, follow-up MRI
was normal in 15 and showed a noncavitating lesion in an
appropriate site for original symptoms in one (Table 1).
On follow-up imaging, 18 of 90 (20%; 95% CI, 12% to
28%) patients showed definite, and a further 7 possible,
cavitation, making a total of 25 of 90 (28%; 95% CI, 19% to
37%) with any evidence of cavitation. In the “pure” sub-
Figure 1. Examples of definite (A) and
possible (B) cavities in the centrum
semiovale on FLAIR MRI, both with con-
comitant WML. C, Cavity in the right
thalamus on CT.
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group, 7 of 47 (18%) had definite cavitation, and an addi-
tional 7 showed possible cavitation, making a total of 14 of 47
with any evidence of cavitation (30%; 95% CI, 17% to 43%).
In sensitivity analyses to exclude patients without a DWI-
positive lesion at baseline (ie, 74 patients with visible lacunar
infarction), definite cavitation was visible in 18 (24%; 95%
CI, 15% to 34%), and possible cavitation in an additional 7.
Therefore, 25 of 74 (34%; 95% CI, 23% to 45%) showed any
evidence of cavitation. In one case, an acute lacunar infarct on
baseline CT was not visible on follow-up MRI.
In the entire group of 90 patients, cavitation was associated
with increasing time to follow-up imaging in those with both
definite and any evidence of cavitation on univariate analysis
(P0.0003 and P0.03, respectively; Tables 2 and 3) and with
deep atrophy in patients with definite cavitation (P0.03).
Figure 2 shows the time from stroke onset to follow-up imaging
in patients with any evidence of, and definite, cavitation. In
patients with any evidence of cavitation, hypertension and
diabetes were negatively associated with cavitation (P0.01 and
0.02, respectively). In multivariate analysis, increasing time to
follow-up and deep atrophy remained significant for patients
with definite cavitation (OR, 1.81; 95% CI, 1.12% to 2.92% and
OR, 3.24; 95% CI, 1.02% to 10.27%). No other patient-related,
stroke-related, or imaging-related variables (age, NIHSS, and all






Cavitation of Infarct at
Follow-Up
Baseline Follow-Up Lesion n Yes No None Possible Definite
MRI MRI Yes 47* 47 0 33 7 7
MRI CT Yes 6 6 0 4 n/a 2
MRI MRI No 16 1 16 1 0 0
CT MRI n/a 10 9 1 6 0 3
CT CT n/a 11 11 0 5 n/a 6
*“Pure” subgroup.
Table 2. Clinical and Imaging Associations of Cavitation in Patients With Any Evidence of Cavitation (n90)
n Where
Not 90







Age in years (meanSD) 68.312.3 66.812 t test 0.59
Male (%) 16 (64) 38 (58) 2 0.81
NIHSS median score (range) 86 1 (0–11) 2 (0–9) Mann–Whitney 0.66
Vascular risk factors
Stroke (%) 1 (4) 11 (17) Fisher’s 0.17
Hypertension (%) 8 (32) 40 (62) 2 0.01
Diabetes (%) 1 (4) 17 (26) Fisher’s 0.02
Imaging parameters
Onset to assessment, median days (range) 16 (0–43) 9 (0–104) Mann–Whitney 0.56
Onset to baseline imaging, median days (range) 17 (0–43) 9 (0–104) Mann–Whitney 0.44
Onset to follow-up imaging, median days (range) 102 (39–1722) 74 (6–1440) Mann–Whitney 0.03
Lacunar size mm (meanSD) 74 9.93.2 9.74.2 t test 0.87
Other lacunes baseline 9 (36) 22 (34) 2 0.85
Deep* WML dichotomized 0:1 vs 2:3 80 7 (27) 24 (39) 2 0.85
Periventricular* WML dichotomized 0:1 vs 2:3 80 13 (68) 35 (57) 2 0.39
Anterior† WML dichotomized 0 vs 1:2 10 3 (50) 3 (75) Fisher’s 0.57
Posterior† WML dichotomized 0 vs 1:2 10 1 (17) 2 (50) Fisher’s 0.5
Deep atrophy dichotomized 0:1 vs 2:3 11 (44) 24 (37) 2 0.54
Superficial atrophy dichotomized 0:1 vs 2:3 5 (20) 11 (17) 2 0.74
Basal ganglia EPVS dichotomized 0:2 vs 3:4 80 3 (16) 18 (30) Fisher’s 0.37
Centrum semiovale EPVS dichotomized 0:2 vs 3:4 80 8 (42) 22 (36) 2 0.64
*Fazekas scale; †van Swieten scale.
EPVS indicates enlarged perivascular spaces.
Potter et al What Proportion of Lacunar Infarcts Cavitate? 269
 at UNIV OF EDINBURGH on June 1, 2010 stroke.ahajournals.orgDownloaded from 
other features of small vessel disease) were associated with any
evidence of, or definite, cavitation.
In the subgroup of 47 patients with a positive baseline
diffusion scan and follow-up MRI, definite cavitation was
associated on univariate analysis with increasing time to
follow-up (P0.009) and superficial atrophy (P0.03). In
those with any evidence of cavitation, hypertension was
negatively associated with cavitation (P0.009). No other
clinical or imaging features were associated with cavitation in
either the whole group or “pure” subgroup.
At baseline, 13 of 90 patients (14%) had subcortical
spongiform lesions separate from the index acute lacunar
infarct (single lesion in 10; 2 lesions in 3). Progression to a
definite cavity on follow-up occurred in 2 of these patients,
but in neither patient did the index lesion show any evidence
of cavitation. From the 11 spongiform lesions that did not
progress to a definite cavity, the index lacunar infarct showed
progression to a definite cavity in 2 patients.
At baseline, 31 of 90 (34%) patients had concomitant
lacunes. Of these 31, 18 (58%) had higher WML scores than
the 17 of 59 (29%) without concomitant lacunes at baseline
(2 P0.007); 4 of 31 (4%) patients developed new lacunes
between baseline and follow-up imaging (unrelated to the
index lesion) over an interval ranging from 76 to 185 days.
Discussion
The proportion of symptomatic lacunar infarcts that undergo
cavitation to lacunes is unknown. In this study, one fifth of
patients with acute lacunar ischemic stroke showed definite
cavitation on follow-up imaging at a median of 227 days (range
54 to 1722) after stroke onset. In a “pure” subgroup (DWI-
positive infarct with follow-up MRI), 15% of patients showed
definite cavitation. Definite cavitation was associated with in-
creasing time to follow-up in univariate and multivariate analy-
sis, but not with age, NIHSS, lesion size or location, or other
features of cerebral small vessel disease, including other lacunes.
Table 3. Clinical and Imaging Associations of Cavitation in Patients With Definite Cavitation (n90)








Age in years (meanSD) 69.611.1 66.612.3 t test 0.33
Male (%) 13 (72) 41 (57) 2 0.23
NIHSS median score (range) 86 2 (0–11) 1 (0–9) Mann–Whitney 0.61
Vascular risk factors
Stroke (%) 1 (6) 11 (15) Fisher’s 0.45
Hypertension (%) 6 (33) 42 (58) 2 0.056
Diabetes (%) 1 (6) 17 (24) Fisher’s 0.11
Imaging parameters
Onset to assessment, median days (range) 17 (0–43) 9 (0–104) Mann–Whitney 0.43
Onset to baseline imaging, median days (range) 18(0–43) 10 (0–104) Mann–Whitney 0.49
Onset to follow-up imaging, median days (range) 227 (54–1722) 72 (6–1440) Mann–Whitney 0.0003
Lacunar size mm (meanSD) 74 9.282.82 9.954.14 t test 0.44
Other lacunes at baseline 6 (33) 25 (35) 2 0.91
Deep* WML dichotomized 0:1 vs 2:3 80 4 (39) 27 (40) 0.76
Periventricular* WML dichotomized 0:1 vs 2:3 80 8 (67) 40 (59) Fisher’s 0.75
Anterior† WML dichotomized 0 vs 1:2 10 3 (50) 3 (75) Fisher’s 0.57
Posterior† WML dichotomized 0 vs 1:2 10 1 (17) 2 (50) Fisher’s 0.5
Deep atrophy dichotomized 0:1 vs 2:3 11 (61) 24 (33) 2 0.03
Superficial atrophy dichotomized 0:1 vs 2:3 5 (28) 11 (15) 2 0.24
Basal ganglia EPVS dichotomized 0:2 vs 3:4 80 3 (25) 3 (25) 18 (26) 1
Centrum semiovale EPVS dichotomized 0:2 vs 3:4 80 5 (42) 25 (37) 2 0.75
*Fazekas scale; †van Swieten scale.
EPVS indicates enlarged perivascular spaces.
Figure 2. Time to follow-up imaging in patients with and without
definite cavitation.
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The association with increasing time to follow-up remained
significant in the “pure” subgroup. If these proportions are
similar in other populations, up to four fifths of symptomatic
lacunar infarcts may resemble, and be misidentified as, WML at
any time up to 5 years after stroke, possibly longer.
Definite cavitation was associated with deep atrophy in
univariate and multivariate analysis and with superficial
atrophy in the “pure” subgroup. Our data indicate that age,
stroke severity, and other features of small vessel disease
(WML, concomitant lacunes, and enlarged perivascular
spaces) were not linked to cavitation. On the other hand,
hypertension was negatively associated with cavitation in
patients with any evidence of cavitation (in both the whole
group and “pure” subgroup) and diabetes in the whole group.
The main strengths of our study are that patients were
carefully characterized clinically to be certain of the clinical
diagnosis of lacunar stroke, all data were collected according
to prespecified criteria, and most patients had baseline MRI,
including diffusion. Thus, we can pinpoint precisely when the
index lesion started and follow its evolution with precision.
The 2 studies from which these data are derived were
performed prospectively in the same hospital, using the same
data collection, case ascertainment, diagnostic methods, phy-
sicians, radiologists, and imaging equipment. We tested
associations in the whole, as well as “pure” subgroup and
found that they were similar.
Potential limitations were inclusion of a small proportion
of patients without a lesion on MRI at baseline; some patients
with nonlacunar stroke may have been inadvertently in-
cluded, despite careful clinical characterization. This may
have meant we underestimated the proportion of patients with
cavitation. However, after excluding MRI-negative patients,
proportions with any evidence of and definite cavitation were
similar to the whole group, and to the “pure” subgroup, with
overall point estimates 15% to 33%.
Minimum time to follow-up imaging was relatively short,
but several patients without definite cavitation had follow-up
imaging at 4 years, and we identified patients with definite
cavitation at 54 days. Sample size was relatively small and
precluded more complex analyses, so we cannot exclude
weak associations between cavitation and imaging-, stroke-,
or patient-related features. We were unable to investigate the
influence of some factors (eg, duration of symptoms or
contrast enhancement) because this information was not
collected. Follow-up timing was not fixed, with variable
times to follow-up; in the study of lacunar stroke, follow-up
was at between one and 3 months, and all patients were
recalled for imaging (although not all attended), whereas in
the stroke registry, follow-up mostly occurred if the patient
developed new symptoms. These selection criteria in the
original studies may have influenced cavitation detection
rates. Larger studies with fixed follow-up time points are
required to obtain more precise data on cavitation.
No previous studies have examined cavitation rates in symp-
tomatic lacunar ischemic stroke, so there is little information
with which to draw comparisons. Longitudinal studies show that
WML and lacunes increase in number over time, with hyper-
tension (among others) being a risk factor for new lacunes, and
diabetes and hypertension being risk factors (among others) for
WML progression.15,16 We found that increased WML severity
was associated with concomitant lacunes on baseline imaging, in
agreement with previous studies.17,18 Gouw15 found that WML
progression was modestly correlated with number of new
lacunes at follow-up; we were unable to investigate for such a
correlation. The apparent coassociation of lacunes and WML
suggests that lacunes may represent the extreme end of a
spectrum of small vessel changes.
Factors associated with cavitation have been investigated
in multiple sclerosis; in longitudinal studies, a ring-enhancing
lesion pattern is associated with cavity development,19–22 but
predictive power is limited because of variability in cavity
development, with some evidence that cavitation is patient-
specific. Differences in multiple sclerosis lesion evolution in
the same patient have also been demonstrated, suggesting
local inflammatory reaction or location may be more relevant
than individual susceptibility in leading to permanent axonal
loss.23 Duration of symptoms may influence whether cavita-
tion occurs (we did not record this), although we found no
association with NIHSS, another marker of stroke severity. In
animals, duration of middle cerebral artery occlusion has
been shown to influence infarct cavitation.24
The molecular processes underlying cerebral tissue damage
and repair, through the stages of tissue infarction and “rarefac-
tion,” leading to gliosis and cavitation, are complex, and as yet
incompletely identified.25 Histologically, a phase of chronic
inflammation, including cavitation, was identified from 10 days
to 53 years in patients with cortical and lacunar infarction.26 In
our study, the earliest time at which a lesion demonstrated any
evidence of cavitation was 39 days, and 54 days for definite
cavitation. Matrix metalloproteinases are important factors for
tissue remodeling implicated in all main cerebrovascular dis-
eases including ischemia and WML in vascular dementia.27,28
Higher levels of matrix metalloproteinase-9 may be related to
neurological deterioration in the first 7 days after acute lacunar
infarction, but there is no information on whether high matrix
metalloproteinase levels are associated with cavitation.29
Thirteen patients in our study had spongiform lesions (possi-
ble cavities) separate from the index lesion at baseline; in 2
patients, these progressed to definite cavities, but the index
lesion showed no cavitation. Similarly, 2 patients with definite
cavitation of the index lesion showed no progression to cavita-
tion in nonindex spongiform lesions. Cavitation may therefore
occur on a “per lesion” rather than “per patient” basis.
What are the implications if only one of 5 acute symptom-
atic lacunar infarcts becomes a cavity and the other 4 continue
to resemble WML? In epidemiology (including risk factor)
and pathophysiology studies of lacunar infarction, which only
count lacunes as old lacunar infarcts, the true burden of
lacunar disease may be underestimated by as much as 5 times.
With the difficulties in distinguishing between WML and
noncavitated lacunar infarction, consideration should be
given to abandoning the term WML in favor of a term such
as small vessel changes, correlating acute lacunar infarcts,
WML, and lacunes with symptoms wherever possible. Our
findings should be confirmed in larger prospective studies of
acute lacunar stroke, with follow-up at prespecified time
intervals.
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Summary
Lacunes are often counted in epidemiological studies as old
lacunar infarcts, but we found definite cavitation of symp-
tomatic lacunar infarcts occurring in only one fifth of pa-
tients; most lacunar infarcts may continue to resemble WML.
The true burden of lacunar stroke disease on imaging may
thus be substantially underestimated in studies that only count
lacunes. We found that cavitation was associated with in-
creasing time to follow-up imaging and deep cerebral atro-
phy. Larger prospective studies, with prespecified follow-up
intervals, are required.
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Wide Variation in Definition, Detection, and Description of
Lacunar Lesions on Imaging
Gillian M. Potter, MBChB, BSc (Hons), MRCP, FRCR; Fergal J. Marlborough;
Joanna M. Wardlaw, MD, FRCR, FRCP, FMedSci
Background and Purpose—Variation in the definition of lacunar lesions on imaging and difficulties in their detection may
be hampering lacunar stroke research. We assessed literature definitions of imaging lacunar lesions and the definitions
and detection of lacunar lesions among small-vessel disease researchers.
Methods—We assessed definitions of imaging lacunar lesion in 50 randomly selected articles from 3 stroke-related
journals and an online survey of small-vessel disease researchers. In the literature review, we assessed clinical/imaging
definitions of lacunar stroke. In the survey, we assessed lacunar lesion detection, effects of lesion appearance,
background white matter lesions, and provision of relevant data.
Results—Among 50 articles, imaging definitions were varied and often limited; size was stated in 21 of 43 (49%) studies of
acute and in 9 of 20 (45%) studies of old lesions and site in 18 (42%) and 4 (20%), respectively. Clinical definitions also
varied, and images were read mostly by nonradiologists. Among 56 survey respondents, multiple descriptions were used for
recent and old, symptomatic and asymptomatic, lesions on imaging. Most agreed on definitions for site (98%) and “old
lacunar infarct” (61%) size. Cavitated (vs noncavitated) lesions were usually identified as lacunar lesions; with increasing white
matter lesions, however, noncavitated lesions were very unlikely to be identified, even with prior imaging available (7.8%).
Conclusions—Imaging definitions of lacunar lesions vary widely, in part due to variation in lesion detection and classification.
A consensus for imaging definitions of small-vessel disease features would be helpful. (Stroke. 2011;42:00-00.)
Key Words: acute stroke  acute stroke syndromes  acute cerebral infarction  brain infarction  lacunar infarcts
 cerebral lacunes  white matter disease  leukoaraiosis  diagnostic methods  other diagnostic testing
 computed tomography  magnetic resonance imaging
Lacunar stroke accounts for 25% of ischemic stroke.1The lacunar hypothesis implies that classic lacunar syn-
dromes are caused by small, deep brain infarcts, secondary to
occlusion of a single penetrating artery.2 However, no clinical
stroke syndrome is absolutely specific with respect to patho-
physiology. The clinical value of the lacunar hypothesis has
been questioned by some, because as many as 20% of lacunar
strokes may be caused by pathologies other than a small, deep
infarct, including hemorrhage and cortical infarction.3,4 Lacunar
infarcts are often defined in stroke registries by a combination of
clinical features (with or without inclusion of risk factors) and
imaging findings,5 and controversy exists as to whether emboli
are an important cause of lacunar infarction.6–8
On brain imaging, lacunar lesions form part of a spectrum
of features of cerebral small-vessel disease (SVD), which
often have overlapping appearances. Some symptomatic la-
cunar infarcts may never cavitate.9 Several radiologic terms
used for lacunar lesions (for example, “lacunar infarct,”
“lacunar stroke,” and “lacune”) appear to be used inter-
changeably,10 which may be contributing to the current
debate on the causes of lacunar stroke.6–8
A survey of 13 neuropathology laboratories showed wide
variation in the definitions of SVD features.11 Variations in
clinical, neuropathologic, and radiologic terminology and
definitions have complicated research in other related areas
such as vascular dementia.11–17 Ways of reducing heteroge-
neity by providing standardized classification systems for the
imaging assessment of other radiologic features of SVD
(white matter lesions [WMLs]18 and brain microbleeds19)
have been addressed but not the consistency of imaging
assessment in lacunar stroke.
In this study, we surveyed the literature to quantify the
range and variation of imaging definitions of lacunar lesions
and related methodology, including clinical definitions, and
used an online survey to assess how current SVD researchers
detect and describe lacunar lesions.
Methods
Literature Review
We searched PubMed for articles published between 1998 and 2008
in 3 journals with a focus on stroke (Stroke, Cerebrovascular
Diseases, and the Journal of Neurology) by using the terms “lacu-
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nar,” “lacune,” and “subcortical.” We tested the data collection form
on 10 articles before assessing another 50 articles describing lacunar
stroke studies in humans. Articles were selected at random by using
a random-number generator. Data were extracted by 2 observers
(G.M.P., F.J.M.), with data cross-checked by G.M.P., and the third
author arbitrated any disagreements. When there were 2 articles by
the same authors, we took care to avoid data duplication.
We collected data on corresponding author discipline and inclu-
sion of a radiologist in the authorship. We collected details about
terminology, definitions, lesion descriptors, imaging modality, tim-
ing of imaging, description of magnetic resonance imaging (MRI)
sequences, and clinical definitions, including the stroke classification
system used and whether imaging findings were incorporated into
the clinical definition. For old lacunar lesions only, we assessed
differentiation from enlarged perivascular spaces (EPVSs) and cor-
relation with prior relevant symptoms. We also collected data about
discipline, number, blinding, and experience of readers.
Literature Review Analysis
We assessed the proportion of articles providing clinical and imaging
definitions, imaging modality used, corresponding author discipline, and
the number with a radiologist in the authorship. We listed all terms used
to describe lacunar lesions on imaging and the proportion using each.
We determined proportions (1) describing lesion size, site, attenuation/
intensity, and clinical terminology; (2) providing details about the
timing of imaging; (3) attempting to correlate old lesions with symp-
toms; and (4) attempting to differentiate old lesions from EPVSs.
Online Survey
We established an online survey (SurveyMonkey) to send to re-
searchers with an interest in cerebral SVD. We asked questions about
participant discipline, previous publication on lacunar stroke, and
involvement of a radiologist in image interpretation.
To assess definitions, we asked participants to select a single answer
from a list of several options for site and size of lacunar lesions and
definition of EPVSs. To assess detection and description of lacunar
lesions, we used 10 case-based examples on brain computed tomogra-
phy (CT) and MRI. MRI sequences included axial T2, fluid-attenuated
inversion recovery (FLAIR), and diffusion-weighted imaging (DWI).
We provided a size marker/description of size in each case. We included
a “comments box” for all questions. We tested the effects of lesion
appearance, presence of concomitant WMLs, and provision of prior
imaging on lesion detection. We chose images that allowed us to test 1
or several of these features and included varying amounts of relevant
prior information. For case-based examples of old lacunar lesions, we
showed T2 and FLAIR sequences (while withholding the positive
baseline DWI), provided a history of baseline symptoms in the relevant
hemisphere, and indicated that no hemorrhage was visible on MRI
gradient-echo imaging. To assess the degree of certainty in lesion
detection, we asked participants to indicate whether they thought the
lesion was present: “yes, definitely”; “yes, probably”; “yes, possibly”; or
“no.” We identified SVD researchers from our literature review and
from prior knowledge among our stroke research group (for example,
previous collaboration). We tested the survey initially in our stroke
research group. A survey web link was sent to 147 SVD researchers. We
indicated that the survey would take 10 to 15 minutes to complete and that
responses were anonymous. We allowed 3 weeks for completion and sent
2 reminders, extending the deadline by a further 2 weeks each time. We also
encouraged sending of the survey link to other interested colleagues.
Survey Analysis
We assessed the number of participants completing each question, their
discipline, and previous publication on lacunar stroke (including in-
volvement of a radiologist). For definitions of lacunar lesions and EPVSs,
we assessed the number of participants selecting each of the definitions
provided. In the case-based examples, we assessed the effects of lesion
appearances, concomitant WMLs, provision of prior imaging on lacunar
lesion detection/description, and differentiation of lacunes from EPVSs.
Results
Literature Review
Article Type, Authorship, and Type of Lesion
From a total of 362 articles, we randomly selected 50 articles (22
from Stroke, 13 from the Journal of Neurology, and 15 from
Cerebrovascular Diseases), consisting of 47 original articles and
3 case reports. The corresponding author was usually a neurol-
ogist (34 of 50, 68%). The authorship included a radiologist in
13 (26%) articles: 8 of 13 (62%) were general radiologists and 5
(28%) were neuroradiologists (that is, a neuroradiologist con-
Table 1. Terms Used for Acute (n43) and Old (n20) Lacunar Lesions on Imaging in
the Literature
Acute Lacunar Lesions (n43) n (%) Old Lacunar Lesions (n20) n (%)
“Infarct”/“lesion” No reference to age
Lacunar infarct/lesion 22 (51.2) Lacunar infarct/lesion 8 (40)
Subcortical infarct/lesion 6 (14) Lacunar stroke 1 (5)
Subcortical MCA territory infarct 1 (2.3) Subcortical lesion 1 (5)
Deep subcortical infarct 1 (2.3) Deep infarct 1 (5)
Small, deep lesion 2 (4.7) Small infarct 1 (5)
Deep brain/focal infarct 2 (4.7) Reference to age
Hypodense lesion* 1 (2.3) Old lacunar infarct 1 (5)
Striatocapsular infarct 1 (2.3) Chronic subcortical infarct 1 (5)
Lesion 1 (2.3) Reference to symptoms
“Stroke” Silent lacunar infarct 4 (20)
Subcortical stroke 1 (2.3) Nonspecific/no reference to lesion
Deep ischemic stroke 1 (2.3) Lesion 1 (5)
Nonspecific/no reference to lesion No reference to lesion 1 (5)
Focal hyperintensity on DWI 1 (2.3)
No reference to lesion 1 (2.3)
MCA indicates middle cerebral artery; DWI, diffusion-weighted imaging.
*On CT and MRI.
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tributed to 10% of articles overall). Thirty (60%) studies con-
cerned acute lacunar lesions and 7 (14%), old lacunar lesions; 13
(26%) studies concerned both. Thus, a total of 43 articles were
relevant for definitions of acute lacunar lesions and 20, of old
lacunar lesions.
Radiologic Terminology and Definitions for
Lacunar Lesions
Thirteen different terms were used for acute and 10 for old
lacunar lesions (Table 1). “Lacunar infarct” and “lacunar
stroke” were used for both acute and old lesions. An imaging
definition was provided in 26 of 43 (60%) articles describing
acute and in 8 of 20 (40%) articles describing old lesions.
Among these, 13 articles concerned both acute and old
lesions, and most (6 of 13, 46%) failed to provide a definition
for either type of lesion: 4 (31%) provided a definition for
only 1 lesion type, 1 (8%) used the same definition for both,
and only 2 (15%) provided a separate definition for each.
Radiologic Descriptors for Lacunar Lesions: Site and Size
Lacunar lesion site was defined in 18 of 43 (42%) studies of
acute and in 4 of 20 (20%) studies of old lesions, with marked
variation in descriptions (Table 2). Size was provided in 21 of 43
(49%) and in 9 of 20 (45%) studies, respectively, with a greater
maximum size used for acute (25 mm) versus old (20 mm)
lesions (Table 2).
EPVSs and Their Differentiation From Lacunes
Of studies on old lacunar lesions, most (17 of 20, 85%)
articles did not distinguish EPVSs from old lacunar lesions. A
description of EPVSs was given in 7 of 50 (14%) articles on
acute lesions, with 7 different descriptions given.
Clinical Terminology, Definitions, and Descriptions
Thirty-eight (76%) articles specified the clinical terminology
used (Table 3). A clinical stroke classification system was used
in 8 of 50 (16%) articles (6 using a risk factor–based system,20
1 a risk factor–free system,1 and 1 a combination of systems). A
clinical stroke definition was provided in 25 of 50 (50%) articles,
with most (19 of 25, 76%) referring to a “classic lacunar
syndrome,” either with or without reference to associated imag-
ing findings (Table 3). From 20 articles concerning old lesions,
correlation with possible, relevant, previous stroke symptoms
was attempted in only 2 (10%) cases.
Imaging Modality and MRI Sequences
Among 43 studies concerning acute lesions, 22 (51%) used
MRI and 7 (16%) used CT. DWI was performed in 33%.
Most (31, 72%) did not provide any details on the timing of
imaging in relation to the onset of stroke symptoms. For old
Table 2. Descriptions of Site and Size for Acute (n43) and
Old (n20) Lacunar Lesions in the Literature
Acute lacunar lesions, site defined, n (%) 18 (42)
General description where site defined
Areas supplied by deep perforants 7 (38.9)
Subcortical MCA territory 1 (5.56)
Specific territories where site defined
Supratentorial white matter 1 (5.56)
IC, thalamus, BG, CR, pons, and CS 1 (5.56)
Lentiform nucleus 1 (5.56)
Thalamus, capsule, protuberance, and mesencephalon 1 (5.56)
Subcortical, ie, CR, IC, and BG 1 (5.56)
CR, BG, thalamus, and caudate nucleus 1 (5.56)
IC, CR, CS, CN, P, GP, thalamus, midbrain, pons, and medulla 1 (5.56)
Old lacunar lesions, site defined, n (%) 4 (20)
Territory supplied by deep/superficial small perforating arteries 1 (25)
Deep in the brain 1 (25)
Frontal, parieto-occipital, temporal, BG, and infratentorial
regions*
1 (25)
IC, thalamus, BG, CR, pons, and CS 1 (25)
Acute lacunar lesions, size defined, n (%) 21 (49)
Minimum size stated† 4 (9)
Maximum size stated‡ 19 (44)
Old lacunar lesions, size defined, n (%) 9 (45)
Minimum size stated† 6 (30)
Maximum size stated‡ 8 (40)
MCA indicates middle cerebral artery; IC, internal capsule; BG, basal ganglia;
CR, corona radiata; CS, centum semiovale; CN, caudate nucleus; P, putamen;
and GP, globus pallidus.
*As used for white matter hyperintensities.
†For acute lesions, range, 3–5 mm; old lesions, range, 10–20 mm.
‡For acute lesions, values of 2, 3, or 5 mm; old lesions, range, 10–20 mm.
Table 3. Terminology and Descriptions Used for Clinical
Lacunar Stroke (n38) and Clinical Definitions Used for
Lacunar Stroke (n25) in the Literature
Terminology and descriptions used for clinical
lacunar stroke (n38)
n (%)
Lacunar stroke/syndrome/infarction 28 (75.7)
Lacunar, large-vessel cervical, or intracranial
atherosclerosis
1 (2.7)
Ischemic stroke 2 (5.4)
Subcortical MCA territory infarction/lacunar syndrome 1 (2.7)
Subcortical stroke/lesion/infarction 3 (8.1)
Acute focal symptoms, eg, hemiparesis or acute aphasia,
diagnosed according to ICD-9
1 (2.7)
Pure sensory stroke 1 (2.7)
Cerebrovascular attack 1 (2.7)
Clinical definitions used for lacunar stroke (n25) in
the literature
Lacunar syndrome (with or without description of each of
the 5 classic syndromes)
14 (56)
Lacunar syndrome with reference to imaging findings 5 (20)
Symptoms specific to condition under investigation 1 (4)
Nonspecific
Acute focal deficit confirmed by an associated lesion
on CT or MRI
1 (4)
Focal neurologic symptoms 1 (4)
Minor focal cerebrovascular events 1 (4)
Ischemic stroke 1 (4)
Syndrome associated with lacunar infarction in the deep
white matter or brain stem
1 (4)
MCA indicates middle cerebral artery; ICD, International Classification of
Diseases.
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lesions, MRI was used in 15 of 20 (75%) articles, CT in 4
(20%), and both modalities in 1 (5%). MRI sequences used to
diagnose lacunar lesions were described in 11 (31%) studies
concerning acute and in 7 (44%) studies concerning old
lacunar lesions. Most articles did not provide a description of
lesion attenuation or signal intensity.
Discipline, Number, and Blinding of Image Readers
Among the 20 of 50 (40%) articles providing details on who
interpreted brain imaging, most (13 of 20, 65%) indicated that
imaging was interpreted by nonradiologists (including at least 1
neurologist in 12 articles and a neuropathologist in 1). Overall,
17 of 50 (34%) studies provided information on blinding of
readers, 6 of 50 (12%) indicated the level of reader experience,
and 23 of 50 (46%) reported the number of readers.
Online Survey of SVD Researchers
Of 147 researchers with an interest in cerebral SVD to whom
the online survey was sent, 56 responded to the survey: 46 of
56 (82%) completed all 10 case-based questions and 44 of 56
(79%) completed the entire survey. The majority of partici-
pants were neurologists (25 of 44, 57%). Other disciplines
were stroke physicians (12 of 44, 27%), neuroradiologists (6
of 44, 14%), and a geriatrician (1 of 44, 2%). Most respon-
dents (37 of 44, 84.1%) had published articles on SVD, most
with involvement of a radiologist (27 of 37, 73%).
Radiologic Definitions of Lacunar Lesions and EPVSs
For definitions of lacunar lesion site, most (43 of 44, 97.7%)
respondents selected “territory of deep perforating arteries–brain
stem, basal ganglia and white matter” (Table 4). Definitions
selected for size of acute and old lacunar lesions were more
varied: for “acute lacunar infarct,” 17 of 44 (38.6%) selected 3 to
20 mm, and 9 of 44 (20.5%) selected 3 to 25 mm (Table 4); for
“old lacunar infarct,” 27 (61.4%) selected 3 to 15 mm and 1
participant selected 3 to 25 mm. Numbers of participants
selecting each size category (3 to 15 mm, 3 to 20 mm, or 3 to
25 mm) were similar for both “old lacunar infarct” and “lacune.”
For the EPVSs definition, most (27 of 44, 61.4%) selected
“small, round, or linear lesions along the course of penetrating
arteries with intensity close to CSF” (Table 4). Definitions we
provided that did not include specific size criteria were selected
more often than those that did (32 of 44, 72.7%, vs 11 of 44,
25%, respectively). Heterogeneity in descriptions for site, size,
and presence of cavitation existed between each group of
clinicians, including neuroradiologists.
Old Lacunar Lesion Detection/Description: Effect of
Lesion Appearance, WMLs, and Prior Imaging
There was a strong tendency to identify cerebrospinal fluid–
containing cavities as lacunar infarcts. Thus, cavitated lesions
were identified as lacunar stroke lesions with certainty by 29
of 46 (63%) participants (Figure 1A). In the presence of
concomitant WMLs, cavitated lesions were much more likely
to be identified as lacunar stroke lesions than were noncavi-
tated lesions (29 of 46, 63%, vs 4 of 51, 7.8%, respectively;
Figure 1, A and B; 2 P0.001), even when baseline FLAIR
images were provided (Figure 1C). Indeed, when shown a CT
scan with a cavity of cerebrospinal fluid density in the
thalamus (without information on whether the original pres-
Table 4. Definitions of Lacunar Lesions and EPVSs (Single Answer Allowed, n44, Except Where Indicated) in the
Online Survey of Current SVD Researchers
“What do you consider the best definition of size for the following lacunar lesions?” 3–15 mm 3–20 mm 3–25 mm Unsure
Acute lacunar infarct, n (%) 13 (29.5) 17 (38.6) 9 (20.5) 4 (9.1)
Old lacunar infarct, n (%) 27 (61.4) 12 (27.3) 1 (2.3) 3 (6.8)
Lacune, n (%)* 24 (55.8) 9 (20.9) 1 (2.3) 7 (16.3)
“What do you consider the best definition regarding site of lacunar lesions?” n (%)
Territory of deep perforating arteries—brain stem, basal ganglia (caudate nucleus,
lentiform nucleus, internal capsule, thalamus),
and white matter (corona radiata, centrum semiovale)
43 (97.7)
Subcortical MCA territory 0 (0)
Clinically relevant areas 0 (0)
Deep white matter of brain and/or brain stem 1 (2.3)
Deep in the brain 0 (0)
“What do you consider the best definition of enlarged perivascular (Virchow-Robin)
spaces?”
n (%)
2 mm, round or linear lesions along the course of penetrating arteries with
intensity close to CSF
7 (15.9)
2 mm, round or linear lesions at point of entry of MCA lenticulostriate arteries
into basal ganglia, with intensity close to CSF
4 (9.1)
Small, round or linear lesions along the course of penetrating arteries, with
intensity close to CSF
27 (61.4)
Small, round or linear lesions at point of entry of MCA lenticulostriate arteries into
basal ganglia, with intensity close to CSF
5 (11.4)
Uncertain 1 (2.3)
MCA indicates middle cerebral artery; CSF, cerebrospinal fluid.
*n43.
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enting lesion was a hemorrhage or infarct), most respondents
selected “lacunar infarct” (25 of 56, 44.6%; Figure 2).
Noncavitated lesions were identified as lacunar stroke lesions
only when they were large and in the absence of other WMLs
(33 of 50, 66%, Figure 1D).
Radiologic Differentiation Between Lacunes
and EPVSs
Prominent EPVSs were frequently mistaken for lacunar
infarcts (for example, 21 of 47, 44.7%, selecting “5
lacunes” when shown the example in Figure 3).
Figure 1. Effect of cavitation and WMLs on level/certainty of detection of old lacunar stroke lesions.
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Radiologic Terminology: Effect of Lesion Site
Lacunar lesion descriptions varied depending on site, being
greatest for a lesion in the brain stem. From a list of multiple
terms provided, 20 of 56 (35.7%) opted to provide an
alternative description for the brainstem lesion, many of
which implied an underlying mechanism (Figure 4).
Discussion
In a sample of 50 articles from the lacunar stroke literature and
in an online survey of cerebral SVD researchers, there was
marked variation in imaging terminology and descriptions for
lacunar lesions. In the literature review, any type of imaging
definition was provided in 26 (60%) studies of acute and in 8
(40%) of old lacunar lesions, with the terms “lacunar infarct”
and “lacunar stroke” used for both acute and old, symptomatic
and asymptomatic, lesions. Few articles attempted to differenti-
ate old, cavitated lacunes from EPVSs or to seek relevant
previous symptoms. Clinical terminology also varied widely and
was provided in only 50% of studies. Most articles used a risk
factor–based clinical stroke classification system, and the mi-
nority indicated a definition for lacunar stroke that incorporated
both clinical and imaging information. For acute lesions, only a
third of those using MRI used DWI. Nonradiologists interpreted
images in most cases. Most studies did not describe lesion
attenuation/signal intensity or the diagnostic sequences used. In
the online survey, most agreed on definitions for lacunar lesion
site and EPVS, but there was less agreement for lacunar lesion
size. There was wide variation in lesion recognition and classi-
fication: cavitated lesions of any size were detected with the
highest degree of confidence but were described by multiple
terms, including “lacunar infarct” and “lacunar stroke” (without
information about a possible previous hemorrhage or relevant
symptoms). Detection of noncavitated lacunar infarcts in the
presence of WMLs was poor, and differentiation of lacunes from
EPVSs was poor.
The strengths of our study include assessment of multiple
aspects of definitions and terminology for both acute and old
lacunar lesions, both in the literature and among interested
experts. For the literature review, we selected articles at random
from 3 journals with a stroke focus, which are likely to be
reasonably representative of articles in the stroke literature. We
collected data on clinical and imaging-related data, thus enabling
a wider overall impression of potential problems in lacunar
stroke research. We designed a structured online survey to assess
multiple aspects of lacunar lesion description and detection. We
tested the survey among local stroke researchers to improve the
design and relevance before its distribution. Images were care-
fully chosen to allow us to test specific features that might
influence lacunar lesion detection and description. By specifi-
cally identifying researchers with an interest in cerebral SVD,
we gathered opinions that are likely to be most relevant to
lacunar stroke research.
There are limitations of our study. For the literature review,
we randomly selected 50 articles from a total of 362 articles
Figure 3. Differentiation of lacunes from EPVSs
(data shown for 47 respondents).
Figure 2. Effect of lesion appearance on lacunar
lesion description.
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in a PubMed search of 3 stroke-related journals; therefore,
our data represent a small sample of the lacunar stroke
literature. We had planned to sample a larger proportion, but
there seemed little point when the first 50 articles yielded so
much variation in imaging/clinical definitions of lacunar
lesions and related methodologies. Although we did not test
other journals, it is unlikely that articles in nonstroke-focused
journals would show any less variation. In the online survey,
only a third of those invited to participate took part, and a
minority were neuroradiologists; however, neurologists have
contributed the highest proportion of the lacunar stroke
literature. The reasons for nonparticipation and any differ-
ences between participants/nonparticipants are unknown, as
the responses were anonymous. Forty-four people completed
the entire survey, so our data represent only a fraction of
opinions; however, most were interested in SVD, therefore,
we believe that the responses were sufficient in both detail
and quality to document a lack of harmony in imaging
assessment of lacunar lesions, even among interested experts
who would be more likely to communicate frequently with
each other at meetings and through the literature. In most
cases, we allowed only a single answer, but participants were
able to add further comments by using a “comments box.”
As in a previous study of neuropathology laboratories,11 we
found marked variation in lacunar lesion definitions. In the
survey, we found marked variation for brainstem lesions and
a tendency to imply causation, rather than simply to describe
the imaging appearance. In both the literature and the online
survey, we found interchangeable use of terminology for
acute and old, symptomatic and asymptomatic, lacunar le-
sions, implying a similar etiology, even though etiology may
be heterogeneous.10 Identification of old lacunar lesions was
best for cavitated lesions, but because only a fifth of symp-
tomatic lacunar infarcts cavitate, cavitation is an unreliable
marker for prior lacunar infarction.9
Variation in imaging definitions and heterogeneity in the
reporting of other lacunar stroke-related features may be
contributing to ongoing controversies in lacunar stroke re-
search,6–8,21–25 for example, bias in clinical classification
systems20,26; misclassification of cortical as lacunar stroke,
based on clinical symptoms alone3,4; suboptimal detection of
acute lacunar infarcts; difficulties in differentiating old la-
cunes from EPVSs; and limited information on previous
neurologic symptoms.
Many SVD researchers do not have access to neuroradiol-
ogy expertise. It is important that radiologic assessment of
lacunar lesions is performed by those with at least some
experience, training, and interest in the field. A standardized
approach to imaging definitions of lacunar lesions is essential
to improve the understanding of lacunar stroke and SVD.
This may be best achieved by aiming for a consensus among
interested experts, both radiologists and clinicians, with
examples and perhaps a validated test set of images, which
could be used for training. The imaging definition of lacunar
lesions on brain imaging should include an accurate descrip-
tion of the size, shape, location, and appearance in terms of
CT attenuation or MRI signal intensity (on all appropriate
MRI sequences, but particularly T2, FLAIR, T2*, and DWI).
Recent or prior lacunar hemorrhage, which causes 5% of
true lacunar strokes,27,28 should be identified by T2* or
susceptibility-weighted sequences as a routine. Observers
should describe what they see, not what they think they see,
Figure 4. Effect of lacunar lesion site on descrip-
tions used.
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as any assumed etiology may be erroneous and further
complicate efforts to improve understanding of the true
underlying cause in cerebral SVD. The imaging definition
should be considered in conjunction with clinical information
about the acute stroke and any prior stroke or underlying
neurologic impairment.
In our center, we define a recent lacunar “infarct” (as distinct
from a hemorrhage) on MRI as a “round or ovoid lesion of
increased signal relative to white or deep gray matter on DWI,
FLAIR, or T2; hypointense on the apparent diffusion coefficient
map (or decreased attenuation relative to white/gray matter on
CT) measuring 20 mm in maximal diameter, in the cerebral
hemispheric white matter or basal ganglia or in the brain stem.”
In concurrence with some, but by no means all, SVD research-
ers, we consider 20 mm, rather than 15 mm, the upper limit for
acute lacunar infarcts. Lacunar lesions may or may not cavitate
with time to form “lacunes.”9 We use the term “lacune” to mean
cerebrospinal fluid signal/attenuation-containing cavities that are
round or ovoid lesions, measuring 3 to 20 mm in the cerebral
hemispheric white matter, basal ganglia, or brain stem. We try to
correlate both acute lacunar lesions and old lacunes/noncavitated
lacunar lesions with recent or previous stroke symptoms and
signs, respectively. Because many acute lacunar lesions will
decrease in size over time, we are cautious about calling cavities
1.5-cm diameter “lacunes” unless there is no other explana-
tion. We define clinical lacunar syndromes according to the
Oxfordshire Community Stroke Project Classification, a risk
factor–free definition based on neurologic symptoms and signs
only.1
Other research groups must have other definitions, as with
ours, possibly arising from particular circumstances of their
own practice, such as available technologies, interests, exper-
tise, and beliefs about likely causes of lacunar stroke. How-
ever it is achieved, a consensus in lacunar lesion definition,
with agreement on use of terminology and then more consis-
tent and accurate use of the terms, accurate lesion description,
correlation with relevant clinical symptoms/prior hemorrhage
wherever possible, an attempt to distinguish between old
lacunes and EPVSs, and avoidance of assumptions about
etiology, is urgently needed.
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Cerebral small-vessel disease







The term cerebral small-vessel disease (SVD) encom-
passes a range of features visible on brain imaging,
including lacunar infarction (from the Latin lacunae,
a tiny hole, pit, or cavity), leukoaraiosis (from the
Greek leuko, white, and araiosis, rarefaction), en-
larged perivascular spaces (producing an appearance
of état criblé, or cribriform state, from the Latin crib-
riform, perforated), and brain microbleeds. The in-
vestigative approach to cerebral SVD—including
lacunar stroke—has been revolutionized in the last 4
decades by the advent of CT and MRI, which have
overcome many of the limitations imposed by the
old pathology-centered approach,1 whereby low early
case-fatality rates necessitated most pathologic mate-
rial being examined long after clinical symptoms had
occurred. MRI in particular has markedly improved
our ability to detect cerebral SVD in vivo, enabling
detection of microangiopathic changes such as en-
larged perivascular spaces and microbleeds, although
there is marked variation in imaging terminology
and descriptions for lacunar lesions.2
Until recently, there has been relative neglect of
small-vessel lacunar stroke— once considered the
most benign ischemic stroke subtype—with atten-
tion having been mainly focused on large-artery cor-
tical ischemic stroke, a trend reflected in the advances
made in therapeutic options for stroke. The progno-
sis during the first few years for small-vessel stroke is
more favorable (in terms of survival and disability)
than large-vessel ischemic stroke; but in the long
term, there is a greater risk of death, stroke recur-
rence, cognitive dysfunction, and dementia than
previously realized,3 and a similar loss of quality-
adjusted life expectancy compared to large-artery
stroke. Similarly, leukoaraiosis, once considered a
neutral term, is now known to be a marker of poor
prognosis, particularly in terms of increased mortal-
ity and risk of dementia.4 The prognostic significance
of newer markers of cerebral SVD, namely enlarged
perivascular spaces and brain microbleeds, have yet
to be fully established.
In this issue of Neurology®, Melkas et al.5 show
that in a well-characterized ischemic stroke cohort
with ultra-long (12-year) follow-up, acute index
stroke attributable to cerebral SVD was associated
with poorer long-term survival and higher risk of car-
diac death than other stroke subtypes. Limitations
imposed by the authors’ use of a risk-factor–based
stroke classification system and selection bias from
inclusion of only hospitalized patients with SVD
may account for differences in findings compared to
another recent study comparing vascular outcomes
between ischemic stroke subtypes,6 and should be
considered in future confirmatory studies.
Despite its importance, data from clinically elo-
quent lacunar strokes offer a skewed view and proba-
bly minimize the true extent of the problem,
particularly in regards to the cognitive damage pro-
duced by these lesions in the elderly. Silent lacunar
strokes occur in as many as one-third of people over
the age of 65, and more than double the risk for
development of dementia, particularly when present
in the thalamus.7 The clinical manifestations of most
silent lacunes include problems of cognition, mood,
and behavior that may fall in a blind spot of clinical
neurologists.8 These small-vessel lesions affect partic-
ularly executive function, attention, and speed of
processing and probably sever central cholinergic
pathways.9 Despite a focus on the causes and associa-
tions of cerebral SVD in recent years, the exact
mechanisms underlying lacunar stroke, and cerebral
SVD, remain unclear, with proposed mechanisms in-
cluding lipohyalinosis, arteriosclerosis, poor cerebral
blood flow, vasospasm, and abnormal endothelial
function.10 Other potentially important factors not
usually considered include hyperhomocysteinemia,
low values of vitamin B12,11 and obstructive sleep
apnea.12 Acute treatment and secondary prevention
of ischemic stroke is therefore currently similar across
all stroke subtypes; current therapeutic options are
likely to remain limited until further progress is
made in understanding the pathophysiologic pro-
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cesses underlying cerebral SVD. The recent accelera-
tion in studies aiming to elucidate the true etiology
of cerebral SVD, including the utilization of newer
imaging techniques for detecting and following mi-
croangiopathic markers, is extremely promising and
highlights the increasingly urgent search for a poten-
tial therapeutic target for this disabling and life-
threatening disease.
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An awareness of the abnormalities that mimic microbleeds on gradient-recalled echo (GRE) 
magnetic resonance imaging (MRI) is essential to investigations of their prognostic and 
therapeutic significance, as well as future implementation of the results of these 
investigations in clinical practice. These ‘microbleed mimics’ have similar morphologies and 
signal properties to microbleeds on T1- & T2-weighted spin echo and GRE MRI sequences.(1) 
The keys to the identification of microbleed mimics are an awareness of their distinctive 
imaging hallmarks and the use of other investigations that might help distinguish them from 
microbleeds. 
Microbleed mimics either contain blood products, or they do not (instead resembling 
microbleeds because of shared signal intensity and morphology on GRE MRI). In this 
chapter, we describe both types of microbleed mimic, outline how these can be 
differentiated from true brain microbleeds, and suggest a topographical approach to the 
recognition of microbleed mimics on brain imaging. 
 
Search strategy 
In February 2010, we searched Ovid Medline with an electronic strategy used in a prior 
systematic review,(2) combined it with the textword ‘mimic’, and selected pertinent articles 
for this chapter. We also used our personal bibliographies and experience of identifying 




A. Microbleed mimics that do not contain blood products, but with MRI signal properties 
similar to microbleeds 
 
1. Partial volume artefact 
MR images consist of a matrix of picture elements, or pixels, reflecting the content of 
volume elements, or voxels. Voxel and pixel size influence spatial resolution and thus 
contrast. All anatomical structures within one voxel add to its averaged signal intensity in 
the final image. The smaller the voxel size, the better the spatial resolution of the MR image; 
however, the bigger the voxel size, the better the signal (and signal-to-noise ratio). In 
general, the signal-to-noise ratio is the determining factor for the final voxel/pixel size. 
Averaging of signal intensities of different structures within voxels – with loss of contrast 
between different tissues – is known as partial volume effect. In the brain, partial volume 
artefact occurring adjacent to the petrous temporal bones, paranasal sinuses, frontal bones, 
orbit,(3) and occipital bones (4) can lead to small hypointense areas on GRE and T2-
weighted imaging (T2WI) which mimic microbleeds (Figure 1). Awareness of the anatomical 
sites predisposed to partial volume artefacts, and review of adjacent slices in these areas, 





Figure 1. Microbleed mimics due to partial volume artefact on axial GRE MRI, occurring 




2. Paramagnetic substances 
GRE sequences used in the detection of microbleeds are sensitive not only to blood 
breakdown products (deoxyhaemoglobin, methaemoglobin, haemosiderin and ferritin), but 
also to other paramagnetic substances such as calcium, manganese and iron, all of which 
may appear as foci of low signal. Basal ganglia mineralisation is a frequent finding on brain 
imaging in older adults, and in some cases it is associated with disordered calcium 
metabolism, extrapyramidal syndromes, or neuropsychiatric disorders.(5) Where basal 
ganglia mineralisation is suspected, computerised tomography (CT) imaging of the brain 
may be helpful in identifying calcification (Figure 2), although correlation of suspected basal 
ganglia calcification on MRI with CT was mentioned in only 14 of 53 studies identified by a 
systematic review.(2)  
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Figure 2. Basal ganglia mineralisation mimicking microbleeds. Minor, symmetric basal 
ganglia mineralisation, with small, solitary foci of low signal on axial GRE magnetic 
resonance imaging (A, arrows). Asymmetric basal ganglia mineralisation on axial GRE MRI 
(B), demonstrating multiple hypointense foci on the left (arrow) and a solitary hypointense 
focus on the right (arrowhead). Axial CT brain in the same patient (C) confirms the presence 
of calcification in the left basal ganglia (arrow). 
 
3. Air embolism, iatrogenic devices, and metallic embolism 
There has been a single case report of cerebral air emboli causing multiple, bilateral, small 
round foci of hypointensity on  GRE imaging,(6)  and there are several descriptions of 
multifocal GRE hypointensities due to embolisation of metallic fragments from prosthetic 
heart valves.(7) Non-metallic ventricular shunt tubes in cross-section have been also been 
reported as potential mimics of microbleeds.(8) In such cases, correlation with the clinical 
history and review of all MRI sequences, as well as use of other types of imaging (such as 




4. Blood vessels 
On GRE imaging, foci of low signal representing vascular flow voids may be mistaken for 
microbleeds (especially when seen in cross section). Most often, these are flow voids in pial 
and leptomeningeal vessels in the cerebral sulci, but flow voids in small, deep perforator 
(lenticulostriate) vessels supplying the deeper structures of the brain may also be mistaken 
for microbleeds (Figure 3).(3;9) However, in contrast to true microbleeds, flow voids do not 
demonstrate susceptibility (‘blooming’) artefact on GRE sequences. Furthermore, flow 
voids, but not microbleeds, may be seen as linear structures on consecutive axial slices.  
Careful examination of lesion morphology on consecutive axial slices, and review of T2-
weighted imaging (on which vascular flow voids are more easily seen compared to GRE), 
should help to correctly distinguish small vessel branches from microbleeds situated close to 
blood vessels.  
 
Figure 3. Flow voids of leptomeningeal vessels imaged in cross section, appearing as 




B. Microbleed mimics containing blood products 
 
5. Diffuse axonal injury 
Diffuse axonal injury, a type of traumatic brain injury usually caused by rapid rotational 
acceleration and deceleration of the brain, leads to shearing of axons in susceptible areas 
such as the grey-white matter junction, splenium of the corpus callosum, internal capsule 
and dorsolateral brainstem.(10) Multiple, small hypointensities  on T2-weighted imaging, 
fluid-attenuated inversion recovery (FLAIR) and GRE MRI sequences may appear following 
diffuse axonal injury.(11)  These lesions may be differentiated from microbleeds on the basis 
of the clinical history as well as other associated imaging abnormalities (such as 
parenchymal contusions and skull fractures). 
 
6. Cavernous malformations 
Cavernous malformations are composed of clusters of thin-walled endothelial vessels, 
missing components of the blood-brain barrier, without intervening neural tissue.(12) On 
MRI, their hallmark is a hypointense rim of haemosiderin, within which there is a core of 
variable signal intensity.(13) On MRI, a mixed signal intensity core (representing 
haemorrhage in different stages of evolution) gives many cavernous malformations a 
distinctive ‘mulberry’ or ‘popcorn-like’ appearance (Figure 4), but this appearance is type II 
of four proposed sub-types of familial cavernous malformation: type I – subacute 
haemorrhage; type II – mixed subacute and chronic haemorrhage; type III – chronic 
haemorrhage; and type IV – punctuate hypointensity.(14) In general, types I–III can usually 
be distinguished from microbleeds by the presence of blood in various stages of evolution 
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and a haemosiderin rim on T1- and T2-weighted imaging, but type IV cavernous 
malformations, appaearing as punctuate hypointensities, exhibit similar signal 
characteristics to microbleeds on MRI. Some type IV lesions evolve into type I-III lesions over 
time.(15) However, to what extent type IV lesions are distinct from microbleeds is less clear, 
especially when they are solitary, or they are unaccompanied by type I-III cavernous 
malformations, a family history, or a relevant genetic mutation. 
  
Figure 4. Typical ‘popcorn-like’ appearance of a cavernous malformation on axial T2 (A) and axial 
GRE (B) brain MRI (arrows). 
 
 
7. Haemorrhagic metastases 
Diffuse haemorrhagic micrometastases, e.g. from renal cell carcinoma or melanoma, may 
lead to the appearance of multifocal microbleeds.(16) Differentiation of these metastases 
from microbleeds may be aided by clinical history and careful examination, as well as 
associated imaging findings such as perilesional oedema (particularly after recent 
 9 
haemorrhage) and typical signal characteristics of the lesions on other MRI sequences (e.g. 
T1 hyperintensity in melanomatous deposits (16)). 
 
8. Haemorrhagic transformation of a cerebral infarction 
In haemorrhagic transformation of recent infarcts, small (petechial) areas of haemorrhage 
may be seen within, or along the margin of, the infarct. In most cases, identification of this 
particular microbleed mimic should be possible from the clinical history and examination, 
and from associated imaging findings, particularly on diffusion-weighted imaging.(4) 
 
Suggested topographical approach to the interpretation of microbleed mimics 
The approach we have outlined to distinguishing microbleeds from mimics on the basis of 
the presence blood products may be further refined by considering the anatomical location 
of the abnormalities identified. In lobar regions of the brain (cortical grey matter, subcortical 
white matter, and grey-white matter junction), common microbleed mimics include vascular 
flow voids and hypointensities due to partial volume artefact. In deep regions of the brain 
(basal ganglia, thalamus, and internal and external capsule) mineralisation of the basal 
ganglia and flow voids from perforating vessels should be considered. Other mimics tend 
not to be so easily distinguished on anatomical grounds. We have recently devised an online 
guide to aid the rating and interpretation of microbleeds, which describes our approach to 
microbleed mimic interpretation, and also highlights difficulties which may be encountered 




Future influences on microbleed mimics 
The development of susceptibility-weighted imaging (SWI, Chapter 4) has increased the 
detection of structures containing extravascular blood products, as well as those containing 
venous deoxygenated blood.(17) SWI may improve the detection of small vascular 
malformations such as telangiectasia, developmental venous anomalies and dural 
arteriovenous fistulae when compared to standard MRI sequences. SWI may also help 
distinguish the diamagnetic and paramagnetic effects of calcium and blood respectively,(18) 
but whether the greater sensitivity of SWI diminishes or compounds the problem of 
microbleed mimics in comparison to GRE MRI remains to be determined. 
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